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ASSESSMENT OF AN OPTIMAL
PROGNOSTIC SYSTEM FOR
PREDICTING MORTALITY IN
PATIENTS AWAITING LIVER
TRANSPLANTATION: CTP VS MELD
Arunkumar Krishnan
Stanley Medical College, Chennai, India
Background: Decompensated cirrhosis is associated
with a poor prognosis and liver transplantation pro-
vides the only curative treatment option with excellent
long-term results. The model for end-stage liver disease
(MELD) score is now used for allocation in liver trans-
plantation (LT) waiting lists, replacing the Child-Tur-
cotte-Pugh (CTP) score. However, the optimal strategy
based on scoring systems and/or waiting time is still
under debate. Aim of the study to compare the CTP
scores and MELD score for 3, 6 months survival in cir-
rhotic patients waiting for liver transplant.
Methods: We investigated 216 consecutive patients
listed for single-organ liver transplantation for nonful-
minant liver disease between April 2010 and June 2011.
To assess the ability of MELD and CTP score predict-
ing the risk of death, the study was performed by range
by using c-statistic for area under the receiver operating
characteristic curve.
Results: 56 patients died during the observation period.
The mean CTP score at baseline, 3, 6 months was 7.4,
7.67 and 8.1 respectively for patients in the waiting list
7.63, 8.9 and 9.48 respectively for patients who died on
waiting. The mean MELD at 3, 6 months was 12.2,
13.37 and 16.99 respectively for patients in the waiting
list and 14.8, 19.25 and 21.57 respectively for patients
who died on waiting. The sensitivity and specificity to
identify mortality or severe deterioration for CTP was
83.9% and 89.5%, respectively; for MELD 88.6%,
91%, respectively. In stratified analysis, there were sig-
nificant (<0.001) differences between MELD and CTP
for the c-statistic in patients with low and intermediate
range MELD scores at 3 and no significant difference
in 6 months.
Conclusion: MELD has a better performance over the
CTP score in determination of priorities for organ allo-
cation. The outcome with lower range MELD cannot
be reliably predicted only with their MELD scores, and
alternative prognostic markers should be used in con-
junction to enhance the predictive accuracy. Because in
patients with a longer time on waiting list CTP may
serve as an additional factor for assessment of patient
prognosis. So, prognostic markers like ascites and hyp-
onatremia should be added with MELD to enhance the
predictive accuracy.
196
SERUM AMYLASE LEVELS
FOLLOWING ERCP IN DIAGNOSING
POST ERCP PANCREATITIS; IS IT A
SIGNIFICANT INDICATOR WITHOUT
ABDOMINAL PAIN?
Nadeesha Nawarathna
Department of Surgery, Faculty of Medicine, University
of Kelaniya, Kandy, Sri Lanka
Background: ERCP is an invasive pancreatico-biliary
investigation. Pancreatitis is a known complication fol-
lowing ERCP. In many units, amylase and lipase levels
are routinely done to diagnose post ERCP pancreatitis.
Aims: To describe the pattern of abdominal pain fol-
lowing ERCP. To assess the correlation between serum
amylase and abdominal pain following ERCP and to
describe the value of serum amylase in diagnosing post
ERCP pancreatitis.
Methods: Consecutive 94 patients who underwent
ERCP at the National Hospital Sri Lanka and North
Colombo Teaching Hospital over a period of 6 months
were included in this study. Pre and serial post proce-
dural pain scores and amylase levels at 4 and 24 h were
assessed. Abdominal pain was assessed using a pain
scale from 0 to 10. Data were analysed by Minitab
software.
Results: A significant worsening of abdominal pain
was taken as an increase in the pain score of 3 units
post procedure when compared to the pre procedure
value. Out of 80 patients 22 (27.5%) experienced a sig-
nificant worsening of pain at 4 h and 7 (9.21%) experi-
enced a significant worsening of pain at 24 h post
procedure. Out of 94 patients, 44 patients (46.8%) had
elevated amylase at 4 h post procedure. When signifi-
cant abdominal pain was cross tabulated against ele-
vated amylase, at 4 h post procedure, the Chi square
test failed to show a significant association (p = 0.311).
Conclusion: Patients who undergo ERCP may develop
abdominal pain which regresses spontaneously in the
majority at 24 h post procedure. Although many
patients have elevated amylase post procedure it does
not have an association with abdominal pain. There-
fore a routine measurement of amylase levels post pro-
cedure is of limited value.
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RISK FACTORS FOR LUNG
METASTASIS IN PATIENTS WITH
HEPATOCELLULAR CARCINOMA
AFTER SURGERY
Yong-Bo Yang1, Yu-Fang Chen1, Ning-Yang Jia1,
Dong Chen1, Xing-An Long1, Hong Meng2 and
Hong-Yan Cheng1
1Department of Radiology, Eastern Hepatobiliary
Surgery Hospital, Second Military Medical University,
225 Changhai Road, Shanghai 200438, China;
2Department of Health Statistics, Second Military
Medical University, 800 Xiangyin Road, Shanghai
200433, China
Background and Aims: Lung is the most common
extrahepatic metastasis organ that detected in HCC
patients, which contributes to a poor prognosis. So we
designed the research to investigate risk factors for lung
metastases.
Methods: A total of 284 patients with HCC that
adopted surgery and were detected lung metastasis in
our hospital were analyzed respectively. Calculate the
cumulative incidence of the different risk factors for
lung metastasis using the Kaplan–Meier method and
the Log-Rank test differences between groups. All 21
positional risk factors, including preoperative labora-
tory tests and imaging findings, and postoperative
pathology, entered into COX regression model for uni-
variate analysis and followed by multivariate analysis.
Results: Maximum diameter of tumor  10 cm, multi-
focal lesions and merging tumor thrombosis in preoper-
ative imaging findings, and incomplete or absent tumor
capsular, larger necrosis and merging satellite lesions in
postoperative pathology were significant high risk fac-
tors for lung metastasis in patients with HCC after sur-
gery by COX univariate and multivariate analysis. 193
patients adopted adjuvant TACE treatment after sur-
gery, and could significantly extend the time to lung
metastases for high-risk patients (p = 0.010). 219
patients had already recurred or just recurred in the
liver when detected lung metastasis, and the time to
lung metastasis in high-risk patients was significantly
longer than non-high-risk patients (p < 0.001). As to
non-high-risk patients with treatment after recurrence,
the time to lung metastasis was significantly longer
than those without recurrence when detecting lung
metastasis (p = 0.014). But there was no significant
impact on the high-risk patients.
Conclusions: Lung metastasis tended to occur signifi-
cantly earlier in patients with tumor maximum diame-
ter  10 cm, multifocal lesions and merging tumor
thrombosis in preoperative imaging findings, and
incomplete or absent tumor capsular, larger necrosis
and merging satellite lesions in postoperative pathol-
ogy. Adjuvant TACE for high-risk patients or compre-
hensive treatment after recurrence for non-high-risk
patients, could postpone the occurrence of lung metas-
tases.
228
CHANGES IN PORTAL VENOUS
SYSTEM IN IDIOPATHIC NON-
CIRRHOTIC PORTAL HYPERTENSION:
A PROSPECTIVE LONG TERM
FOLLOW-UP STUDY
Arunkumar Krishnan
Stanley Medical College, Chennai, India
Background/Aim: Cirrhosis is the most common cause
of portal hypertension but portal hypertension can also
be present in the absence of cirrhosis, a condition
referred to as non-cirrhotic portal hypertension (NCPH).
NCPH includes extra hepatic portal vein obstruction
(EHPVO) and non-cirrhotic portal fibrosis (NCPF). The
natural history of NCPH is not clear. Aim of the present
was to determine prospectively the changes in the portal
venous system in patients with NCPH.
Method: Patients with a diagnosis of NCPF and
EHPVO registered since 2004 were serially followed at
an yearly interval for changes in liver size, its echotex-
ture, and in the intra and extrahepatic portal venous
system. Baseline demographic details, LFT, and co-
morbid illness including virological profile were noted.
Patients with co-morbid illness and those with known
etiology of cirrhosis were excluded from the study.
Results: There were 54 patients with NCPF (M:F
1:1.8) and 40 patients with EHPVO (M:F ratio 1.6:1).
The mean age was 24.9 years and 41.2 years respec-
tively. During follow up, 40 out of 54 and 26 out of 40
patients with NCPF and EHPVO respectively had no
progression of disease. 24 patients with NCPF pro-
gressed to cirrhosis over a mean period of 5.21 years.
Eight patients developed ascites and required diuretics.
18 patients with EHPVO progressed to NCPF over the
mean period of 8.6 years, 14 patients further progressed
to cirrhosis over a mean period of 5.1 years. Overall
40% of patients with EHPVO progressed to cirrhosis
over a mean period of 13.7 years.
Conclusion: NCPH is a spectrum wherein EHPVO pro-
gresses to NCPF and further to cirrhosis over a period
of 13.7 years at least in a proportion of patients.
229
WHETHER TRANSARTERIAL
CHEMOEMBOLIZATION INCREASED
THE RISK OF LUNG METASTASIS OR
NOT IN PATIENTS WITH PRIMARY
LIVER CANCER
Yong-Bo Yang1, Yu-Fang Chen1, Ning-Yang Jia1,
Dong Chen1, Xing-An Long1, Hong Meng2 and
Hong-Yan Cheng1
1Department of Radiology, Eastern Hepatobiliary
Surgery Hospital, Second Military Medical University,
225 Changhai Road, Shanghai 200438, China;
2Department of Health Statistics, Second Military
Medical University, 800 Xiangyin Road, Shanghai
200433, China
Purpose: Many patients with primary liver cancer
(PLC) were often detected lung metastasis after transar-
terial chemoembolization (TACE) in the previous clini-
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cal work. So we designed this retrospective multivariate
analysis to investigate whether TACE increased the risk
of lung metastasis or not.
Materials and methods: A total of 368 patients with
PLC were detected lung metastasis in our hospital and
divided into four groups according to different forms
of treatment: Group 1. 128 patients with only conven-
tional TACE; group 2. 35 patients with only surgery;
group3. 45 patients with surgery and conventional
TACE; group4. 160 patients with surgery, adjuvant
TACE and conventional TACE. Time to progression
(TTP) was defined from final diagnosis of PLC to
detection of lung metastasis. Calculate the incidence of
lung metastasis by Kaplan–Meier method for each fac-
tor and compare the difference between groups of each
factor by Log-rank test. 14 potential factors entered
into COX regression model for univariate analysis and
followed by multivariate analysis.
Result: Maximum diameter of tumor  10 cm, multi-
focal lesions and merging tumor thrombosis were sig-
nificant high risk factors for lung metastasis in patients
with PLC by COX univariate and multivariate analysis.
The proportion of high-risk patients in group 1 was
significantly higher than that of other three groups
(p < 0.001), and lung metastasis also occurred signifi-
cantly earlier than that in groups with surgery combin-
ing with TACE (p 1 vs. 3 = 0.003, p 1 vs. 4 < 0.001).
Nevertheless, there was no significant difference
between groups with surgery (group 2–4) regardless of
either conventional TACE or adjuvant TACE.
Conclusion: Lung metastasis tended to occur signifi-
cantly earlier in patients with tumor maximum diame-
ter  10 cm, multifocal lesions and merging tumor
thrombosis. However, there was no significant differ-
ence between groups with different forms of treatment
and neither conventional TACE nor adjuvant TACE
could increase or decrease the risk of lung metastasis.
237
10-YEAR STUDY ON SURGICAL
MANAGEMENT OF RECURRENT
PYOGENIC CHOLANGITIS
Michael Co
Tung Wah Hospital, University of Hong Kong, Hong
Kong S.A.R., China
Background: Recurrent pyogenic cholangitis (RPC) is
prevalent in Southeast Asia. Owing to the relative rar-
ity of this disease, management of RPC differs from
centers to centers. Here we aim to review our 10-year
results of patients with RPC receiving surgical treat-
ment at our unit.
Methods: We carried out a retrospective review of 80
patients who had undergone surgical treatment for
RPC from January 2001 to December 2010 from a pro-
spectively maintained database. We analyzed and
reviewed the immediate and long-term surgical out-
comes of these patients. Multivariate analysis was used
to analyse the independent risk factors for residual or
recurrent stones formation. P-value of less than 0.05
will be considered statistically significant.
Results: All patients received hepaticocutaneousjejunos-
tomy (HCJ) for biliary drainage and stone removal.
Additional hepatectomies were performed in 38 patients
with intrahepatic ductal stricture or liver segmental
atrophy. 23 patients (28.8%) had residual stones while
25 patients (31.3%) had recurrent stones. All patients
with residual stones received repeated choledoschoscopy
(Mean = 3.3 sessions) for stone removal. Ductal clear-
ances were confirmed in all these patients subsequently.
4 patients (5%) developed cholangiocarcinoma during
follow-up, 2 patients died of the malignancy. Complica-
tion rate was 17.5%, most of them (64%) were wound
infections; there was no surgical-related mortality. We
found that gender, extent of disease (unilobar vs. bilo-
bar disease) and type of operation (HCJ alone vs.
HCJ + hepatectomy) were all not associated with
increased risk of residual or recurrent stone. Raised pre-
operative bilirubin level is the only identifiable indepen-
dent risk factor associated with increased risk for recur-
rent stone (p < 0.01) but not residual stone.
Conclusion: RPC is a unique disease entity which
require high-level of expertise. We recommend hepati-
cojejunstomy as primary drainage procedure, while hep-
atectomy should be reserved for complicated disease.
244
DEVELOPMENT OF A
QUESTIONNAIRE (EORTC MODULE)
TO MEASURE QUALITY OF LIFE OF
MALIGNANT OBSTRUCTIVE
JAUNDICE PATIENTS IN CHINA, THE
EORTC QLQ-MOJ11
Zou Zhi Hui
Eastern Hepatobiliary Surgery Hospital, 225 Changhai
Road, Yangpu District, Shanghai, China
Quality of life (QOL) is an important prognostic indi-
cator in clinical trials in oncology patients. The QOL
of malignant obstructive jaundice (MOJ) patients is rel-
atively poor and the prognosis is rather grim. MOJ
patients have similar symptoms and prognostic compli-
cations. It is necessary to develop a specific module to
evaluate the QOL of this kind of patients. The aim of
this study is to describe the development of the disease-
specific QOL questionnaire for MOJ patients in China.
The questionnaire was designed according to the Euro-
pean Organization for Research and Treatment of Can-
cer (EORTC) QOL group guidelines. Thirty-three QOL
issues were identified from literature search and inter-
view with patients (n = 15). Semi-structured interviews
with health-care professionals (n = 15) reduced the
issues to 23 items forming a provisional questionnaire.
The disease-specific QOL questionnaire was tested in
85 patients from the Eastern Hepatobiliary Surgery
Hospital in Shanghai, China. Descriptive statistics, Var-
iability method, Correlation coefficient method, Step-
wise regression and Factor Analysis were used to
reduce the module to 11 items conceptualized as con-
taining three scales and two single items. This module
accompanies with QLQ-C30 were used in 145 MOJ
patients in the same hospital to test its reliability and
validity. This article recommends the EORTC QLQ-
MOJ11 and QLQ-C30 to measure QOL in clinical trials
in MOJ patients and the module can reflect the QOL
status of MOJ patients in China.
© 2013 The Authors
HPB 2013, 15 (Suppl. 2), 15–82 HPB © 2013 Americas Hepato-Pancreato-Biliary Association
CONCURRENT SESSIONS ORALS 17
245
QUANTIFICATION OF HBV CCCDNA IN
PATIENTS WITH HEPATOCELLULAR
CARCINOMA
Hui Wang
Department of Laboratory Medicine, Eastern
Hepatobiliary Surgery Hospital Second Military
Medical University, Shanghai 200438, P.R. China
Hepatocellular carcinoma (HCC) is the fifth most com-
mon cancer and the third leading cause of cancer-
related death in the world. Chronic hepatitis B virus
(HBV) infection, chronic hepatitis C virus (HCV) infec-
tion, prolonged dietary aflatoxin exposure, alcoholic
cirrhosis, hereditary factor, and smoking are mainly
causes of HCC development. In China, the HBV infec-
tion is the major risk factor for HCC, and approxi-
mately 90% of HCC patients are HBV long-term
carriers. HBV covalently closed circular DNA (HBV
cccDNA), which is one important intermediate in the
life cycle of HBV, accumulates in cell nuclei and acts as
a template for the transcription of viral genes. The
transcriptional state of cccDNA molecules and the pro-
duction of pregenomic RNA (pgRNA) indicate the
degree of viral replicative activity. The aim of this
study was to evaluate the content of HBV cccDNA in
paired tumor and adjacent non-tumor tissues in HCC
patients. Paired tumor and adjacent non-tumor liver
tissues, as well as matched serum samples from 113
HCC patients were collected. Serum HBV DNA、int-
rahepatic total HBV DNA, cccDNA, and HBV geno-
type were measured using real-time quantitative PCR
(Shanghai Fosun Med-Tech Development Co., Ltd).
Serum HBsAg levels were quantitatively determined
using the HBsAg QT assay (Roche). In adjacent non-
tumor liver tissues, total HBV DNA and cccDNA lev-
els had significantly strong correlations with serum
HBV DNA levels (r = 0.670, p < 0.001, and r = 0.562,
p < 0.001, respectively), HBeAg-positive patients had
significantly higher median total HBV DNA and
cccDNA levels than HBeAg negative patients
(p < 0.001, p < 0.01, respectively). However, in tumors,
serum HBV levels had weak correlations with total
HBV DNA and cccDNA levels (r = 0.358, p < 0.001,
and r = 0.241, p = 0.016, respectively), and total HBV
levels was significant higher in HBeAg-positive patients
than that in HBeAg-negative patients (p < 0.05). Serum
HBsAg levels or HBV genotypes showed no correla-
tions with HBV DNA or cccDNA levels in both tumor
and adjacent non-tumor liver tissues. Kaplan–Meier
survival curves revealed that patients with higher
cccDNA levels and HBV DNA levels in tumor tissues
had significantly shorter diseases-free survival time than
that with lower cccDNA and total HBVDNA levels
(log-rank p = 0.017, and log-rank p = 0.043, respec-
tively).
Conclusion: Serum HBV DNA levels can reveal the
intrahepatic HBV cccDNA and total HBV DNA lev-
els in adjacent non-tumor livers. High levels of total
HBV DNA and HBV cccDNA in liver tumors may
serve as significant independent predictors for HCC
recurrence.
257
WHO HAS BETTER PROGNOSIS IN
THE PATIENTS WITH RESECTED
MULTIPLE HCC
Seung Duk Lee
National Cancer Center, Goyang-si, Republic of Korea
Background: The role of hepatic resection in patients
with multiple hepatocellular carcinoma (HCC) is still a
matter of debate. However, surgical resection is possi-
ble with various types of hepatectomies.
Methods: Consecutive patients who underwent curative
hepatic resection for multiple hepatocellular carcinoma
at the National Cancer Center, Republic of Korea from
April 2001 to December 2008 were enrolled in this ret-
rospective study. Clinicopathologic factors, cancer-spe-
cific survival, and disease-free survival were analyzed.
Prognostic factors were also analyzed including AFP,
radiologic, and pathologic data.
Results: The 140 patients in this study had a median
follow-up of 33.0 months. Five-year overall and dis-
ease-free survival rate were 50.6% and 22.7%, respec-
tively. In univariate analysis of overall and disease-free
survivals, preoperative AFP level >400 ng/mL, radio-
logic beyond Milan criteria, pathologic tumor number
>3, total tumor size >10 cm, microvascular invasion,
major vessel invasion, serosal invasion, and intrahepatic
metastasis were poor prognostic factors. In multivariate
analysis, pathologic tumor number >3 and microvascu-
lar invasion were independent risk factors for overall
survival (HR: 1.783, 95% CI 1.022–3.109, p = 0.042 of
tumor number >3; HR: 2.195, 9%CI 1.119–4.307,
p = 0.022 of microvascular invasion). For disease-free
survival, preoperative AFP level >400 ng/mL and
microvascular invasion were independent risk factors
(HR: 1.772, 95% CI 1.115–2.816; p = 0.015 of AFP
level >400 ng/mL; HR: 2.030, 95% CI 1.187–3.470,
p = 0.010 of microvascular invasion).
Conclusions: Preoperative AFP level, tumor number,
and microvascular invasion were independent risk fac-
tors in patients of resected multiple HCC.
258
RITUXIMAB, PLASMA EXCHANGE,
BASILIXIMAB, AND IVIG WITHOUT
GRAFT LOCAL INFUSION AND
SPLENECTOMY: A NEW SIMPLIFIED
PROTOCOL IN ABO INCOMPATIBLE
LIVING DONOR LIVER
TRANSPLANTATION
Seung Duk Lee
National Cancer Center, Goyangsi, Republic of Korea
Background: Although graft local infusion treatment
and splenectomy have been established as a pivotal
strategy in ABO incompatible (ABOi) living donor liver
transplantation (LDLT), these procedures have been
associated with a high rate of intraoperative and post-
operative complications.
Methods: From January to August 2012, seven patients
of ABOi LDLT were performed in National Cancer
Center, Republic of Korea. Our protocol for ABOi
© 2013 The Authors
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LDLT has been implemented using rituximab (300 mg/
m2) at preoperative 2 weeks, followed by plasma
exchange (target before transplantation: isoagglutinin
titer  1:8), basiliximab (20 mg, operation day and
postoperative 4 day), and intravenous immune globulin
(0.8 g/day, postoperative 1 and 4 day) without graft
local infusion and splenectomy.
Results: Of seven patients, two for liver cirrhosis and
five for hepatocellular carcinoma underwent transplan-
tation and there were five males/two females. Mean
age, MELD score, and graft-to-recipient weight ratio
of these patients were 49, 11.3, and 0.83, respectively.
Initial number of isoagglutinin titer showed 1:8 for 2
patients, 1:32 for 3 patients, 1:128 for 1 patient, 1:256
for 1 patient. There was no rebounding elevation of the
isoagglutinin titers after transplantation. Furthermore,
there was no graft failure, antibody-mediated rejection
and acute cellular rejection in these patients. Mean
duration of hospital stay was 13 days. There was one
patient with postoperative bleeding and one patient
with extrahepatic biliary stricture treated with percuta-
neous transhepatic biliary drainage.
Conclusions: The new simplified ABOi LDLT protocol
using rituximab, plasma exchange, basiliximab, and
IVIG without graft local infusion and splenectomy
showed good graft outcomes without immunological
failure. This protocol seems to be safe and effective
modality for ABOi LDLT.
259
18F-FDG-PET/CT PREDICTS EARLY
TUMOR RECURRENCE IN LIVING
DONOR LIVER TRANSPLANTATION
FOR HEPATOCELLULAR CARCINOMA
Seung Duk Lee
National Cancer Center, Goyangsi, Republic of Korea
Purpose: There has been little information about the
prognosis including 18F-fluorodeoxyglucose positron
emission tomography/computed tomography (18F-
FDG PET/CT) for the early recurrence for HCC after
liver transplantation.
Methods: Consecutive patients who underwent 18F-
FDG PET/CT and subsequent living donor liver trans-
plantation for HCC at the National Cancer Center,
Republic of Korea, from March 2005 to June 2011
were enrolled in this retrospective study. Clinicopatho-
logic factors and survivals were analyzed with respect
to the recurrence time after surgery.
Results: The 191 patients with a median follow-up of
26.1 months were evaluated. There were 20 patients
(10.5%) with early recurrence ( 6 months), 18
patients (9.4%) with late recurrence (>6 months), and
153 patients (80.1%) with no recurrence. The median
overall survival of patients with early recurrence was
very poor (19.0 months), with no survivors beyond
3 years. Fifty five patients (28.8%) displayed increased
PET/CT tumor uptake. Three year overall and disease-
free survival for PET/CT positive patients were 65.5%
and 57.1%, respectively, while PET/CT negative
patients showed respective values of 89.8% and 86.8%
(p = 0.001 vs. p < 0.001). Tumor variables associated
with PET/CT-positive finding were preoperative AFP
level, Milan, UCSF criteria, maximum tumor size, total
tumor size, differentiation, vascular invasion, and sero-
sal invasion. PET/CT positive status was identified as
an independent prognostic factor for disease-free sur-
vival influencing early recurrence in multivariable anal-
ysis (HR 3.945, 95% CI 1.196–13.016, p = 0.024).
Conclusions: 18F-FDG PET/CT is an independent and
significant predictor of early tumor recurrence in living
donor liver transplantation for HCC.
265
DIFFERENT PATTERNS OF CHANGES
IN AFP AND AFP-L3 AFTER
HEPATECTOMY FOR HCC AND ITS
PROGNOSTIC SIGNIFICANCE
Feng Zhang
The Four Department of Hepatic Surgery, Eastern
Hepatobiliary Surgery Hospital, Shanghai, China
Background: To identify patterns of changes in serum
AFP and AFP-L3 after surgical resection of hepatocel-
lular carcinoma (HCC), analyze correlations of these
patterns with postoperative HCC recurrence and
patient survival, and evaluate the value of such changes
on postoperative therapeutic efficacy and prognoses.
Methods: From August 2003 to December 2004, 318
patients with positive serum AFP who received surgical
resection were enrolled in the study. Pre- and postoper-
ative serum AFP and AFP-L3 levels were measured
simultaneously and continuously, and patterns of their
postoperative changes during long-term follow-up peri-
ods were observed and summarized.
Results: A high ratio of AFP-L3 to total AFP was
shown to correlate with pathologic features of aggres-
siveness. The overall 1-, 3- and 5-year recurrence rates
of the whole series were 28%, 57% and 84%, and the
overall 1-, 3- and 5-year survival rates were 86%, 61%
and 33%, respectively. There were three type patterns
of changes in serum AFP and AFP-L3 after hepatec-
tomy for HCC, which were classified into three groups
(group A had AFP-L3 disappear; group B had AFP-L3
<10%; and group C had AFP-L3>10%). Patients with
positive postoperative AFP-L3 had significantly earlier
recurrence when compared with those with negative
results. The overall survivals were significantly shorter
in the positive than the negative postoperative AFP-L3
group.
Conclusions: Postoperative changes in serum AFP and
AFP-L3 levels occurred in five distinct patterns, which
were closely correlated with HCC recurrence and
patient survival, and had different prognostic values.
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THE RECURRENCE PATTERN AND
OUTCOMES AFTER RESECTION OF
INTRAHEPATIC
CHOLANGIOCARCINOMA
Sung Pil Yun1 and Sang Jae Park2
1Department of Surgery, Postgraduate School of
Medicine, Pusan National University, 305 Gudeok-Ro,
Seo-Gu, Busan 602-739, Korea; 2Center for Liver
Cancer, National Cancer Center, 323 Ilsan-ro,
Ilsandong-gu, Goyang-si, Gyeonggi-do, Republic of
Korea
Background and aims: Recurrence is common after sur-
gery for intrahepatic cholangiocarcinoma (46.3–83.3%).
After recurrence of intrahepatic cholangiocarcinoma
following resection, the prognosis is known to be dis-
mal.
Methods: Between April 2001 and August 2010, 99
patients underwent hepatic resection for intrahepatic
cholangiocarcinoma. We analyzed the recurrence pat-
tern and its outcomes after resection of intrahepatic
cholangiocarcinoma, retrospectively.
Results: The overall survival rates of the 99 patients at
1, 3, and 5 year were 72.7%, 53.6%, and 35.9%,
respectively. Recurrences developed in the 70 of 99
patients. There were 49 men and 21 women, with a
median age of 61 years. The median time from resec-
tion to recurrence was 7 months (range, 0–48 month).
According to the first recurrence sites, 27 patients had
intra-hepatic recurrence only (IH) and 43, with extra-
hepatic recurrence (EH). In the 27 patients of the IH
group, the median time to recurrence was 8 months
(range, 1–48 month). The median time from recurrence
to death was 27 months (range, 0–99 months) and the
1-, 3- and 5-year survival rates since recurrence were
72.9%, 37.4%, and 32.8%, respectively. Among the 27
patients, 22 patients underwent surgical resection (4),
TACE (9), TACE+RFA (2), TACE+CTx (1), RFA (1),
CTx (4) and LDLT (1) for the recurred disease. After
those treatments for the 22 patients, additional extra-
hepatic recurrences developed in 5 patients, while 5
patients have been disease-free for 8–78 months since
they underwent TACE (4) or RFA (1) for the recurred
disease. In the 43 patients of the EH group, the median
to recurrence 6 months (range, 0–34 month). The sites
of recurrences included lymph nodes, peritoneum, lung
and bone. 21 of 43 patients had both intra- and extra-
hepatic recurrences. Twenty-five patients underwent
conservative therapy including CTx. (16), RTx. (6),
TACE (4), RFA (2) and surgical resection (3). In the
EH group, the median time from recurrence to death
was 5 months (range, 0–66 months) and the 1-, 3- and
5-year survival rates since recurrence were 30.1%, 6%,
and 0%, respectively.
Conclusions: As compared with the EH group, the IH
group had better overall survival rates after recur-
rences. In some patients of the IH group, aggressive
local treatments gave chances for another disease-free
status.
268
PERCUTANEOUS RADIOFREQUENCY
ABLATION VERSUS PARTIAL
HEPATECTOMY FOR SMALL
CENTRALLY LOCATED
HEPATOCELLULAR CARCINOMA
Wei-Xing Guo
Eastern Hepatobiliary Surgery Hospital, Shanghai,
China
Aims: To compare the results of percutaneous radiofre-
quency ablation (RFA) with partial hepatectomy (PH)
in the treatment of small centrally located hepatocellu-
lar carcinoma (HCC).
Background: With advances in RFA, it is not known
whether the minimal invasive approach with percutane-
ous RFA could attain comparable survival outcomes
but with a lower morbidity in patients with small cen-
trally located HCC.
Methods: From January 2002 and December 2007, 196
patients who had small centrally located HCC with the
largest tumor  5 cm in diameter, and without major
vascular invasion or extrahepatic metastases, and were
treated with either PH (n = 102) or RFA (n = 94) were
studied.
Results: There was no procedure related mortality in
both groups of patients. Major complications happened
significantly more often after PH than RFA (19.6% vs.
8.5%). The hospital stay was significantly longer after
PH than RFA (median, 13 vs. 4). The 1-, 3-, and 5-
year overall survival rates for the PH and RFA groups
were 89.2%, 74.1% and 63.1% and 94.3%, 74.7% and
49.8%, respectively (p = 0.96). The 1-, 3-, and 5-year
disease free survival rates for the two groups were
59.8%, 42.4%, 40.8% and 57.9%, 36.4%, 34.0%,
respectively (p = 0.50). The PH Group had similar
overall survival and disease-free survival comparing to
the RFA Group.
Conclusion: PH is equal to RFA in the treatment of
choice for small centrally located HCC. However, RFA
had the benefits of lower procedure-related morbidity
and shorter hospital stay.
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MICROWAVE ABLATION FOR
HEPATIC MALIGNANCIES: A MULTI-
INSTITUTIONAL ANALYSIS
Ryan Groeschl
Medical College of Wisconsin, Milwaukee, WI, USA
Background: Although many hepatobiliary centers
have moved from radiofrequency ablation to micro-
wave ablation (MWA), the factors that influence local
control with MWA are not well described. We hypoth-
esized that tumor size, number of tumors, and tumor
histology significantly affected MWA success and
recurrence-free survival (RFS).
Methods: Consecutive patients with hepatic malignancy
treated by MWA were included from four high-volume
institutions (2003–2011), and grouped by histology:
hepatocellular carcinoma (HCC), colorectal metastases
(CM), neuroendocrine metastases (NM), and other can-
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cers. Fisher’s exact and Kruskal–Wallis tests compared
group characteristics. Independent significance of out-
come variables was established with logistic regression
and Cox proportional hazards models.
Results: Four-hundred seventy three ablation proce-
dures were performed (139 HCC, 198 CM, 61 NM,
and 75 other) for a total of 875 tumors. Patient and
tumor characteristics are shown in Table 1. Median fol-
low-up was 18 months. Concurrent hepatectomy was
performed in 178 patients (38%). Thirty-day morbidity
and mortality rates were 18.4% and 0.8%, respectively.
Complete ablation was confirmed for 839 of 865
tumors (97.0%) on follow-up cross-sectional imaging.
NM had greater odds of an incomplete ablation com-
pared to other histologies (odds ratio: 3.07, 95% confi-
dence interval [CI]: 1.08–8.67, p = 0.035), however this
was not significant in adjusted models. The local recur-
rence rate was 6.1% overall, and was highest for HCC
tumors (10.3%, p = 0.051). RFS did not vary signifi-
cantly between histologies. In multivariable models,
tumor size  3 cm was the only variable predicting
poorer RFS (hazard ratio: 1.60, 95% CI: 1.02–2.50,
p = 0.039). Independent predictors of poorer OS
included age, number of tumors ablated, and tumor
size  3 cm.
Conclusions: In this large dataset, patients with  3 cm
tumors showed a propensity for early recurrence,
regardless of histology. Higher rates of local recurrence
were noted in HCC patients, which may reflect underly-
ing liver disease. Accounting for recurrence at any site,
however, there were no significant differences in RFS
between tumor histologies.
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LIVER GAS JET DISSECTION
EXPERIMENTAL RESEARCH
Denys Skoryi
Institute of General and Urgent Surgery of AMS of
Ukraine, Kharkiv, Ukraine
Background: There exists a great variety of liver paren-
chyma dissection techniques. Each of them has its
advantages and disadvantages. The objective of this
research lies in developing a new method of liver paren-
chyma dissection and its comparing with the existing
ones.
Methods: The original method of gas jet dissection of
biological tissues and the apparatus for its realization
«Pneumojet» (Patent no. 41570 U, UA; Patent no.
44610 U, UA) (Figure 1) were developed in our insti-
tute. The way of separation of tissues of parenchyma-
tous organs includes introduction onto the surface of
the operated organ of handling medium under a pres-
sure exceeding its durability, which allows to separate
vessels from the parenchyma till the crossing moment,
then to carefully clip or legate them and just after that
to cross, if necessary applying various ways of achieve-
ment of definitive hemostasis (Figure 2). Efficiency
comparison of gas-jet (original apparatus “Pneumojet”,
Ukraine), ultrasonic («SONOCA 300», Soring, Ger-
many), water-jet («Hydrojet», Erbe, Germany) methods
of dissection and Clamp crushing technique was carried
out on 24 mini-pigs. Depending on the liver paren-
chyma dissection technique, the animals have been
divided into four groups. We did not use Pringle
maneuver. All mini-pigs with pneumodissection under-
went: intraoperational angiopulmonography («Trido-
rosOptimatic – 1000» by «Siemens» production), direct
monitoring of pressure in the pulmonary artery (cardio-
monitor «Utas», Ukraine), intraoperational ultrasonic
research of the pulmonary artery and echocardioscopy
of the right heart (SAL 77A, Toshiba make).
Results: Intraoperative angiopulmonography, monitor-
ing of pressure in the pulmonary artery, intraoperative
ultrasound did not reveal any traces of the gas in the
bloodstream.
The sizes of the resected section of liver and, accord-
ingly, wound surfaces that were formed as a result of
operation, did not differ in the investigated groups. The
mean blood loss at the resection stage was the smallest
in the group of animals that had a gas jet dissection
(3.5  0.15 mL/cm2) and the highest in the Clamp
crushing technique group – 5.5  0.46 mL/cm2 (indica-
tors have statistically authentic differences p < 0.05).
The dissection speed was the highest in the Clamp
crushing technique group – 2.9  0.25 cm2/min and
was credibly higher than in the gas jet (2.4  0.16 cm2/
min), ultrasonic (2.4  0.13 cm2/min) and water-jet
(2.5  0.14 cm²/min) dissection groups (Table 1).
Conclusions: The research conducted proves high effi-
ciency and safety of the proposed gas jet technique of
hepatic parenchyma dissection in the course of liver
resections. The gas-jet dissection, therefore, can be rec-
ommended for further improvement and clinical appli-
cation.
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A PROSPECTIVE RCT COMPARING
PARTIAL HEPATECTOMY WITH TACE
FOR MULTINODULAR HCC OUTSIDE
OF MILAN CRITERIA
Lei Yin
EHBH, Shanghai, China
Background: Partial hepatectomy (PH) is an effective
treatment for large but resectable hepatocellular carci-
noma (HCC). However, its role in the treatment of
resectable multinodular hepatocellular carcinoma
(MNHCC) outside of Milan Criteria is not clear.
Whether PH is better than transcatheter arterial chemo-
embolization (TACE) for these patients is unknown.
Patients and methods: This prospective randomized
controlled trial was conducted on 173 patients with
resectable MNHCC outside of Milan criteria (tumor
number  2 with diameter of biggest tumor >3 cm)
who were treated in our centre from November 2008 to
September 2010. The patients were randomly assigned
to the PH group and the TACE group. The primary
outcome measure was overall survival (OS) from the
date of randomization. A multivariate Cox proportional
hazards regression analysis was performed to assess the
prognostic factors of OS for MNHCC after treatment.
Results: The baseline clinical characteristics were well
matched between the two groups (the PH group n = 88
and the TACE group n = 85). There was no significant
difference in 30-day mortality between these two
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groups. The 1-, 2- and 3-year OS rates were 76.1%,
67.9% and 53.9%, respectively, for the PH group com-
pared with 52.9%, 36.3% and 21.5% respectively, for
the TACE group (p = 0.001). Multivariate Cox propor-
tional hazards regression analysis revealed the type of
treatment, age and tumor number were significant
prognostic factors of OS for MNHCC.
Conclusions: The OS for MNHCC outside of Milan
criteria (tumor number  2 with diameter of biggest
tumor >3 cm) was superior after PH than TACE. PH
is the treatment of choice for resectable MNHCC.
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RESECTION FOR HEPATOCELLULAR
CARCINOMA PATIENTS WITH
METACHRONOUS PULMONARY
METASTASES: AN UPDATE ANALYSES
Siu Ho Kenneth Chok
Department of Surgery, Queen Mary Hospital, HK
SAR, Hong Kong S.A.R., China
Background and aims: Data on outcome of pulmonary
metastases from HCC is scarce. The aim of the present
study is to investigate whether there is any improve-
ment in survival for patients with resectable and unre-
sectable lung metastases from hepatocellular carcinoma
(HCC) over the years.
Methods: Data of 280 patients (238 men and 42
women) who underwent liver resection with curative
intent for HCC with metachronous lung metastases
during the period from December 1989 to December
2010 were reviewed. All patients had tumor-free resec-
tion margin in the hepatectomy specimen. Overall sur-
vival (OS) was compared in patients with resectable
and unresectable lung metastases and in different time
periods (Era I: 1989–1995 and Era II: 1996–2010).
Results: The unresectable group had significantly more
patients with advanced tumor staging (p = 0.015). 44
out of 234 patients (18.8%) and 12 out of 46 patients
(26.1%) had only isolated lung metastases. The median
OS for patients with unresectable and resectable dis-
eases was 7.46 and 40.36 months, respectively
(p < 0.0001). The 1- year, 3-year and 5-year OS rates in
patients with unresectable and resectable diseases were
34.1% vs. 86.7%, 8.1% vs. 53.9%, 3.5% vs. 31.8%,
respectively. The median OS for patients with unresec-
table and resectable diseases in Era I was 5.59 vs.
43.15 months (p < 0.0001) whereas the counterparts in
Era II was 8.38 vs. 32.90 months, respectively
(p < 0.0001). The OS for patients with resectable dis-
eases did not differ significantly between two Eras
(p = 0.443) but there was significant improvement of
survival in patients with unresectable diseases in Era II
(p = 0.041). The 1-year, 3-year and 5-year OS rates in
patients with unresectable diseases in Era I and Era II
were 11.1% vs. 38.4%, 5.6% vs. 9.1%, 2.8% vs. 3.5%
(p = 0.041), respectively. The 1-year, 3-year and 5-year
survival rates in patients with resectable diseases in Era
I and Era II were 90% vs. 85.8%, 80% vs. 45.9%,
40% vs. 29.5% (p = 0.443), respectively. Patients with
unresectable diseases with or without Sorafenib as the
first treatment option did not have any significant dif-
ference in OS (p = 0.357).
Conclusion: OS for patients with resectable lung metas-
tases had better survival than those unresectable
patients. Patients with unresectable lung metastases in
Era II also had a better OS than those in Era I.
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ROBOTIC LAPARASCOPIC CENTRAL
PANCREATECTOMY: AN INITIAL
REPORT IN CHINA
Rong Liu
Fuxing Road, No. 28, Beijing, China
Background: Central pancreatectomy has been accepted
as a valid surgical alternative to more extensive stan-
dard resections for the treatment of benign and board-
line central pancreatic tumors. However it is a rare
surgical procedure, even in open surgery. With the
development of laparoscopic experiences, a few cases of
laparoscopic central pancreatecomy have begun to be
reported, but they are believed to be conducted by sur-
geons with tremendous skills and experiences. Since
early 2000s, the da Vinci system provided a new plat-
form for laparoscopic surgery. In this article, we
reported our initial experience of this new minimal
invasive approach to central pancreatectomy.
Methods: From December 2011 to June 2012, four
female patients, with a mean age of 42 years (range, 15
–68), underwent robot-assisted laparoscopic central
pancreatectomies at the Department of Surgical Oncol-
ogy of the Chinese PLA Hospital in Beijing, China.
Two of the patients had symptomatic cystadenomas,
and two patients had neuroendocrine tumors, which
were discovered incidentally. The da Vinci Surgical Sys-
tem (Intuitive Surgical, Sunnyvale, CA) was used to
perform all steps of the intervention. All remnant pan-
creases were managed using pancreaticogastrostomy.
Results: The median operative time was 330 min
(range, 240–390), and the median estimated intraopera-
tive blood loss was 150 mL (range, 100–300). No trans-
fusion was given during the operative period. There
were no mortalities. One patient developed a postoper-
ative pancreatic fistula and bleeding, which was man-
aged conservatively. The median postoperative hospital
stay was 13 days (range 10–30 days). No endocrine or
exocrine deficiencies were observed in the patients dur-
ing a mean follow-up of 12 weeks (range, 4–24).
Conclusions: Central pancreatectomy can be selected
carefully as an appropriate surgical option for benign
and boardline malignant lesions of the neck and proxi-
mal body of the pancreas. The robotic surgical system
may allow surgeons to perform complex and difficult
laparoscopic procedures more easily and effectively.
334
RECENT INSIGHT ON THE SERUM
BIOMARKERS OF HEPATOCELLULAR
CARCINOMA
Chun-Fang Gao
EHBH 225 Changhai Road, Shanghai, China
Hepatocellular carcinoma (HCC) is the major form
of primary liver cancer (PLC). It is one of the most
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common cancers worldwide and the third leading cause
of cancer-related death. The most important risk fac-
tors for HCC are chronic hepatitis B or C infection,
cirrhosis, non-alcoholic fatty liver diseases, alcoholic
liver disease, and exposure to aflatoxin and other car-
cinogens. The laboratory screening tests for HCC
include tumor markers and the index of hepatic dam-
age (ALT, AST, ASTm), cholestasis (bilirubin, ALP,
GGT), hepatic synthesis (Alb, PT, bilirubin) in addition
to image techniques. So far, alpha-fetoprotein (AFP) is
the most widely used biomarker for screening, early
diagnosis and treatment monitoring. But up to now,
the sensitivity and specific of AFP has lead to a lot of
clinical concerns. Since the early diagnosis of HCC is
extremely important in improving the total survival
and outcomes of patients, the discovery of new sensi-
tive markers ensuring early diagnosis to maximize the
therapeutic response has long been the hot topic in this
field. In this presentation, we will summarize some
important biomarkers and their principal use in refer to
publications. These biomarkers include proteins or gly-
coproteins, growth factors, interleukins, enzymes, pro-
teomic or glycomic markers, microRNAs panels,
epigenetic markers, tumor-driven autoantibodies, HBV
genome mutation, etc. In addition, the assessment for
the biomarkers routinely used in EHBH (AFP, AFP-
L3, AFU, etc.) was made retrospectively based on large
sample size analysis which is the priority of the routine
lab. By the way, we will present some of our most
recent researches on microRNAs, CTGF, N-glycan bio-
markers, cell free DNA, DNA methylation, etc. Techni-
cal problems are among important issues in biomarker
researches and assessment. The distance between bench
(research) and bed (applied clinical practice) is long.
Well designed randomized clinical trials using standard-
ized, optimized protocols and large series of patients
are required so that the practical value of identified bi-
omarkers could be well defined.
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DIGITAL HEPATIC VEIN TYPING AND
ITS APPLICATION IN LIVER SURGERY
Chi-Hua Fang
Department of Hepatobiliary Surgery, Zhujiang
Hospital, The Southern Medical University, Guangdong
Pro, China
Background: Studies on anatomical variations of hepa-
tic veins are certainly focused to the utmost by surgical
clinicians. Digital medical technology has been a new
method on the study of clinical anatomy.
Objective: To study the value of hepatic vein variation
in reserving normal hepatic tissue to extremity.
Methods: We collected original data scanned with 64
slice helical CT from 80 liver neoplasm cases. We car-
ried out three-dimensional reconstruction with self-
researched abdominal medical image three-dimensional
system (MI-3DVS). Three-dimensional models were
used to observe the variation characteristics of the
hepatic veins and perform individual liver sectioning,
cubing and virtual operation.
Results: The display rate of reconstructed models of
liver, hepatic vein and liver lesions among 80 cases was
100%. Among them, 18 cases (22.5%) had a slim and
short branch as right hepatic vein, and all of them had
surrounding hepatic vein to compensate; 13 cases
(16.2%) appeared with thick inferior right hepatic vein;
5 (6.25%) cases had vice right hepatic vein. There were
13(16.25%) of 80 cases with section IV hepatic vein.
Among the 13 cases (16.25%), 6 cases (7.5%) had sec-
tion IV hepatic vein entering left hepatic vein, 4 cases
(5%) entering middle hepatic vein, and 3 cases (3.75%)
entering postcava directly. On individual liver section,
there were 64 cases with 8 sections, 3 cases with 10 sec-
tions, 7 cases with 9 sections, 1 case with 7 sections, 3
cases with 6 sections and 2 cases with 5 sections. In 63
patients undergoing operation, preoperative simulation
surgery procedure is consistent with the actual surgery.
Conclusion: It is fast and clear to carry out three-
dimensional reconstruction with MI-3DVS, which has
practical value on individual liver section, operation
risk assessment and choice of the best operation solu-
tion.
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EXPERIENCE OF LAPAROSCOPIC
PANCREATODUODENECTOMY IN OUR
HOSPITAL
Hiroki Sunagawa
Hirokisunagawa, Chibana 6-25-5, Okinawa Japan
Introduction: Now laparoscopic surgery is widely per-
formed and spreading to the abdominal malignancies.
Gagner et al. reported laparoscopic pancreatoduoden-
ectomy (lap-PD) for chronic pancreatitis in 1994. Now-
adays, lap-PD can be performed with similar short
term outcomes to open method. And many surgeons
have shown that this procedure is feasible in patients
with benign and low-grade malignant pathology. But
lap-PD represents one of the most advanced abdominal
operations owing to the necessity of a complex dissec-
tion and reconstruction.
Methods: We started this procedure from, June 2011.
13 patients lap-PD were performed in our hospital.
Basically, a totally laparoscopic approach was used for
the entire procedure. The surgeon stood between the
patient’s legs and at left side of the patient depending
on the situation. After pneumoperitoneum at 8 mmHg,
omentum was divided widely and gastroepiploic artery
and vein were clipped and divided. The first portion of
the duodenum at 2 cm distal to the pylorus was sec-
tioned. After resection of the common hepatic artery
nodes, the gastroduodenal artery was double clipped
and divided. And then the portal vein was identified at
the superior border of the pancreatic head and the
supra mesenteric vein was identified at the inferior bor-
der. The inferior border of the pancreatic neck was
opened and tunnel was made above the supra mesen-
teric vein. A kocher maneuver was performed from the
left side. The jejunum was transected 10 cm distal to
the ligament of Treitz. The jejunal stamp was passed
under the superior mesenteric vessels. The head and
uncinate process of the pancreas were dissected from
the superior mesenteric vessels with ligasure (Tyco
Healthcare). The inferior pancreatoduodenalaretery
was clipped and divided. The bile duct was ligated and
© 2013 The Authors
HPB 2013, 15 (Suppl. 2), 15–82 HPB © 2013 Americas Hepato-Pancreato-Biliary Association
CONCURRENT SESSIONS ORALS 23
dissected. The neck of the pancreas was divided with
an ultrasound shears. Finally, the pancreatic duct was
divided with scissors. A choledochojejunostomy was
performed with running suture using 4-0 PDS. An end-
to-side pancreatojejunostomy was performed using the
duct-to-mucosa anastomosis (4-0 PDS) with the inter-
nal stent and Kakita‘s method (4-0 Prolene). An end-
to-side duodenojejunostomy was performed with Albert
–Lembert method. Trocars were removed and trocar
sites were closed.
Results: The median operative time was 683 min. And
the median amount of the blood loss was 300 mL. The
median duration of the hospital stay was 13 days.
Conclusions: Operative time was long. But this proce-
dure was performed safely. In this meeting, we present
a video of our actual surgery, and report the results.
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HEPATIC ARTERY INJECTION OF
IODINE-131-LABELED METUXIMAB
COMBINED WITH
CHEMOEMBOLIZATION FOR
INTERMEDIATE HCC
Lu Wu
Eastern Hepatobiliary Surgery Hospital, Changhai Road
225, Shanghai 200438, P. R. China
Background: Hepatocellular carcinoma (HCC) is the
fifth and seventh most common cause of cancer in men
and women, respectively. Transcatheter arterial chemo-
embolization (TACE) is the standardized therapy for
the intermediate stage of HCC. However, the 3 year
overall survival remains low (<30%) for these patients.
Thus, there is a critical need for the development of
treatment modalities to improve the survival rate. This
study aimed to evaluate whether the combination of
131I-metuximab with chemoembolization could
improve treatment efficiency.
Methods: Between January 2009 and January 2010, a
prospective two-arm nonrandomized study was per-
formed in intermediate HCC patients. 68 out of 148
patients (combination therapy group) were treated after
132 courses of intra-arterial 131I-metuximab injections
combined with chemoembolization (mean, 1.94 per
patient; median, 2; range, 1–2), followed by 152 ses-
sions of TACE (mean, 2.24 per patient; median, 2;
range, 0–4). The remaining 70 patients (monotherapy
group) were treated after 296 sessions of TACE (mean,
4.23 per patient; median, 4; range, 1–7).
Results: The overall median survival for the combina-
tion therapy group and the group treated only with
TACE was 26.7 months (95% CI, 20.7–31.3 months)
and 20.6 months (95% CI, 15.3–24.7 months), respec-
tively. The combination therapy group had a signifi-
cantly higher survival rate than that of TACE only
group (p = 0.038). Age  65, serum albumin  35,
and treatment category (combination therapy or TACE
alone) were independent prognostic factors for survival
according to multivariate analysis.
Conclusions: The combination of 131I-metuximab and
chemoembolization extended survival in patients with
intermediate HCC compared with TACE alone, and
was well tolerated by Child-Pugh A and B patients.
This combination seems to be a promising treatment
modality for patients with intermediate HCC.
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DELAYED GASTRIC EMPTYING AFTER
PANCREATICODUODENECTOMY
USING INTERNATIONAL STUDY
GROUP OF PANCREATIC SURGERY
(ISGPS) DEFINITION
Charing Chong
Prince of Wales Hospital/The Chinese University of
Hong Kong, Hong Kong S.A.R., China
Background and aims: Delayed gastric emptying (DGE)
is one of the commonest post-operative complications
following pancreaticoduodenectomy (PD) and is usu-
ally the leading cause of prolonged hospital stay. Eval-
uation of its prevalence post-operatively was thwarted
by an inconsistency in DGE definition before and the
discrepancy in the definition had resulted in a wide var-
iability in the prevalence of operative mortality and
morbidity reported. In 2007, the International Group
of Pancreatic Surgery (ISGPS) suggested a definition
for DGE. The aim of this study is to evaluate the inci-
dence and clinical features, as well as associated risk
factors of delayed gastric emptying (DGE) after pan-
creaticoduodenectomy, employing the International
Study Group of Pancreatic Surgery (ISGPS) consensus
definition.
Methods: Patients demographic, surgical details, clini-
cal course and pathology of 92 consecutive patients
who underwent pancreaticoduodenectomy (classical
Whipple or pylorus-preserving pancreaticoduodenecto-
my) from January 2002 to December 2011 at a single
tertiary academic institution were analyzed using uni-
variate and multivariate analyses.
Results: DGE developed in 29 (31.5%) out of 92
patients included. Among these 29 patients, 17 (18.5%)
of them had grade A, while 4 (4.3%) and 8 (8.7%) had
grade B and grade C DGE, respectively. Perioperative
outcomes were presented. DGE was associated with
longer post-operative length of stay (17 days vs.
13 days, p = 0.016). Univariate logistic regression anal-
ysis showed that intra-operative blood loss (p = 0.02)
and increased median number of lymph node dissected
(p = 0.036) was associated with DGE. Multivariate
regression analysis revealed that only increased number
of lymph nodes resected (p = 0.013) was a significant
independent indicator of DGE.
Conclusions: ISGPS definition and grading systems
for DGE are applicable and correlate well with clini-
cal course. The incidence of DGE using the ISGPS
definition was similar to other studies, which also
employed ISGPS definition. An association between
more extensive lymphatic dissection and DGE may
warrant reconsideration on the extend of lymphaden-
ectomy.
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THE UNEVEN DISTRIBUTION OF
LIVER FAT ESTIMATED FROM MR
TRIPLE–ECHO CHEMICAL SHIFTING
IMAGES AND ITS CLINICAL
IMPORTANCE
Young Rok Choi
101 Daehak-Ro Jongno-Gu, Seoul, South Korea
Background: The study was aimed to evaluate the cor-
relation between the real fat change on liver biopsy and
the estimated fat fraction using MR triple-echo chemi-
cal shifting gradient echo imaging (MRC) as well as
the difference in fat fraction among each segment(S),
section(SE) under the estimated fat fraction on MRC.
Methods: Between June 2011 and February 2012, 81
liver donors who had both the pathologic report for
the liver biopsy and MRC images were selected in liv-
ing donor liver transplantation. Fat fraction was esti-
mated at each segment, section. Also fat fractions for
the peripheral and deep part of S4, S5, S6, S7 and S8
(S5–8) were measured separately (Figure 1). Then cor-
relations between each fat fraction were analyzed and
distribution of fat fraction according to the area of the
liver was investigated statistically. Results
The estimated fat fraction on peripheral part of S5 from
MRC had a strong correlation with pathologic macro-
vesicular fat change of the liver wedge biopsy(r = 0.816,
p = 0.000). And it was closely correlated with fat frac-
tions in the other peripheral and deep portion of each
segment (p = 0.000). There were differences of fat frac-
tion between peripheral and deep part in S5–8 (all
p < 0.05). Besides that, there were significant differences
in fat fraction (F (4.003, 58.032) = 8.684, p = 0.000)
between deep parts of each segment as compare to no
difference among peripheral parts of S4, S6, S7 and S8.
Furthermore, the range of fat fraction has the linear
relation corresponding the estimated fat fraction in
peripheral S5 from MRC (p = 0.063, Figure 2).
Conclusions: This study showed that the distribution of
liver fat is uneven and the difference of regional fatty
change can be wide according to the amount of fat
deposition from MRC reflecting a real macro-vesicular
fatty change in the liver.
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CLINICAL OUTCOMES OF SURGICAL
RESECTIONS FOR PRIMARY LIVER
SARCOMA:DIAGNOSTIC AND
THERAPEUTIC CHALLENGE
Qing-He Tang
EHBH 225 Changhai Road, Shanghai, China
Background: Due to the rarity of primary hepatic sar-
coma, the natural history, optimal management and
prognosis are poorly characterized.
Methods: From January 2002 to December 2009, 37
consecutive patients with liver sarcoma who received
hepatic resection were retrospectively studied. Patient
demographics, tumor characteristics, treatment, adju-
vant therapy and actuarial survival were retrospectively
reviewed.
Results: Of the 37 patients with primary hepatic sar-
coma (12 malignant fibrous histiocytoma, 2 angiosarco-
ma, 9 undifferentiated embryonal sarcoma, 6
epithelioid hemangioendothelioma, 2 rhabdomyosar-
coma, 1 leiomyosarcoma, 1 fibrosarcomas, 2 liposarco-
ma, 1 carcinosarcoma), 22 underwent R0-resection and
had a 5-year disease-specific survival of 18.1%. No pre-
operative diagnosis of a primary liver sarcoma was
made. There were six patients with epithelioid heman-
gioendothelioma and their 5-year disease-specific sur-
vival was 50%. In the four surviving patients, three
had epithelioid hemangioendothelioma including one
with tumor recurrence and pulmonary metastases.
Another patient with undifferentiated embryonal sar-
coma was still alive 44 months after surgery, who
received re-resection for intrahepatic recurrence, adju-
vant chemotherapy and radiation therapy for pulmo-
nary metastasis. Of the remaining 13 patients in whom
R0-resection was not possible, there was no 3-year sur-
vivor.
Conclusion: The majority of patients with primary liver
sarcoma present with right upper quadrant pain, fever
and a liver mass. Hepatic resection was safe for
patients with resectable primary liver sarcoma. There is
a trend that the outcome after surgery was related to a
negative resectional margin. Liver resection combined
with adjuvant chemotherapy are the mainstays of treat-
ment for UES. Further improvement in outcome will
require the development of more effective adjuvant sys-
temic therapies.
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A CD166 NEGATIVE SUBPOPULATION
OF PANCREATIC CANCER CELLS HAS
STRONG INVASIVE AND MIGRATORY
ACTIVITY
Kenji Fujiwara
3-1-1, Maidashi, Higashi-ku, Fukuoka-shi, Fukuoka,
Japan
Background: CD166 expression is correlated with prog-
nosis in several cancers. However, its significance in
pancreatic cancer is not clear. The aim of this study
was to clarify the significance of CD166 expression in
pancreatic cancer.
Methods: We performed immunohistochemistry (IHC)
to investigate CD166 expression in surgically resected
pancreatic cancer tissue. We also performed flow
cytometry to analyze expression of CD166 in pancre-
atic cancer cell lines and proliferation, invasion and
migration assays to compare the properties of CD166+
and CD166– cells.
Results: In IHC, there was no significant difference in
prognosis between CD166 high staining group (15
patients; 48.4%) and CD166 low staining group (16
patients; 51.6%). In flow cytometry, CD166 was
expressed in pancreatic cancer cells in wide range (0–
99.5%). In proliferation assay, there was no significant
difference between CD166+ pancreatic cancer cells and
CD166 cells. In invasion and migration assays,
CD166– cells showed stronger biological behaviors in
their invasion and migration than did CD166+ cancer
cells (p < 0.05).
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Conclusion: These data suggest that CD166 cells exhi-
bit more aggressive behavior evidenced by increased
cell invasion and migration. CD166 pancreatic cancer
cells may play an important role in progression of pan-
creatic cancer.
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ROBOTIC DISTAL PANCREATECTOMY:
COMPARISON WITH LAPAROSCOPIC
AND OPEN TECHNIQUE
Emilio Vicente
calleO~na 10, Madrid, Spain
Background: Robotic surgery has become accepted
practice across many organ systems overcoming many
of the insufficiencies of classic laparoscopic technique.
However, in pancreatic field, robotic has yet to be rig-
orously evaluated against the gold standard of open
and laparoscopic approach.
Aim: In this study, we analyze the perioperative out-
come of robotic surgery focusing on distal pancreatec-
tomy comparing these results with the laparoscopic and
open technique.
Methods: In 2-years period (October 2010–July 2012),
28 patients underwent distal pancreatectomy at our
center with three different operative approach: 9
robotic, 10 laparoscopic and 9 with open technique. All
relevant data were gathered and collected in a retro-
spectively maintained database. All patients received a
long-course neoadjuvant therapy with surgery per-
formed 3–4 weeks after radiation treatment.
Results: In the examination of the groups, we did not
observed significant difference in the mean age, sex,
indication for surgery and tumoral size. Except for
ASA risk score and PET uptake (higher in robotic
group). Of note, mean operating time of these groups
was no significant, resulting in 315 min (240–420) for
the robotic group and 250 (180–300) and 366 (240–720)
min for the laparoscopic and open group, respectively.
Significant difference was observed in operative blood
loss in the open group (3.44 mean units) when com-
pared with robotic (0.5 mean units) (p < 0.001) or lapa-
roscopic (0 units) technique (p < 0.01).
In regard to postoperative outcomes, a reduction in
mean length of stay was noted in the robotic group
(8.87 days) when compared with laparoscopic
(19.16 days) (p = NS) and open group (20.44 days)
(p < 0.05). If no significant differences was found
between open (13.2  5.8) versus robotic mean lymph
nodes resected (5  7.84), it exists when compared with
laparoscopic approach (3.75  2) (p < 0.05).
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IMPACT OF PET SCAN ON THE
PROGNOSIS OF NEUROENDOCRINE
TUMOR OF PANCREAS
Hipolito Duran
calleO~na 10, Madrid, Spain
Introduction: Neuroendocrine tumors (NET) of the
pancreas, despite increasing incidence, are still rare. In
contrast to Ki-67 proliferation index and tumoral size
that are well known prognostic factors of NET, thus
introduced in the recent WHO classification, the rule of
positron emission tomography (PET) scan is still
unknown.
Aim: Objective of this study is to test the role of the
PET scan as prognostic factor of NET comparing with
Ki-67 index and tumoral size.
Methods: We retrospectively gathered data about 78
consecutive patients that underwent pancreatic surgery
from March 2009 to March 2011. NET of were find in
21 cases (26.9%): 11 male and 10 women. Mean age
was 58 years (range: 35–73 years). WHO NET classifi-
cation was: eight neuroendocrine tumor (38%); nine
well-differentiated tumors (42%); four poor differenti-
ated tumors (19%). Mean tumoral size was 1.56 cm in
neuroendocrine tumor and 5.05 cm for neuroendocrine
carcinoma (p < 0.05). The prognostic validation of
PET is based upon a bivariant study: positive/negative
PET with Ki-67 index and tumoral size.
Results: PET scan was positive in 12 cases (mean SUV
of 6.34). Patients with positive PET scan has a Ki-67
mean index of 22% and a mean tumoral size of
4.5 cm; while patients with negative PET scan has a
Ki-67 mean index of 11.6% and a mean tumoral size
of 3.5 cm (p < 0.05).
Conclusion: Positive PET scan may represent a prog-
nostic factor as it seems to be related with a worse
prognosis in NET of pancreas (higher tumoral size and
Ki-67 index). Consistent further studies are needed to
confirm this result.
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CLINICOPATHOLOGIC ANALYSIS AND
PROGNOSIS OF GASTROINTESTINAL
STROMAL TUMORS OF DUODENUM
AND SMALL INTESTINE: COMPARED
TO THOSE OF STOMACH
In Woong Han
Siksa-dong 814, Ilsandong-gu, Kyoungki-do, South
Korea
Background and aims: Gastrointestinal stromal tumors
(GISTs) are most common mesenchymal neoplasm in
the digestive tract. This study aimed to analyze the clin-
icopathologic features, to explore the prognostic factors
in patients with GISTs located in upper gastrointestinal
(GI) tract, and to clarify duodenal and small intestinal
GISTs differ from gastric GISTs in clinical, pathologi-
cal, and immunohistochemistrical aspects.
Methods: 297 patients with GIST in duodenum
(n = 40), small intestine (n = 61), or stomach (n = 196)
underwent surgical resection between 1996 and 2010.
Results: The patients with duodenal GIST were rela-
tively younger than those with gastric GIST
(51.1  13.8 vs. 56.7  11.1 years, p = 0.012). Mean
mitotic counts, and the ratio of muscle invasion of duo-
denal GISTs were larger than those of gastric GISTs,
respectively (34.9  86.8 vs. 15.5  34.8 cm, p = 0.025;
26/26 vs. 131/155, p = 0.010). Mean size of small intes-
tinal GISTs was relatively larger than that with gastric
GISTs (8.4  4.7 vs. 6.2  4.7 cm, p = 0.016). The
positivity of smooth muscle actin and S100 of duodenal
and small intestinal GISTs in the immunohistochemis-
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try were larger than those of gastric GIST, respectively
(11/33 and 15/49 vs. 24/166, p = 0.006; 6/34 and 8/53
vs. 8/169, p = 0.008). Five-year survival rate (5YSR) in
patients with GIST located in duodenum, small intes-
tine, and stomach were 66.6%, 80.8%, and 91.0%,
respectively (p = 0.002). After survival analysis in
patients with GIST located in upper GI tract, male
gender (HR = 7.196, p = 0.043), R2 resection
(HR = 21.820, p = 0.019), and the expression of S100
(HR = 15.622, p = 0.023) were identified as indepen-
dent adverse prognostic factors. Advanced T stage
(HR = 3.895, p = 0.061), mucosal involvement
(HR = 4.448, p = 0.073), and no use of adjuvant imati-
nib treatment (HR = 2.683, p = 0.060) were revealed
adverse prognostic factors with statistically marginal
significance. Limited to duodenal and small intestinal
GISTs, additional adverse prognostic factors were iden-
tified, such as, combined epithelioid cell component
(5YSR 61.5 vs. 87.2%, p = 0.009), and immunopositivi-
ty of PDGFRA (5YSR 36.4 vs. 77.2%, p = 0.043). The
rate of progressive disease was greater in patients with
duodenal and small intestinal GISTs than in those with
gastric GISTs (42.2% vs. 13.0%, p < 0.001).
Conclusion: Primary duodenal and small intestinal
GISTs differ from primary gastric GISTs in terms of
clinical, pathological, and immunohistochemistrical
aspects. More aggressive treatment should be consid-
ered in patients with duodenal or small intestinal GIST
than in those with gastric GIST.
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SURGICAL TREATMENT OF
HEPATOCELLULAR CARCINOMA
WITH HEPATIC VEINS AND INFERIOR
VENA CAVA TUMOR THROMBUS
Ai-Jun Li
EHBH 225 Changhai Road, Shanghai, China
Introduction: Hepatocellular carcinoma (HCC) is a
common malignant tumor,1–19 with 11–23% of cases
associated with venous thrombus,3 and about 3.8%
with inferior vena cava tumor thrombus (IVCTT),1 and
in about 2% of tumor thrombus (TT) can extend to
the right atrium.2 Thus, HCC with IVCTT is very rare,
with only approximately 300 cases reported in the
world literature since 1924.18 HCC with IVCTT may
be complicated by lung metastasis, pulmonary infarc-
tion, secondary Budd–Chiari syndrome, ball-valve
thrombus syndrome, and heart failure.3,11 Furthermore,
it is associated with an increased risk of sudden death
due to heart failure or pulmonary embolism, and is a
condition that needs urgent management. The progno-
sis of patients with HCC and IVCTT is extremely poor,
with reported survival as short as 1.9 months,15 which
is worse than for patients with portal vein tumor
thrombus.
Background: We aimed to evaluate hepatectomy and
hepatic veins and inferior vena cava tumor thrombus
resection in patients with hepatocellular carcinoma
(HCC), and selection of surgical technique.
Methods: We retrospectively reviewed 10 patients with
HCC who underwent hepatectomy with hepatic veins
and inferior vena cava tumor thrombus resection.
Results: The hepatic vein and inferior vena cava tumor
thrombus was posterior to the liver and below the dia-
phragmin 8 case, which was treated by radical hepatec-
tomy and removal of IVCTT with total hepatic
vascular exclusion. The hepatic veins and inferior vena
cava tumor thrombus was above the diaphragm but
still outside the atriumin in one case, which was treated
by radical hepatectomy and removal of IVCTT by inci-
sion of the diaphragm. There were no surgical compli-
cations and one patient is still alive with cancer-free
status after 5 years. The median survival time was
18.2 months, and 1-year and 2-year survival rates were
53.8% and 15.4%, respectively.
Conclusions: Hepatic resection and removal of hepatic
vein and inferior vena cava tumor thrombus was safely
performed in 10 patients with HCC.
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PURE LAPAROSCOPIC RESECTION OF
THE GALLBLADDER TOGETHER WITH
THE GALLBLADDER BED AND
EXTRAHEPATIC BILE DUCT FOR
GALLBLADDER CANCER
Hidehito Arimitsu
Nitona-Chou, Chiba-City, Chiba, Japan
Background and aims: Although the recent develop-
ments in technological innovations, improvements in
surgical skills and the extensive experience of surgeons
have greatly enlarged the applications for laparoscopic
liver resection, laparoscopic resection of biliary malig-
nancy has not yet become widely accepted. We herein
describe a pure laparoscopic resection of the gallblad-
der together with the gallbladder bed and extrahepatic
bile duct for gallbladder cancer.
Methods: A 71-year-old male with gallbladder cancer
showing cystic neck and duct infiltration underwent a
pure laparoscopic resection of the gallbladder together
with the gallbladder bed, extrahepatic bile duct, and
lymph node around the hepato-duodenal ligament and
pancreatic head. The jejunal limb was delivered
through a window in the transverse mesocolon. An
end-to-side hepaticojejunostomy was performed intra-
corporeally.
Results: The procedure took 319 min, and operative
bleeding was 170 cc. The patient was discharged on the
19th postoperative day because the patient had devel-
oped biliary leakage that later resolved spontaneously.
A histological examination showed adenocarcinoma.
The surgical margins were histologically clear (R0
resection).
Conclusions: We successfully performed pure laparo-
scopic resection of the gallbladder together with the
gallbladder bed and extrahepatic bile duct. We believe
that the present procedure for carefully selected
patients with T2 carcinoma of the gallbladder repre-
sents a valid therapeutic option.
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EVALUATION OF CHEMOTHERAPY
INDUCED LIVER INJURY IN PATIENTS
WITH COLORECTAL CANCER LIVER
METASTASES
Sung-Pil Yun1, Hyung-Il Seo1, Young-Lae Jung1, Suck
Kim2 and Dong-Uk Kim3
1Department of Surgery, Postgraduate School of
Medicine, Pusan National University, Busan, Korea;
2Department of Radiology, Postgraduate School of
Medicine, Pusan National University, Busan, Korea;
3Internal medicine, Postgraduate School of Medicine,
Pusan National University, Busan, Korea
Background and aims: Adjuvant chemotherapy
improves survival in patients with curatively resected
colorectal cancer. But up to 50% of patients will
develop hepatic metastases during their course of dis-
ease. Surgical resection of liver is the only potentially
curative treatment for patients with liver metastases.
The aim of this study is to show that commonly used
chemotherapeutic drug are associated chemotherapy
induced liver injury which was recognized to impair the
function of the remnant liver.
Methods: Between June 2007 and March 2012, data of
29 liver resection performed for colorectal liver metas-
tases were analyzed, retrospectively. 11 patients had
liver resection without chemotherapy, while 18 patients
had history of adjuvant, neoadjuvant chemotherapy
before liver resection. We analyzed patients’ clinical
data, histopathology of resected liver and post-opera-
tive outcome between two groups.
Results: In the comparison of patients’ clinical date,
there was no statistically significant difference in the
sex, age, extent of hepatectomy, ICG-R15, PIVKA-II,
CEA, pre-operative AST, cholesterol, bilirubin, PT,
INR and fatty liver score of preoperative CT between
non-chemotherapy group and chemotherapy group.
Whereas, patients in the chemotherapy group had
higher pre-operative ALT(p = 0.043), lower PLT level
(p = 0.032) compared to patients in the non-chemother-
apy group. In the comparison of histopathology of
resected liver, there was no significant difference in the
fibrosis stage and sinusoidal dilation, but in the chemo-
therapy group, necro-inflammatory grade was signifi-
cantly high (p = 0.018). In the comparison of post-
operative outcomes, there was no significant difference
in post-operative AST, ALT, normalization of AST
and ALT and amount of drain.
Conclusions: In this study, chemotherapy group had
high ALP and low PLT which is related to necrosis of
hepatocytes and liver dysfunction, and had high necro-
inflammatory grade which is related to severe steato-
hepatitis.
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COMPARISON OF RESULTS OF THE
RADIOFREQUENCY ABLATION AND
RESECTION FOR RESECTABLE
COLORECTAL LIVER METASTASIS
PATIENTS
Sung Pil Yun1, HyungIl Seo1, Young Lae Jung1, Suck
Kim2 and Dong Uk Kim3
1Department of Surgery, Postgraduate School of
Medicine, Pusan National University, Busan, Korea;
2Department of Radiology, Postgraduate School of
Medicine, Pusan National University, Busan, Korea;
3Internal Medicine, Postgraduate School of Medicine,
Pusan National University, Busan, Korea
Background and aims: Surgical resection is standard
treatment for metastatic lesion of the patients with
colorectal cancer liver metastasis. And RFA is consid-
ered with alterative treatment for colon cancer liver
metastasis. We analyzed 5-years survival rate and dis-
ease free survival rate between resection group and
RFA group for resectable colon cancer liver metastasis
and evaluated usefulness of the RFA.
Methods: Between July 2004 and June 2009, 17
patients underwent RFA (RFA group) and 12 patients
underwent hepatic resection (resection group) for colon
cancer liver metastasis without extrahepatic metastasis.
We analyzed clinicopathological features between resec-
tion group and RFA group such as sex, ages, T stage,
lymph node metastasis, lymphovascular invasion, peri-
neural invasion, size of metastatic lesion, lymph node
ratio and timing of chemotherapy, retrospectively.
Results: There were no significant difference between
the resection group and RFA group in sex, ages, T
stage, lymph node metastasis, lymphovascular invasion,
perineural invasion, lymph node ratio and timing of
chemotherapy. But size of metastatic lesion was signifi-
cantly higher in resection group (2.02  1.169 cm vs.
3.51  1.23) (p = 0.03). Five year survival rate in
patients who underwent resection was 66.7% and in
patients who underwent RFA was 37.8%, and there
was no significant difference (p = 0.29). Five year dis-
ease-free survival rate in patients who underwent resec-
tion was 32.4% and in patients who underwent RFA
was 17.6%, and there was no significant difference
(p = 0.053). In univariate analysis of 5-year survival,
size over 3 cm was poor prognostic factor in the RFA
group (p = 0.005). In univariate analysis of 5 year dis-
ease-free survival, men, age over 65, T stage I–III, pri-
mary colon cancer, no lymph node metastasis and size
over 3 cm had poor disease free survival but in multi-
variate analysis, there was no significant difference.
Conclusions: There were no significant difference
between the resection group and RFA group in 5 year
survival rate and 5 year disease-free survival rate. Size
over 3 cm was poor prognostic factor in the RFA
group in univariate analysis. In conclusion, RFA can
be an alternative to resection for metastatic lesion less
than 3 cm, but additional research will be needed.
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IS THERE A ROLE FOR HEPATIC
PEDICLE LYMPHADENECTOMY IN
INTRAHEPATIC
CHOLANGIOCARCINOMA?
Dong Hun Kim
Samsung Medical Center, Sungkyunkwan University
School of Medicine, Seoul, South Korea
Background: While the role of lymphadenectomy for
extrahepatic cholangiocarcinoma is well established,
routine lymphadenectomy in intrahepatic cholangiocar-
cinoma (ICC) remains controversial. This retrospective
study aimed to the prognostic factors for survival in
patients with resected ICC comparing the outcome of
hepatic pedicle lymph node dissection (LND).
Methods: The data of 144 patients with ICC who
underwent liver resection over 14 years were retrospec-
tively collected. These patients were divided into those
with LND performed (LND (+)) and those not (LND
(–)).
Results: Ten surgeons had attended surgery by their
own surgical policies; two performed routine LND dur-
ing liver resection while other eight did not. There were
66 patients (45.8%) in the LND (+) group and 78
patients (54.2%) in the LND (–) group. The demo-
graphic data were comparable between the two groups
except the presentation of clinical symptoms
(p = 0.034), type of resection (p < 0.001) and adjuvant
treatment (p = 0.029). There were no statistically signif-
icant difference between LND (+) and LND () groups
in terms of overall survival (p = 0.201) and disease-free
survival (p = 0.759). Positive resection margin
(p = 0.026), lymph node metastasis (p = 0.018) and
mass-forming type of ICC (p = 0.030) were identified
to the independent prognostic factors of overall sur-
vival.
Conclusion: Routine LND did not show survival bene-
fit, however, it seemed to be crucial in nodal staging
and prognostication of the disease, which was essential
for decision on adjuvant treatment.
418
HEPATIC FAILURE DETERMINES THE
OUTCOME AFTER EXTRACORPOREAL
HEPATECTOMY AND
AUTOTRANSPLANTATION
Pei-Hung Wen
Changhua Christian Hospital, Chiayi City, Taiwan
Background and aims: Extracorporeal hepatic resection
(ECHR) and liver autotransplantation has been
reported in few articles to be used in liver tumors
located with difficult anatomy or those which are con-
ventionally unresectable. However, there were few data
as for the management in hepatocellular carcinoma
(HCC) using this method. The reported outcomes were
still scant. The aim of this study is to report the tech-
nique and outcomes after ECHR with autotransplanta-
tions.
Methods: From January, 2011 to June, 2012, five HCC
were managed with ECHR with liver autotransplanta-
tion in our center. Tumors located centrally, being
close to major vessels, or occupying the confluence of
hepatic veins were thought to be indicated for this
method. A preoperative liver volumetry estimation was
utilized to prevent postoperative insufficient liver vol-
ume. A temporary portocaval shunt was applied for
anhepatic period. After extracorporeal hepatectomy,
the remnant liver was replanted in orthotopic position.
All patient characteristics, demographic data, operation
details, postoperative care, and outcomes were evalu-
ated.
Results: The age of these patients ranges from 60 to
74. The mean operation time was 502 min while the
mean blood loss was 4580 mL. There was one hospital
mortality because of hepatic failure. Postoperative com-
plications included transient hepatic insufficiency, sep-
sis, pleural effusion, and biliary leakage, which were
successfully treated whenever these happened. The lon-
gest survivor is still alive for 20 months, although three
of them experienced a tumor recurrence after the oper-
ation.
Conclusions: The combination of curative extracorpo-
real hepatic resection and hepatic autotransplantation
provided an alternative of treatment in selected patients
having HCC with difficult anatomy. It could also be
extended to the patients with HCC in experienced
transplantation centers. However, postoperative hepatic
failure and tumor recurrence are the problems to be
overcome. A long-term follow-up for the disease-free
survival and overall survival should be further
reported.
421
DURATION OF PRE-OPERATIVE
BILIARY DRAINAGE IN PATIENTS
WITH MALIGNANT OBSTRUCTIVE
JAUNDICE
Sujith Wijerathne
National University Health System NUHS, Normanton
Park, Singapore
Background and aims: The concept of preoperative bili-
ary drainage (PBD) was developed with a view to
reduce the postoperative morbidity and mortality in
patients with malignant obstructive jaundice. The latest
studies have showed that it actually increases the post-
operative complications (POC). PBD is useful in
patients with cholangitis. A guide to a safe duration of
PBD with minimal POC is not well described in litera-
ture. Our aim was to fill this gap in the modern litera-
ture for PBD.
Methods: In this retrospective, single institution study
we analysed data on 87 selected patients who had sur-
gery from August 2000 to November 2010 for malig-
nant obstructive jaundice secondary to periampulary or
pancreatic head tumours. We compared data between
patients who had PBD (drainage-group) and surgery
alone (surgery-group). A subgroup analysis was done
in the drainage-group on POC after ERCP and PTC.
The effect of bilirubin reduction by PBD and effect of
the duration of PBD on the POC was studied. Receiver
operating characteristic (ROC) curve analysis was used
to delineate an optimal duration for PBD.
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Results: The descriptive variables between the surgery
and drainage groups showed no significant differences
except, for all 14 patients who had pre-procedure cho-
langitis were from drainage-group (p = 0.0001). The
POC between the drainage-group and surgery-group
are demonstrated in Table 1. The drainage-group
showed a significantly high incidence of positive intra-
operative bile-cultures (p = 0.0001) and biliary-sepsis
(p = 0.0001) compared to surgery-group. The ‘Bilirubin
Reduction’ does not affect the POC but the ‘Duration
of Drainage’ affects the incidence of positive intra-oper-
ative bile-cultures (p = 0.024) and biliary-sepsis
(p = 0.025). The ROC curve analysis for the predictive
value of ‘Duration of Drainage’ on the incidence of
positive intra-operative bile-cultures showed the area
under the curve was 0.758 (95% CI 0.596–0.920), for
biliary-sepsis it was 0.745 (95% CI 0.590–0.900). The
best cut-off based on the OC curve analysis was
26 days (for positive intra-operative bile cultures – sen-
sitivity 51.6% and specificity 88.9%, for biliary sepsis –
sensitivity 51.9% and Specificity 92.3%).
Conclusion: PBD is associated with a higher incidence
of POC. Hence, it should be used with caution only in
selected cases. We recommend limiting the duration of
PBD to 26 days in such cases.
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EFFECTS OF HUMAN AND PLANT
TETRAPYRROLES ON PANCREATIC
CANCER
Libor Vitek
Na Bojisti, Prague, Czech Republic
Background and aims: Edible blue-green algae and
green plants are known to have chemopreventive
effects. Among other bioactive agents, they contain tet-
rapyrrolic compounds, chlorophylls and phycobilines,
structurally related to bilirubin, a major human bile
pigment possessing substantial bioactive properties
including antioxidant, anti-inflammatory and probably
also chemopreventive actions. The aim of our study
was to assess the effects of chlorophylls and phycobi-
lines, as well as human bile pigments on proliferation
of pancreatic cancer.
Methods: The in vivo effect of oral administration of
blue-green alga Spirulina platensis rich in chlorophylls
and phycocyanobilin was tested on athymic mice xeno-
transplanted subcutaneously with human pancreatic
cancer cells (PaTu-8902). The in vitro studies were per-
formed on PaTu-8902 and MiaPaCa-2 pancreatic can-
cer cells. The effect of various tetrapyrrolles
(chlorophylls a/b, chlorophyllin, phycocyanobilin, bili-
verdin and bilirubin), as well as extract from S. platen-
sis on cell viability (MTT assay) was investigated, as
well as their effect on phosphorylation of key proteins
implicated in cancer cell signaling (Kinex phosphoki-
nome array containing >800 probes, Kinexus, Canada).
The phosphokinome data were analyzed using DAVID
web platform to identify enriched functional protein
classes.
Results: Mice fed lyophilized S. platensis (0.5 g/kg
b.wt) exhibited substantially lower cancer progression
compared to untreated controls (tumor volume 1.2 vs.
2.9 cm3 at day 14 of treatment, p < 0.005). All tetra-
pyrroles (10–125 lmol/L) decreased significantly cancer
cell viability, most likely due to their effect on signaling
protein phosphorylation, with MAPK, VEGF and
ErbB signaling pathway proteins being the most signifi-
cantly affected. Simultaneously, all tetrapyrroles effi-
ciently modulated proteins involved in the p53 tumor
suppressor as well as Bcl2 apoptotic pathways.
Conclusions: Extract from S. platensis, but also individ-
ual tetrapyrroles such as chlorophylls and phycocyano-
bilin, but also human bile pigment bilirubin
demonstrated potent antiproliferative effects on experi-
mental human pancreatic cancer. This data suggest
promising chemotherapeutical potential of plant tetra-
pyrroles, and also support the protective role of biliru-
bin in human body.
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DOES PANCREATICO-JEJUNOSTOMY
REDUCE THE PANCREATIC FISTULA
AFTER DISTAL PANCREATECTOMY
WITH EN-BLOC CELIAC AXIS
RESECTION?
Kenichi Okada, Masaji Tani, Manabu Kawai, Seiko
Hirono, Motoki Miyazawa, Atsushi Shimizu, Yuji
Kitahata and Masaki Ueno
Second Department of Surgery, Wakayama Medical
University, 811-1 Kimiidera, Wakayama, 641-8510,
Japan
Background: The pancreatic fistula is a fatal complica-
tion in distal pancreatectomy with en-bloc celiac axis
resection (DP-CAR). In intra-abdominal hemorrhage
related to pancreatic fistula after DP-CAR, transarteri-
al embolization via pancreaticoduodenal arcade is
extremely difficult to perform by interventional radiol-
ogy. Among the literatures about the management of
the pancreatic stump after distal pancreatectomy, the
most attractive method with low incidence of pancre-
atic fistula was reported in pancreaticoenteric anasto-
mosis.
Methods: We reviewed 26 consecutive patients who
underwent DP-CAR between April 2008 and August
2012. We prospectively assigned the patients into two
groups by period of time to assess the effect of pan-
creatico-jejunostomy (PJ) at pancreatic stump; 13
patients without anastomosis (until February 2011) and
13 patients with Roux-en-Y PJ by duct-to-mucosa fash-
ion (after February 2011).
Results: All 26 patients were pancreatic body/tail carci-
noma including 18 invasive ductal carcinoma, 5 inva-
sive ductal carcinoma derived from intraductal
papillary mucinous neoplasm, 1 acinar cell carcinoma,
1 anaplastic carcinoma, and 1 mucinous carcinoma.
The background of patient characteristics in each
group was similar. The incidence of grade B, C pancre-
atic fistula according to ISGPF criteria revealed two
patients (15.4%) with PJ and five patients (38.5%)
without anastomosis (p = 0.189). The mean amylase
concentrations were decreased in patients with PJ com-
pared with those in patients without anastomosis at all
time points, 1017.8/4896.3 (IU/L) on POD 1
(p = 0.336), 342.7/5013.5 (IU/L) on POD 3 (p = 0.050),
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and 90.4/2275.5 (IU/L) on POD4 (p = 0.044), respec-
tively. There were no significant differences in regard to
mortality and morbidity rates between the groups.
Conclusion: Roux-en-Y drainage of the pancreatic
stump by non-stented duct-to-mucosa anastomosis after
distal pancreatectomy could prevent to increase in
severity of pancreatic fistula by reducing the leakage of
pancreatic juice. We are proceeding to examine the evi-
dence of the present study in a multicenter, randomized
controlled trial for distal pancreatectomy patients
(ClinicalTrials.gov NCT01384617).
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SURGICAL OUTCOME OF
HEPATOCELLULAR CARCINOMA
WITH BILE DUCT INVASION
Xu-Feng Zhang
Department of Hepatobiliary Surgery, The First
Affiliated Hospital of Medical College, Xi’an Jiaotong
University, Xi’an 710061, China
Background and aims: Bile duct invasion (BDI) is a
rare event in hepatocellular carcinoma (HCC). The aim
of the study was to investigate the clinicopathological
characteristics and surgical outcome of HCC with BDI.
Methodology: Clinical data of 446 patients with HCC
undergoing curative surgery was reviewed retrospec-
tively. The clinicopathological parameters and surgical
outcomes were compared between patients with BDI
and without BDI.
Results: 35 (7.8%) patients were identified BDI pre-
and postoperatively. Compared with HCC without
BDI, HCC with BDI displayed higher bilirubin
(p = 0.003), and larger and more multiple lesions
(p = 0.001 and p = 0.002, respectively). Portal vein and
microvascular invasion were predominant in HCC with
BDI (p < 0.001, respectively). Patients with BDI had
compromised survival than those without grossly
(p < 0.001). Vascular invasions were identified as risk
factors promoting early recurrence of HCC with BDI
after surgery (p < 0.05).
Conclusions: BDI indicates more advanced stage of
tumors, thus resulting poorer prognosis. Concomitant
vascular invasion might be a major reason for early int-
rahepatic recurrence and poor outcome of patients with
BDI after surgery.
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SUCCESSFUL TREATMENT OF
ADVANCED HEPATOCELLULAR
CARCINOMA WITH TUMOR
THROMBUS EXTENDING TO
INFERIOR VENA CAVA AND RIGHT
ATRIUM
Guang-Hui Ding1, Jian Wei1, Zhen-Shun Song1,
Chuan-Wu Cao2, Jia-Xing Zhang2 and Li-Hui Wang3
1Department of Hepato-Pancreato-Biliary Surgery,
Shanghai Tenth People‘s Hospital, Tongji University
School of Medicine, 301 Yanchang Road, Shanghai,
China; 2Department of Interventional Radiotherapy,
Shanghai Tenth People‘s Hospital, Tongji University
School of Medicine, 301 Yanchang Road, Shanghai,
China; 3Section of Nei-jing Teaching and Research,
Shanghai University of TCM, 1200 Cailun Road,
Shanghai, China
Background and aims: Hepatocellular carcinoma
(HCC) is one of the most common malignancies
worldwide and the third leading cancer death in
China. HCC growth into the inferior vena cava
(IVC) and right atrium (RA) is rare, and its outcome
is extremely poor. To date, there is still no consensus
on the treatment strategy for HCC with IVC/RA
extension. We herein report complete disappearance
of an advanced HCC with tumor thrombi in IVC
and RA and with multiple lung metastases induced
by transcatheter arterial chemoembolization (TACE)
and an anticancer liver kampo (a prescription of
Chinese herbal).
Methods: A 59-year-old man, who had suffered from
general fatigue and vague pain in RUQ for 3 months,
was diagnosed as advanced HCC with tumor
thrombi in IVC and RA and with multiple lung
metastases. A total of three sessions of TACE were per-
formed, simultaneously treated with an oral anticancer
liver kampo.
Results: The tumor thrombi, liver masses and the lung
metastases were all disappeared. The patient has been
followed-up for more than 5 years without any sign of
intra- or extrahepatic recurrence.
Conclusions: TACE is an effective treatment modality
in the management of unresectable advanced HCC.
The good performance status and well preserved liver
function provide a basis for patient to keep up through
the chemotherapy. To the best of our knowledge, this
is the first case of so far-advanced hepatocellular carci-
noma cured by non-surgical approach.
435
CLINICAL SIGNIFICANCE OF RIGHT
TRISECTIONECTOMY FOR PERIHILAR
CHOLANGIOCARCINOMA
Naoki Matsumoto
65 Tsurumai-cho, Showa-ku, Nagoya, Japan
Objective: To review our experiences with right-sided
hepatectomy for perihilar cholangiocarcinoma, to com-
pare right hepatectomy (R2S1) and right trisectionecto-
my (R3S1), and to evaluate the relation of the length
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of the left hepatic bile duct and Bismuth classification,
and pathological proximal margins.
Methods: This study involved 167 patients who under-
went right-sided hepatectomy for perihilar cholangio-
carcinoma (R3S1, n = 31; R2S1, n = 136) from
January 2001 to May 2012. The length of the left hepa-
tic bile duct was defined as the length between the
stump of the duct and the confluence of the right hepa-
tic duct. Positive margins were defined as the presence
of an invasive carcinoma on the stump.
Results: The length of the resected left hepatic bile duct
was significantly longer in R3S1 than in R2S1
(25.0  6.9 vs. 14.8  5.4 mm, p < 0.001). The positive
margins in Bismuth type IV were higher in R2S1 than
in R3S1 (40.0% vs. 12.0%, p < 0.05). Despite the fact
that patients who underwent R3S1 had more advanced
tumor, survival rates were not significantly different
between the two groups (87.2% at 1 year, 58.9% at
3 years and 48.4% at 5 years in R2S1 vs. 77,4% at
1 year, 43.9% at 3 years and 37.7% at 5 years in
R3S1, p = 0.298).
Conclusions: The length of the resected left bile duct
was longer by 10.2 mm in R3S1 than in R2S1. To
achieve R0 resection, R3S1 is recommended in patients
with Bismuth type IV tumor, if liver function is stable.
441
TOWARD THE IMPROVEMENT IN THE
ACCURACY OF PREOPERATIVE
BILIARY CYTOLOGY FOR
CHOLANGIOCARCINOMA
Tomonori Tsuchiya
65 Tsurumai-cho, Showa-ku, Nagoya, Japan
Purpose: In our previous study, we found that repeated
sampling by catheter aspiration increases sensitivity of
biliary cytology in suspected patients with perihilar
cholangiocarcinoma (Hattori et al. BJS 2011; 98; 704–
709). However, we still do not have a clear answer
regarding to the repeating times and intervals in order
to improve the accuracy rate of biliary cytology.The
purpose of this study was to elucidate an optimal
repeating times and intervals of biliary cytology to
improve the accuracy for the diagnosis of cholangiocar-
cinoma.
Methods: Seventy-seven patients who were to undergo
resection of cholangiocarcinoma after biliary drainage
either by endoscopic naso-biliary drainage (ENBD) or
percutaneous transhepatic biliary drainage (PTBD) were
randomly assigned to the following two groups: group
A, patients underwent biliary cytology once a day for 10
consecutive days; group B, patients underwent biliary
cytology five times a day for 2 consecutive days. The
overall positive rate of biliary cytology, the number of
times that required obtaining initial positive result of
cytology,and the association of positive results and his-
tological type of cholangiocarcinoma were analyzed.
Results: There were no significant difference between
the groups A and B in sex, age, and background dis-
ease. The overall positive rate of biliary cytology was
60.0% in the group A and 46.7% in the group B. The
average repeating times that required obtaining initial
positive result were 2.25 times in the group A and 1.73
times in the group B. In the group A, 56% of positive
cases were positive at the first time and 89% were posi-
tive by the fifth times. In the group B, 64% of positive
cases were positive at the first time and 100% were
positive by the fifth times. Regarding to the histological
type, the positive rate was the highest in the poorly dif-
ferentiated type (83.3%) as compared to other type of
histology (57.1% in the well-differentiated type; 40.0%
in the moderately differentiated type).
Conclusions: Although there was no statistically signifi-
cant difference, the positive rate of cytology was higher
by repeating cytology in a same day. The optimal
repeating times of cytology is 5, and further repeating
would not improve the accuracy of diagnosis.
446
DIFFERENT PROGNOSTIC FACTORS
ACCORDING TO AGE AT THE TIME OF
TRANSPLANTATION IN PEDIATRIC
LIVER TRANSPLANTATION
Jeik Byun
Department of Surgery, Seoul National University
College of Medicine, Seoul, South Korea
Backgrounds: Liver transplantation (LT) has been the
key therapy for end stage liver diseases for over
20 years. However, a few studies of prognostic factors
according to the age in pediatric LT have been pub-
lished.
Methods: Between 1992 and 2010, 152 pediatric recipi-
ents who had undergone their first ABO compatible LT
in our center were retrospectively reviewed. The most
common underlying liver disease was biliary atresia
(BA, n = 94, 61.8%). The mean age of the recipients at
the time of LT was 55 (range, 0–210) months. We
divided patients into two groups; Group I, age under
12 months (n = 43) and Group C, over 12 months
(n = 109).
Results: Fulminant hepatitis (FH) was 4.8% in Group
I and 13.8% in Group C (p = 0.021). The CTP classifi-
cation more than B was more common in Group I
(95.1%) than in Group C (71.7%) (p = 0.001). The
mean PELD score was higher in Group I (21.8) than in
Group C (13.4) (p = 0.049). The postoperative PTLD
and portal vein complication were more common in
Group I (14.0%, 18.6%) than in Group C (1.8%,
3.7%) (p < 0.05). The 1, 5, and 10 patient survival
rates were similar between two groups (p > 0.05); 93%,
89%, and 89% in Group I and 91%, 89%, and 87% in
Group C. The 1, 5, and 10 year graft survival rates
were 93%, 93%, and 93%, in Group I and 92%, 90%,
and 88% in Group C (p > 0.05). However, the factors
affecting on the survival were different. In Group I,
none of the factors affected on survival outcome. In
Group C, underlying liver disease (non-BA, FH) was
only factor of patient survival on multivariate analysis.
Conclusion: FH was more common although PELD
and CTP score was lower in Group C. The survival
outcome of pediatric LT was excellent and similar
between two groups. Underlying liver disease was the
only factor of patient survival in Group C, but not in
Group I. Careful management of non-BA patient, espe-
cially FH, may be mandatory in pediatric LT.
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RADIOLOGY DIFFERENTIAL
DIAGNOSTICS OF RARE CYSTIC
PANCREAS LESIONS
A Stepanova Yuna1,2 and G.G. Karmazanovsky1,2
1Vishnevsky Institute of Surgery, B. Serpukhovskaja St.,
27, Moscow, Russia; 2Sechenov First Moscow State
Medical University, Moscow, Russia
Background: Cystic lesions of the pancreas are an
example of changes in the tactics of patients treatment
in process of accumulation of knowledge of these neo-
plasms. Knowledge of fundamental clinical, pathologic,
laboratory, and imaging information related to specific
cystic pancreatic lesions can be used to decrease misdi-
agnosis, to narrow the differential diagnosis, or, in
some cases, to provide a diagnosis.
Aim: To identify the opportunities of preoperative dif-
ferential diagnostics of rare cystic pancreas lesions
(RCPL).
Materials and methods: 98 patients with RCPL were
examined and treated (2004–2012). Preoperative exami-
nation included: ultrasound, CT and MRI with bolus
contrast enhancement. Morphology: Intraduct papillary
mucinous tumor (IPMN)-30, solid-pseudopapillar
tumor (SPPT)-22, cystic form of duodenal dystrophy
(CDD)-43, cystic teratoma (1), cystic lymphangioma
(1), echinococcus cyst (1).
Results: IPMN: 70,0% male. Diagnosed with three
types: from the main pancreatic duct (MPD) (16), of
the branch-ducts (7), mixed (7). Radiology criteria:
advanced duct, fusiform with lesions of MPD or cystic
cluster structures in branch-ducts and mixed; seal its
walls; parietal papillary growths, there may be a single
extended branch-ducts and tumor masses around
MPD. IPMN preoperative verification 76,7%. Priority
– MRI.
SPPT: 90,9% women. Radiology criteria: formation
size <5.0 cm in diameter: heterogeneous solid structure
with a small cystic inclusions, fluid-filled with a hemor-
rhagic component; formation size >5.0 cm in diameter:
heterogeneous solid structure with cystic inclusions or
cystic structure with a slightly pronounced parietal
solid component. SPPT preoperative verification
31.8%. Priority – MRI.
CDD: 93.0% male. Radiology criteria: thickening of
the duodenum wall with cystic formation, varying
degrees of duodenal stenosis. Location gastro-duodenal
artery on the right of formation is the main differential
diagnostic criterion for the localization in the duode-
num wall. X-rays are also necessary. CDD preoperative
verification 93.0%.
False negative results found in 26.3%.
Conclusion: Preoperational diagnostics of rare cystic
masses of the pancreas is rather difficult. The knowl-
edge of their presence in a combination with character-
istic symptoms of disease allows to make the correct
diagnosis.
Radiology criteria of IPMN and CDD is well defined.
Development of diagnostic criteria SPPT requires the
accumulation of more observations in one hand and
analysis of information. Currently, an important com-
plement to the diagnosis of SPPT is anamnesis.
MRI should be preferred in the algorithm of the survey
at suspicion of RCPL.
451
LAPAROSCOPIC DRAINAGE OF
CRYPTOGENIC LIVER ABSCESS AS
THE FIRST LINE OPTION
Sandhya G Krishnan
National University Hospital, Singapore, Singapore
Objective: The objective of this study is to compare the
outcomes of percutaneously drained (PD) and laparo-
scopically drained (LD) liver abscesses.
Background: The management of cryptogenic liver
abscess is traditionally managed with percutaneous
drainage in most parts of the world. Open drainage is
reserved in the event of inadequate resolution. Laparo-
scopic drainage provides an alternative option, which
potentially provides superior sepsis control while still
allowing for a minimally invasive approach.
Methods: Records of 99 patients treated at our institu-
tion from 2005 to 2011 with radiological evidence of
liver abscesses measuring more than 3 cm were
retrieved. Clinico-pathologic variables were used to
analyze the outcomes for each intervention. Multivari-
able logistic regression was used to identify failures of
intervention defined as persistent sepsis or death, com-
plication associated with intervention, length of antibi-
otic therapy and hospital stay.
Results: Of the 99 patients, 21 had LD and 78 had
PD. Two patients (9.5%) in the LD group failed pri-
mary intervention compared to 29 (37.1%) in the PD
group (p = 0.035). Two (2.6%) patients in the PD
group died of progression of sepsis despite drainage.
PD is more likely to fail as compared to LD [OR 0.03,
95% CI 0.0–0.39; p = 0.008], but there was no differ-
ence in complications related to the intervention
(p = 0.366). Time to defervescence of fever was signifi-
cantly shorter in LD (mean 1.7 days) than in PD (mean
4.4 days) with a p < 0.001. Mean duration of antibiot-
ics between the groups was similar at 44.7 days in the
PD group compared to 42.5 days in the LD group
(p = 0.392). Mean length of hospital stay significantly
shorter in LD; PD at 14.9 days compared to 11.2 in
the LD group (p = 0.006).
Conclusion: Laparoscopic drainage of cryptogenic liver
abscesses results in earlier sepsis resolution and should
be considered as first line therapy.
464
ARANTIUS’ LIGAMENT APPROACH
FOR THE LEFT EXTRAHEPATIC
GLISSONEAN PEDICLE IN PURE
LAPAROSCOPIC LEFT
HEMIHEPATECTOMY
Mamoru Sato
Nitona-Tyou Tyuouku Chibasi, Chiba, Japan
Background and aims: Although the recent develop-
ments in technological innovations, improvements in
surgical skills and the extensive experience of surgeons
have greatly enlarged the applications for laparoscopic
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liver resection, laparoscopic hemihepatectomy has not
yet become widely accepted due to the technical diffi-
culties in controlling each Glissonean pedicle laparo-
scopically. We herein describe a novel technique that
uses Arantius’ ligament approach by which the left
Glissonean pedicle can be easily and safely encircled
and divided en bloc extrahepatically during laparo-
scopic left hemihepatectomy.
Methods: A 62-year-old male with hepatocellular carci-
noma underwent a pure laparoscopic left hemihepatec-
tomy. Arantius’ ligament was divided. Retracting the
caudal stump of the ligament revealed a space between
the left Glissonean pedicle and the liver parenchyma.
The left Glissonean pedicle could be easily encircled
using an Endo Retract Maxi and divided en bloc with
a laparoscopic stapler.
Results: No Glissonean injuries, including bleeding or
biliary leakage, occurred during and after surgery. The
procedure took 339 min and operative bleeding was
minimal. The patient was discharged on the 7th post-
operative day. A histological examination showed com-
bined hepatocellular and cholangiocellular carcinoma.
The surgical margins were histologically clear (R0
resection).
Conclusions: Arantius’ ligament approach for the left
extrahepatic Glissonean pedicle therefore appears to be
feasible and safe for successfully performing pure lapa-
roscopic left hemihepatectomy.
468
MICROWAVE ABLATION WITH OR
WITHOUT RESECTION FOR
COLORECTAL LIVER METASTASES
Stefan Staettner
Muellner Hauptstr. 48, Salzburg, Austria
Background: Surgical resection is the only potentially
curative option for patients with colorectal cancer liver
metastasis (CLM). Ablation with or without resection
has been suggested if complete surgical resection is not
possible. We present a consecutive single centre series
of patients regarded as technically non-resectable and
treated with surgical microwave ablation (MWA) with
or without resection for CLM.
Method: All patients who underwent surgical treatment
with MWA between 5/2005 and 2/2012 were retrospec-
tively analysed according to surgical MWA or MWA
combined with hepatectomy. Data were collected from
a prospectively maintained database.
Results: Forty-three patients (11 females and 32 males)
with a median age of 67 years underwent open MWA.
Twenty-eight had combined liver resection and ablation
(RMWA). Ninety-five lesions with a median largest
diameter of 15 mm (range 8–43 mm) were ablated.
Median overall survival (OS) was 28 months with a
median follow-up of 15 months (range 3–84). Esti-
mated 1-, 3- and 5-year overall survival rates were
82%, 40% and 12% with estimated disease free sur-
vival (DFS) of 31%, 22% and 6%, respectively with
median DFS of 8 months. Overall morbidity was 35%,
postoperative mortality 2%. The local recurrence rate
per treated lesion was 4%.
Conclusion: MWA is a safe and effective method of
achieving disease control for small non-resectable
CLM. Combined RMWA offers good medium term
outcomes, comparable to that seen after two-stage
resection on an intention to treat basis and may
therefore be a safe alternative to two stage hepatecto-
mies.
469
NEOADJUVANT
CHEMOEMBOLISATION OF
COLORECTAL LIVER METASTASES
(CRLM) WITH DRUG ELUTING BEADS
TRANS-ARTERIAL CHEMO-
EMBOLIZATION
Stefan Staettner
Muellner Hauptstr. 48, Salzburg, Austria
Background: Perioperative chemotherapy confers 3-
year progression free survival advantage following
resection of CRLM and good pathologic response is
associated with improved overall survival. However,
systemic neoadjuvant chemotherapy can increase post-
operative morbidity and mortality. TACE using pre-
loaded Irinotecan eluting beads give sustained delivery
of drug directly to tumor, thereby maximising response
and reducing systemic exposure. This study examined
the feasibility and safety of neoadjuvant DEBIRI-
TACE before CRLM resection.
Methods: Patients with resectable CRLM received sin-
gle DEBIRI-TACE (up to 200 mg) 1 month pre-hepa-
tectomy. Primary end-point: tumor resectability,
secondary end-points: safety, radiologic response (RE-
CIST) and pathologic tumor response.
Results: TACE attempted in 49 patients, successful in
40. Reasons for failed TACE included consent with-
drawal (n = 2), bilobar disease (n = 2), tumour involv-
ing gallbladder wall (n = 1), suspected hepatoma
(n = 1), arterial access difficulty (n = 2), contrast med-
ium allergy (n = 1). Post-TACE complications: 1 acute
pancreatitis (3%); 4 post-embolization syndromes
(10%).
Imaging at 4 weeks post-TACE (30 patients): complete
response 0/40 (0%); partial response 1/40 (3%); stable
disease 19/40 (48%); ‘progressive’ disease 10/40 (25%).
40 patients proceeded to surgery, 38 underwent hepa-
tectomy (2 peritoneal disease, resectability rate 95%).
30-day post-operative mortality 5% (n = 2), neither
death TACE related (1 intraoperative pneumomediasti-
num, 1 aspiration pneumonia).
63 lesions (median 2 per patient) targeted with TACE.
Histology: no residual disease 17%; 1–49% residual
disease 59%; >50% residual disease 22%; no response
2%.
Conclusions: Resection after neoadjuvant DEBIRI-
TACE for CRLM is feasible and safe. Single treatment
with DEBIRI-TACE resulted in tumor pathologic
response similar to that seen after protracted systemic
chemotherapy.
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CLINICAL EXPERIENCES OF
CONSECUTIVE 439
PANCREATICODUODENECTOMIES IN
SINGLE CENTER
Seung Duk Lee
National Cancer Center, Goyang-si, Republic of Korea
Background: Pancreaticoduodenectomy has been
known as a standard operation for the tumor of pe-
riampullary lesion. However, this operation has needed
the difficult techniques of massive dissection and multi-
ple anastomoses.
Method: We analyzed the consecutive patients from
June 2001 to June 2012 who have undergone the pan-
creaticoduodenectomy in National Cancer Center,
Republic of Korea. Retrospective data including clini-
copathologic and survival results was evaluated.
Results: Total 429 patients were enrolled during this
period. There were 170 (38.7%) patients with pancre-
atic cancer, 96 (21.9%) with common bile duct cancer,
92 (21.0%) with ampulla of Vater cancer, 17 (3.9%)
with duodenum cancer, and 64 (14.6%) with other dis-
eases. Furthermore, we performed 101 (23.0%) stan-
dard pancreaticoduodenectomy (PD), 306 (68.7%)
pylous preserving pancreaticoduodenectomy (PPPD),
13 (3.0%) hepaticopancreatitoduodenectomy (HPD),
and 19 (4.3%) total pancreatectomy. Mean postopera-
tive hospital stay was 26.4 days, in-hospital mortality
was six patients (1.4%), and complication rate was
22.1%. Pathologic stages were showed with pancreatic
cancer (T1/2/3/4; 5.3%/8.8%/85.3%/0.6%, N1; 68.2%),
CBD cancer (T1/2/3/4; 4.2%/23.2%/68.4%/4.2%, N1;
42.1%), AoV cancer (T1/2/3/4; 22.8%/39.1%/31.5%/
3.3%, N1; 46.7%), and duodenum cancer (T1/2/3/4;
0.0%/17.6%/52.9%/29.4%, N1; 82.4%). Overall and
disease-free survival of 1, 3, 5 year were 76.5%, 51.3%,
42.2% and 58.9%, 45.4%, 42.2%, respectively. Overall
and disease-free survival of 1,3,5 year by disease were
63.7%, 32.6%, 23.5% and 42.3%, 27.5%, 15.4% (pan-
creatic cancer), 77.6%, 41.1%, 32.4% and 56.7%,
42.5%, 34.8% (CBD cancer), 91.3%, 76.6%, 62.9%
and 77.2%, 63.0%, 48.2% (AoV cancer), 77.8%,
54.4%, 45.4% and 38.7%, 19.3%, 19.3% (duodenum
cancer).
Conclusion: Pancreatoduodenectomy could be per-
formed with low mortality. However, low overall and
disease-free survival still remains for periampullary can-
cer.
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CLINICAL CHARACTERISTICS OF
HEPATOCELLULAR CARCINOMA IN
CHILDREN AND COMPARISON WITH
ADULT
Xu-Feng Zhang
Department of Hepatobiliary Surgery, The First
Affiliated Hospital of Medical College, Xi’an Jiaotong
University, Xi’an, China
Background: Heptocellular carcinoma (HCC) is rarely
occurred in children. Limited previous reports identified
HCC in children were exclusively hepatitis B virus
(HBV) related. The present study aims at investigating
clinical characteristics of pediatric HCC and survival in
comparison with adult cases in an era after national
hepatitis B vaccination.
Methods: Overall 2280 cases of HCC in authors’ cen-
ter were retrospectively reviewed. 45 (1.97%) cases of
HCC were diagnosed in children ( 18 years old).
Clinical, pathological and therapeutic data of 45
patients was analyzed. Impacts of different therapeu-
tics, HBV infection and distal metastasis on survival
were evaluated by Kaplan–Meier methods and tested
by log-rank test. 382 adult patients with HCC under-
going surgical resection at the same time period were
enrolled and the survival was compared to 12 pediat-
ric cases.
Results: The mean age of children with HCC was
13.5 years old (ranges, 3–18) with predominantly male
(93.3%). 30 (66.7%) patients and their mother were
HBV positive concomitantly. Although liver damage
was unremarkable, advanced disease prevented avail-
ability of curative resection due to large tumor size
(>10 cm, 66.7%), early metastasis (24.4%), bilateral
involvement (57.8%) and portal vein invasion (46.7%).
The median survival for resectable, TACE and
untreated patients was 28.6, 4 and 5 months, respec-
tively (p < 0.001). Patients with distal metastasis had
significantly poor survival rate than those without
(p < 0.001). 12 children undergoing surgical resection
had worse survival than 382 adults (Median survival,
28.6 vs. 45 months), although the difference was not
statistically significant (p > 0.05).
Conclusion: HBV is a major but not the only cause of
HCC in children. Because of short duration but rapid
progression of disease, pediatric HCC always presented
with advanced stage in aspects of huge hepatomas and
early metastasis, which resulted in compromised sur-
vival than adults. Surgical resection remains the only
help in long term survival.
491
SINGLE-INCISION LAPAROSCOPIC
SPLEEN-PRESERVING DISTAL
PANCREATECTOMY
Hiroo Yanagibashi, Akihiro Cho, Hiroshi Yamamoto,
Osamu Kainuma, Seongjin Park and Hidehito Arimitsu
Chiba Cancer Center, 666-2 Nitona-cho, Tyuo-ku,
Chiba-shi, Chiba, Japan
Background and aims: Single-incision laparoscopic sur-
gery (SILS) is a novel area of minimally invasive sur-
gery, and rapidly evolving in the field of abdominal
surgery as a complement to standard laparoscopic sur-
gery and a safe alternative to natural orifice translumi-
nal endoscopic surgery. However, single-incision
laparoscopic pancreatic resection remains not univer-
sally accepted as an alternative approach for conven-
tional laparoscopic or open surgery because of
technical difficulties and a steep learning curve for sur-
geons. We describe our experience with SILS distal
pancreatectomy in patients with pancreatic cystic lesion
with a successful outcome.
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Methods: A 45-year-old female with pancreatic cystic
lesion underwent a pure SILS distal spleen-preserving
pancreatectomy.
Results: The procedure took 237 min, and operative
bleeding was minimal. The patient was discharged on
the 10th postoperative day. A histological examination
showed benign cystic lesion.
Conclusions: The potential benefits of SILS include
superior cosmesis and possibly lower costs, and a short-
ened time to full physical recovery. Careful case selec-
tion and a low threshold of conversion to conventional
laparoscopic surgery are essential. Multicenter, ran-
domized, prospective studies are needed to compare
short- and long-term outcome measures against those
of conventional laparoscopic surgery.
511
LIVER TRANSPLANTATION FOR
ACUTE-ON-CHRONIC LIVER FAILURE
PATIENTS WITH HIGH MODEL FOR
END LIVER DISEASES SCORE
Bin-Wei Duan
Youan Hospital of Beijing, Capital Medical University,
Beijing, China
Background: Acute-on-chronic liver failure (ACLF) is
a severe clinical condition and the definition remains
controversial. Liver transplantation is the only curative
option for ACLF. However, there is scarce data on
liver transplantation for ACLF.
Aim: We analyzed the preoperative, intraoperative,
postoperative data as well as overall survival of 100
consecutive cases with ACLF retrospectively and try to
define which liver transplantations for these patients
are futile. Results
100 patients with pathology confirmed ACLF under-
taken liver transplantation from June 2004 to Septem-
ber 2012. The preoperative data showed that all
patients were in the serious conditions characterized by
the high model for end liver diseases(MELD) score (32,
19–53), total bilirubin (440.20 μmol/L, 91.90–
971.40 μmol/L), INR (3.012, 1.377–9.850) and compli-
cated with at least one organ dysfunction assessed by
sequential organ failure assessment (SOFA) score (9, 6–
20). The patients performed either deceased or living
donor liver transplantation and the overall hospital
mortality was 20% (20/100). The 1, 3, 5-year accumula-
tive survival rate was 76.8%, 75.6%, 74.1%, respec-
tively and the graft 1, 3, 5-year accumulative survival
rate was 73.3%, 72.1% and 70.6%, respectively. How-
ever, the area under receiver operating characteristic
(AUC) of SOFA score, MELD score as well as Child-
Pugh score were 0.552(0.411, 0.693), 0.547(0.405, 0.690)
and 0.547(0.422, 0.672), none of which could defini-
tively predict the postoperative mortality.
Conclusion: Both deceased and living donor liver trans-
plantation are the definitive therapy option for the
patients with ACLF and the proximate and long-term
survivals are encouraging.
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THERAPEUTIC POTENTIALS OF
HUMAN ADIPOSE-DERIVED STEM
CELL-CONDITIONED MEDIA ON THE
PARTIALLY HEPATECTOMIZED MICE
SayJune Kim, GunHyung Na, HoJoong Choi and
DongGoo Kim
Department of Surgery, Daejeon St. Mary’s Hospital,
The Catholic University of Korea, Daejeon, South Korea
Background and aims: Stem cell therapy is a promising
approach for the liver disease. However, potential
tumorigenicity and low survival rates of implanted cells
could threaten the effectiveness of the cell-based treat-
ment. The use of stem cell-conditioned medium (CM)
may be a feasible approach to overcome these limita-
tions.
Methods: In vitro generated human adipose-derived
stem cells (ADSC) were checked for the surface mark-
ers and stage-specific genes for characterization. CM
was prepared by culturing ADSC for 48 h and concen-
trated 25-fold using ultrafiltration units. Afterwards,
ADSC (1 9 106 cells) and CM were transplanted via
tail vein to the partially hepatectomized mice. At 1, 2,
and 3 post-transplantation days, serum biochemical
parameters and liver specimens were evaluated.
Results: We have shown here that ADSC have the
characteristics of mesenchymal stem cells, and belong
to endodermal and/or early hepatic differentiation
stage. After the transplantation, generally more promi-
nent reductions in markers of liver injury, such as IL-6,
TNFa, alanine aminotransferase, aspartate aminotrans-
ferase, and ammonia, were noted in mice transplanted
with CM. And, more improved regeneration profiles –
such as Ki67 stain, BrdU indices, and mitotic indices –
were comparable between the CM group and ADSC
group. Serologic analyses revealed that CM group, and
cell group as well, more preferably increased mice albu-
min than human albumin, suggesting of their paracrine
effect.
Conclusions: These data provide the clear evidence that
ADSC-CM therapy provides trophic support to the
injured liver by stimulating regeneration. Stem cell-cul-
tured CM utilizes paracrine factors of stem cells with-
out cell transplantation, and therefore, can be
considered as a feasible alternative to stem cell therapy.
526
GENOMIC COPY NUMBER
ALTERATIONS IN KOREAN BILE DUCT
CANCER IN COMPARISON WITH
NORMAL HEALTHY KOREAN
Mee Joo Kang, Jin-Young Jang, Jae Woo Park, Wooil
Kwon, Ye Rim Chang and Sun-Whe Kim
Department of Surgery, Seoul National University
College of Medicine, Seoul, South Korea
Background: The cytogenetic pathogenesis of bile duct
cancer is poorly understood. This study investigated
changes in gene copy number in Korean bile duct can-
cers and compared it with normal healthy Korean. Fur-
thermore, specific copy number changes in bile duct
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cancer were investigated with disease free survival of
bile duct cancer patients.
Methods: Array comparative genomic hybridization
was performed on 24 Korean bile duct cancer speci-
mens and 10 normal healthy Korean. Results were vali-
dated by disease free survival of bile duct cancer
patients.
Results: Total of 984 copy number variation (CNV) in
306 CNV regions (CNVR) were distributed throughout
all 22 chromosomes in Korean bile duct cancer
patients. Korean bile duct cancer patients had mean of
21.8 gains and 19.2 losses and average number of
CNVR was 35.9 per patient. Frequent sites of gain
were located at 22q11.22, 2p11.2-p.11.1, 14q32.33 and
17q12. Frequent site of losses was located at 19q12-
q13.43. Comparing 10 normal healthy Korean controls
with 24 Korean bile duct cancer patients, total of 7,825
CNV and 2,081 CNVR were identified. Twenty signifi-
cant CNVR showed significant differences between nor-
mal healthy Korean and Korean bile duct cancer
patients. Significant gains of copy number were
observed in 2p11.2, 5p15.33, 22q11.21, 22q11.22,
22q11.23, 22q12.2, 22q12.3, 22q13.1, 22q13.31 and
22q13.33. Significant losses of copy number were
observed in 8q11.21, 10q26.3, 11p15.4, 18q21.31 and
18q23. Copy number gain in 5p15.33 and 22q13.33 was
correlated with early systemic recurrence of Korean bile
duct cancer patients.
Conclusion: This study defined regions of the genome
associated with changes in DNA copy number in Kor-
ean bile duct cancer. Copy number gain in 22q11-q13
was most frequent in Korean bile duct cancer and was
correlated with poor disease free survival. The findings
have implications for identification of therapeutic tar-
gets, screening, and prognostication.
527
LONG-TERM PROGNOSIS AFTER
PORTAL VEIN RESECTION FOR
PANCREATIC HEAD CANCER
Mee Joo Kang, JinYoung Jang, Jae Woo Park, Wooil
Kwon, Ye Rim Chang and SunWhe Kim
Department of Surgery, Seoul National University
College of Medicine, Seoul, South Korea
Background: Based on the concept that portal vein
(PV) invasion of pancreatic cancer does not represent
the aggressiveness of the tumor but is caused by the
tumor location, PV invasion was down-staged from T4
to T3. The authors investigated the clinical implication
of PV resection (PVR) and PV invasion.
Methods: Data were collected from 415 patients who
underwent surgery for pancreatic head cancer at Seoul
National University Hospital. Long-term prognosis was
analyzed according to PVR and pathological invasion
of the PV.
Results: The study subjects were at mean age of
61.8 years (male:female = 1.6:1) with median follow up
of 13.7 months (range, 0.4–119.6). Curative intended
resection rate was 67.5% (n = 280), and R0 resection
rate was 57.8% (n = 240). After curative resection,
AJCC 7th staging were distributed as follows; stage IA
(n = 5, 1.8%), stage IB (n = 2, 0.7%), stage IIA
(n = 114, 40.7%), and stage IIB (n = 159, 56.8%).
PVR was performed in 16.8% (n = 47) of curative
resection. R0 resection rate or postoperative complica-
tion rate was comparable between PVR and no-PVR.
Overall median survival of all study subjects was
15.7 months and prognosis was better after R0 resec-
tion than R1 resection (median 22.2 vs. 13.9 months,
p < 0.001). PVR did not affect survival outcome in
patients who achieved R0 resection (median 23.3[PVR]
vs. 21.7[no-PVR] months, p = 0.678). PVR was not a
significant prognostic factor when AJCC stage (stage I,
p = 0.266; stage II, p = 0.502) or nodal status were
matched (N0, p = 0.518, N1, p = 0.532) after R0 resec-
tion. Patients with true pathologic invasion into PVR
had poor survival outcome than those without (median
14.4 vs. 26.5 months, p = 0.030).
Conclusion: PVR has no prognostic impact after R0
resection of pancreatic head cancer, regardless of its
AJCC stage or nodal status. However pathologic inva-
sion into PVR is associated with poor prognosis.
Therefore, PV invasion is not only a matter of tumor
location but also a poor prognostic factor when true
pathologic invasion exists.
542
MANAGEMENT OF RECURRENT
PAPILLARY CARCINOMA OF THE
BILIARY SYSTEM
Priyanka Sali, Rajegowda A. S, Rajiv Shah and P.
Jagannath
Lilavati Hospital and Research Centre, Mumbai, India
Background and aims: Papillary carcinomas of the bili-
ary system are often low grade tumors with a better
outcome. They have a long survival but are known to
have recurrences. Some may be distant whereas some
may be metachronous along the biliary tree. Usually,
they recur at the anastomotic site. Such local recur-
rence is generally considered incurable. We present
three cases of recurrent papillary adenocarcinomas of
the biliary system after R0 resection. Two of these
cases were successfully managed surgically with R0
resection. We highlight the outcomes of reresections for
these diseases.
Methods: Improved imaging techniques allow early
detection of indolent bile duct cancers. Case 1 had a
primary left hepatic duct lesion. He underwent a left
hepatectomy. Histopathology confirmed papillary ade-
nocarcinoma (T2N0) with clear margins. 5 months
later, the patient on routine follow up was detected
with recurrence at the anastomotic site. He underwent
a salvage surgery for the same. Histopathology con-
firmed papillary carcinoma with superficial spread with
TisN0 stage and R0 resection. Case 2 had undergone a
pancreaticoduodenectomy for a periampullary papillary
adenocarcinoma. She had a recurrence twice, first after
6 months in the left ovary and second after 8 months
in the right ovary. She underwent an oophorectomy
each time. Histopathology again confirmed cystic papil-
lary adenocarcinoma. She was continued on chemo-
therapy. These patients died 24 and 36 months later
due to disease progression. Case 3 had also undergone
pancreaticoduodenectomy for an ampullary papillary
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adenocarcinoma of T2N0 stage and R0 resection. She
was detected with recurrence at the anastomotic site
after 17 months. Due to poor general health, she was
not taken for surgery and died 6 months later.
Results: These patients recovered well postoperatively.
Histology showed clear margins. Thus, the survival of
these patients was increased.
Conclusion: Our cases highlight that recurrence follow-
ing an R0 resection for papillary carcinomas of the bili-
ary system is possible and also aggressive salvage
surgery for metachronous multicentric tumors can be
safely undertaken to improve outcome for such
patients.
549
FACTORS RESULTING IN EXCESSIVE
BLOOD LOSS DURING LIVER
TRANSPLANT
Jesse S. L. Hu1, Damian Z. Q. Lee2, Shridhar G. Iyer1,
Alfred Kow1, Krishnakumar Madhavan1 and Stephen
K. Y. Chang1
1Department of Surgery, National University Health
System, 1E Kent Ridge Road, NUHS Tower Block,
Level 8, Singapore 119228, Singapore; 2Yong Loo Lin
School of Medicine, National University of Singapore,
Singapore, Singapore
Background and aims: Liver transplant may be per-
formed for patients with chronic liver disease and those
with hepatocellular carcinoma (HCC). It is a procedure
known to be associated with significant intra-operative
blood loss. Before undergoing liver transplant, it is not
uncommon for patients with HCC to undergo proce-
dures to treat the tumor. The aim of the study is to
investigate the factors that affect blood loss during liver
transplant and whether such pre-transplant treatment
modalities increase risk of excessive blood loss.
Methods: Data from our adult liver transplant data-
base from 2000 to 2011 were retrospectively studied.
Both blood loss and transfusion requirements were
analyzed. Data on factors that could have affected
either blood loss or transfusion requirements were col-
lected and analyzed using SPSS. Statistical tests such as
chi-squared test were used for categorical risk factors
while Mann–Whitney U test was used for numerical
risk factors.
Results: A total of 57 adult patients were studied dur-
ing the period. The mean age of patient at time of
transplant was 57 years-old. The most common reason
for liver transplant was HCC (61.4%). Most of the
patients had Child’s B cirrhosis (42.1%); with equal
numbers of Child’s A and C cirrhosis. 59.6% of
patients had pre-transplant therapy such as liver resec-
tion, radiofrequency ablation and TACE. The median
blood loss during transplant was 4 L (1–26 L). Exces-
sive blood loss is defined as intra-operative blood loss
of more than 3 L. 65.5% of the patients with pre-trans-
plant therapy had excessive blood loss compared to
82.4% of those without previous therapy; however this
is not statistically significant. On subgroup analysis,
there is no difference in median blood loss between the
group who underwent TACE only (5 L) and the group
who underwent resection and/or ablation (5.7 L). Pre-
operative haemoglobin, platelet, MELD score, and type
of graft used were also not associated with excessive
blood loss. However, pre-operative jaundice
(p = 0.005), prolonged prothrombin time (p = 0.004)
and prolonged operative time (p = 0.024) were found
to be associated with excessive blood loss. These same
factors along with presence of ascites (p = 0.004) were
also associated with increased transfusion during trans-
plant. Multivariate analysis of the above factors
showed that pre-operative jaundice (p = 0.047) was
associated with excessive blood loss and ascites was
associated with increased transfusion requirements dur-
ing surgery.
Conclusion: Pre-operative jaundice is associated with
excessive blood loss during transplant while pre-trans-
plant therapy does not seem to.
571
REPORTING THE MARGIN IN
PANCREATICODUODENECTOMIES R0
VERSUS R1
Chandralekha Tampi1, Rajeev Shah2 and Palepu
Jagannath2
1Department of Pathology, Lilavati Hospital and
Research Centre, Bandra-W, Mumbai 400 050, India;
2Department of Surgical Oncology, Lilavati Hospital and
Research Centre, Bandra-W, Mumbai 400 050, India
Background: The anatomic constraints that limit the
radius of excision around the pancreatic head, along
with the absence of a standardised protocol in report-
ing these circumferential margins have led to a wide
variation in the R0/R1 rates in pancreaticoduodenecto-
my. Bread loafing the pancreas and duodenum in the
axial plane, as suggested by the Leed’s protocol, best
exposes, the most frequently involved margins, i.e. the
posterior and medial circumferential margins. It is also
known that adenocarcinomas arising in the pancreatic
head, ampulla, terminal CBD, and duodenum, have
different behaviour and prognosis.
Aim: To analyse the effect of using a standardized pro-
tocol on the margin positivity for adenocarcinoma aris-
ing in the pancreatic head, ampulla, terminal CBD, and
duodenum, and to assess the different ways these
tumor subsets involve the margins.
Methods: A standardized protocol, with sequential slic-
ing in the axial plane was adopted, with subsequent
analysis of the margin positivity in pancreaticoduoden-
ectomy for adenocarcinomas arising in the pancreatic
head, ampulla, terminal CBD, and duodenum. The
analysis was performed on 70 consecutive specimens,
the preprotocol specimens serving as the control group.
Result: Protocol led examination resulted in an increase
in margin positivity. Tumours originating from the pan-
creatic head, ampulla, terminal CBD, and duodenum
showed a consistent difference in their R1 incidence,
both pre and post protocol. In pancreatic head adeno-
carcinomas, R1 increased from 55% to 80%, distal
CBD from 50% to 60% and ampullary from 17% to
39%. Duodenal adenocarcinomas had no R1 in both
pre and post protocol groups. The tumors also involved
the margins differently. Ampullary tumors involved
only the posterior margin, pancreatic adenocarcinomas
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involved the SMV groove more often than the posterior
margin, and distal CBD tumors involved the posterior
margin and SMV groove equally. Size of the tumour
made a significant difference in pancreatic head carcino-
mas with size less than or equal to 2 cm, showing an R1
incidence of 38%, while those above 2 cm had an R1
incidence of 68%.
Conclusion: Standardized surgical pathological exami-
nation, with axial slicing, leads to better evaluation of
the circumferential margins. Ampullary tumors showed
the greatest change in R1 incidence. The highest inci-
dence of margin positivity was seen in pancreatic head
adenocarcinomas (80%), then distal CBD tumors
(60%), and finally the ampullary tumors (39%).
Ampullary tumors involved only the posterior margin,
while pancreatic adenocarcinomas involved the SMV
groove, more often than the posterior margin, and dis-
tal CBD tumors involved the posterior margin and
SMV groove equally.
575
PROSPECTIVE STUDY FOR THE
EFFECTS OF PANCREATIC ENZYME
SUPPLEMENT THERAPY ON QUALITY
OF LIFE AND NUTRITIONAL
ASSESSMENT AFTER
PANCREATECTOMY
Jae Woo Park, JinYoung Jang, Dae Wook Hwang,
EunJung Kim, Mee Joo Kang, Wooil Kwon, Ye Rim
Chang, In Woong Han and SunWhe Kim
Department of Surgery and Cancer Research Institute,
Seoul National University College of Medicine, Seoul,
South Korea
Background and aims: Pancreas is an important organ
in digestion. After pancreas resection, postoperative
pancreas function impairment reported up to 68–80%.
But there were not many studies about effects of pan-
creatic enzyme supplements therapy after operation.
Aim of this study is to analyze the effects of pancreatic
enzyme supplements therapy on nutritional status and
quality of life after pancreas resection.
Methods: This study was prospective RCT (random-
ized controlled trial) comparing pancreatic enzyme sup-
plement (Norzyme) group with placebo group. From
2009 to 2011, 222 patients with informed consent were
enrolled. 64 patients were excluded from this study for
recurrence, follow-up loss and medication protocol vio-
lations. Finally, 158 patients (study group 99, placebo
59) were analyzed with body weight, triceps skin fold
thickness (TSFT), serum albumin, protein, prealbumin,
transferrin, questionnaire about quality of life and
symptoms including diarrhea and steatorrhea (EORTC
QLQ C-30). Follow-up schedules were prospectively
planned; preoperative, postoperative, post-op 3 months
and post-op 6 months.
Results: Study population was 60.4 years old and sex
ratio was 1:0.98 (80 male and 78 female). Mean body
weight was 61.3 kg. Disease for pancreatectomy was
60(38.0%) benign, 98(62.0%) malignant. In this study,
109 pancreaticoduodenectomy (PD), 44 distal pancrea-
tectomy (DP) and 5 other type operations were ana-
lyzed. Diarrhea symptom decreased in Norzyme group
(p = 0.063) but other symptoms and nutritional index
were not different between two groups. As a result of
subgroup analysis between preoperative and 6mo F/U,
Norzyme group showed increased albumin, prealbu-
min than placebo group in PD group (p = 0.075,
0.076), increased protein, prealbumin in chemotherapy
group (p = 0.021, 0.065). In comparison between 3mo
and 6mo F/U, Norzyme group showed better body
weight, relative body weight (RBW) than placebo
group in cancer, cancer with PD, chemotherapy group
(p = 0.028, 0.019, 0.059). Norzyme group also revealed
increased prealbumin in overall study populations
(p = 0.048), increased protein in chemotherapy group
(p = 0.021).
Conclusions: Several symptoms and nutritional factors
showed trend of recovery in Norzyme group. But,
study population number is relatively small and statisti-
cal power is not enough. There are patients with
improved symptom and nutrition with Norzyme sup-
plements in clinical impression. We suggest there is a
need for additional clinical studies using high-dose for-
mulation of Norzyme.
578
RECONSTRUCTION OF DIGESTIVE
TRACT IN ROBOTIC PANCREATIC
SURGERY:
PANCREATICOJEJUNOSTOMY OR
PANCREATICOGASTROSTOMY?
Bai-Yong Shen, Jin-Hua Ye, Xia-Xing Deng, Bo Han,
Yuan-Chi Weng, Wei-Shen Wang, Qian Zhan,
Hong-Wei Li and Cheng-Hong Peng
Department of General Surgery, Ruijin Hospital,
Shanghai JiaoTong University Medical College,
Shanghai Institute of Digestive Surgery, 197 Ruijin Er
Road, Shanghai 200025, China
Objective: To investigate and compare the clinical fea-
tures and surgical techniques of pancreaticojejunostomy
and pancreaticogastrostomy in robotic pancreatic sur-
gery.
Methods: From March 2010 to June 2012, 32 patients
received da Vinci robotic-assisted pancreatic anastomo-
sis in Shanghai Ruijin Hospital were analyzed retro-
spectively.
Results: Operations were successfully performed in 32
cases without conversion to open surgery. There were
13 males and 19 females, with a mean age of
48.88  12.42 years old. The average tumor size was
2.52  1.21 cm, and the average diameter of pancreatic
duct was 3.39  1.75 mm. The average operation time
of pancreatic anastomosis was 56.45  13.23 min,
which included 17 cases of pancreaticojejunostomy and
15 cases of pancreaticogastrostomy. The postoperative
complications included pancreatic fistula in 12 cases
(37.5%), pancreatic anastomotic bleeding in three cases
(9.4%), delayed gastric emptying in one case (3.1%).
All of them were recovered after conservative treat-
ment. The mean postoperative hospital stay was
23.47  8.77 days. The drainage period of pancreatic
anastomosis was 18.34  7.65 days, and flatus recovery
time was 3.31  2.58 days. Compared with pancreat-
icojejunostomy group, the pancreaticogastrostomy
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group needed more time to complete the pancreatic
anastomosis and presented a higher rate of pancreatic
fistula (p < 0.05). But there was no significant differ-
ence in postoperative hospital stay, anastomotic drain-
age time, anal flatus recovery time.
Conclusions: Both pancreaticogastrostomy and pancre-
aticojejunostomy are safe and feasible. The method of
pancreatic anastomosis in robotic pancreatic surgery
should be selected by the whole surgical procedure and
regional condition.
580
MINIMALLY INVASIVE DISTAL
PANCREATECTOMY: WHAT IS THE
ADVANTAGE OF ROBOTIC SURGICAL
SYSTEM
Qian Zhan, Cheng-Hong Peng, Xia-Xing Deng,
Yuan-Chi Weng, Qin Liu, Bo Han, Jia-Qiang Zhang,
Hong-Wei Li and Bai-Yong Shen
Department of General Surgery, Ruijin Hospital,
Shanghai JiaoTong University Medical College,
Shanghai Institute of Digestive Surgery, 197 Ruijin Er
Road, Shanghai 200025, China
Background: Laparoscopic distal pancreatectomy is
now a mature and effective minimally invasive proce-
dure. However, the traditional operation may become
more critical than the robotic laparoscopic operation
under the complex situation. The aim of this study
was to evaluate the advantages and disadvantages
between the laparoscopic and robotic distal pancrea-
tectomy.
Materials and methods: Between September 2005 and
April 2012, 21 patients underwent robot-assisted lapa-
roscopic distal pancreatectomies (RDP group, n = 21)
and 30 patients underwent the traditional laparoscopic
(LDP group, n = 30) in our center. Data for operation
time, blood loss and complications were collected and
statistically analyzed.
Results: There was no statistical difference between the
two groups with regard to age, gender, mean operation
time, blood loss, pancreatic fistula rate, complication
rate, postoperative hospital stay, conversion rate and
tumor size. There was only one conversion to open
surgery in RDP group and the conversion rate was
4.76% (1/21). Compared with LDP, RDP group had a
significantly higher spleen-preserving rate of benign
tumor (61.54% (8/13) vs. 25.00% (6/24), p = 0.039),
and more retrieved lymph nodes (4.14  2.73 (2–9) vs.
1.33  1.21 (0–3), p = 0.041).
Conclusions: Robot-assisted distal pancreatectomy is a
feasible, less-invasive option for the tumor in the pan-
creas tail. Although we cannot provide domestic evi-
dences to promote the robotic procedure as a better
choice than the laparoscopic one, it has apparent
advantage in the surgeries which are complicated and
close to the vessels. And another characteristics of the
robotic surgical system were thought to be very helpful
during the spleen-preserving distal pancreatectomy and
standard left pancreatectomy.
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LAPAROSCOPIC LIVER RESECTION
FOR LARGE HEPATIC TUMORS
Jai Young Cho, HoSeong Han, YooSeok Yoon, Dae
Wook Hwang, Yujin Kwon, Young Ki Kim, Billy
James Uy and Makhmud Malikov
Seoul National University Bundang Hospital, Seongnam,
South Korea
Background: Although the limitations of laparoscopic
liver resection have been overcome in various fields,
there are still controversies on indication according to
the size of the tumor. The aim of this study was to
assess the feasibility of the laparoscopic liver resection
for the large hepatic tumors.
Methods: Total 146 patients who underwent laparo-
scopic hepatic resection during March 2004 to Decem-
ber 2011 for the hepatic tumors excluding IHD stones
and metastatic tumors were included in the study.
Among them, 33 patients underwent operation for the
tumors larger or equal to 5 cm. Outcome was com-
pared between small (<5 cm; n = 113) and large group
(>5 cm; n = 33).
Results: In large tumor group, there were 16 patients
who underwent major hepatic resection and 17 patients
who underwent minor hepatic resection. The major
resections were six right hemihepatectomies, four left
hemihepatectomies, five right posterior sectionectomies
and one central bisectionectomy. The minor liver resec-
tions were 10 left lateral sectionectomy, 5 segmentecto-
mies, which were 4 S6, and 1 S5 segmentectomy and 1
S3 tumorectomy. There was no difference in intraoper-
ative and postoperative outcomes, namely the rate of
conversion, mean operative time, blood loss, and post-
operative hospital stay between both groups. Also,
there was no significant difference in rate of morbidity
and mortality between both groups. In HCC, there
were two death and three death during the follow up
for each group and there was no significant difference
in disease free survival and overall survival for each
group (Figure 1).
Conclusions: Laparoscopic liver resection for 5 cm or
larger hepatic tumors is feasible.
590
A NOVEL ANTI-REFLUX STENT FOR
THE PALLIATION OF MALIGNANT
BILIARY OBSTRUCTIONS: A
PROSPECTIVE RANDOMIZED STUDY
IN 104 CASES
Bing Hu, Dao-Jian Gao, Tian-Tian Wang, Ya-Min
Pan and Jun Wu
Endoscopy Department, Eastern Hepatobiliary Hospital,
Second Military Medical University, Shanghai, China
Background: Endoscopic placement of self-expandable
metallic stent (SEMS) has been a well-established treat-
ment for unresectable biliary tumors. Cholangitis fol-
lowing stenting, however, ranged from 6.5% to 22% in
reported series and was more frequent in the subgroup
of patients with cross-papillary SEMS placement. In
this study, we designed a new anti-reflux metal stent
(ARMS), conducted a randomized controlled study to
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assess the potential benefit of this antireflux mecha-
nism.
Methods: The study was approved by the Institutional
Review Board and gained informed consent from all
patients. From January 2009 to May 2011, a total of
104 patients with unresectable non-hilar malignant bili-
ary obstruction were randomized into two groups:
ARMS group (n = 52) and ordinary metal stent (OMS)
group (n = 52). There were no statistically different
between the groups as regarding to ages, genders,
tumor types or total bilirubin levels. Both groups
underwent standard ERCP procedure with placement
of either ARMS or ordinary uncovered SEMS across
the duodenal papilla. Subsequent follow-up was con-
ducted at 1–2 monthly intervals through clinic or tele-
phone visit. The endpoint of this study was stent
occlusion or patient death.
Results: The stents were successfully deployed in all
patients without obvious early complications. Closed
follow-up was achieved in all patients except for two
cases in ARMS group. Satisfied jaundice control,
defined as serum bilirubin declined to normal level
within 1 month, was achieved in 47 and 45, respectively
(p = 0.176). There were fewer episode of fever before
stent occlusion in ARMS group when compared with
OMS group (p = 0.031). 12 and 24 stent occlusions
were observed in ARMS and OMS group with the
mean patent duration of 16.6 and 9.9 months, respec-
tively (p = 0.031). There was no difference in patient’s
survival between the two groups (Table 1).
Conclusions: It is feasible to develop SEMS with dura-
ble valve preventing enteric-biliary reflux. Anti-reflux
SEMS is effective and safe in palliating malignant bili-
ary obstruction with fewer complications of cholangitis.
ARMS has longer patency when compared with con-
ventional SEMS, but unable to improve patient’s sur-
vival.
592
ENDOSCOPIC MANAGEMENTS OF
BENIGN BILE DUCT STRICTURES
WITH REMOVABLE METAL STENTS
Bing Hu, Dao-Jian Gao, Feng-Hai Yu, Tian-Tian
Wang, Ya-Min Pan and Jun Wu
Department of Endoscopy, Eastern Hepatobiliary
Hospital, The Second Military Medical University,
Shanghai, China
Background: Endoscopic management of benign biliary
stricture remains challenging. The current method, mul-
tiple plastic stents placement, is associated with multi-
ple endoscopic sessions and probably poor long-term
efficacy. Covered self-expandable metal stents (SEMS),
primary designed for the palliation of malignancies,
have been temporarily used for this setting and showed
promising results. However, there is no dedicated
SEMS for the resolution of benign biliary stricture.
Methods: A short fully covered SEMS (FCSEMS) with
a retrieval suture was designed. Between July 2008 and
April 2012, a total of 44 patients with benign biliary
strictures were placed with this FCSEMS endoscopi-
cally. The whole stent was kept inside bile duct across
the stenosis with the retriever out of papilla. The stents
were removed on a schedule by forceps under endos-
copy.
Results: Till April 2012, placement of the FCSEMS
was successfully on the first attempt in 45 patients (Fig-
ure 4). Successful stent removal was achieved in all
cases (35/35). Stent migration was found in 3/35
patients (8.6%). Stenosis recurrence occurred in 6.5%
(2/31) of patients and final stricture resolution was
achieved in 90.3% (28/31).
Conclusions: Endoscopic treatment of benign biliary
stricture using removable FCSEMS is technically feasi-
ble, safe, and effective. This dedicated SEMS facilitates
retrieval of stent even after more than 1 year with low
occurrence of migration. The novel stent may play
increasing roles in the future management of benign
bile duct stricture.
607
A PROSPECTIVE STUDY OF THE USE
OF COMPUTER-ASSISTED 3-
DIMENSIONAL COMPUTED
TOMOGRAPHY FOR PREOPERATIVE
PLANNING OF CHOLEDOCHAL CYSTS
Zhao-Yang Zhang and Jia-Hong Dong
Hospital and Institute of Hepatobiliary Surgery, Chinese
PLA General Hospital, Fuxing Road 28, Beijing 100853,
China
Background and aims: Precisely evaluate the stenosis
and dilatations of intrahepatic bile duct (IHBD) is
important for successful management of complex
choledochal cyst. Preoperative 3-dimensional imaging
to delineate the morphology of IHBD may help in
planning for successful operation.
Methods: We used the IQQA-liver workstation for 3D
images reconstruction. Preoperative surgical planning
was developed for 55 patients with CCs based on 3D
and 2D-CT/MRCP images, respectively, and compari-
son was made to the differences between the two plans.
The accuracy of the plans was evaluated according to
the actual anatomic findings during the operations.
Results: The results showed that in the cases of type I,
IVb and V, the surgical planning based on the 3D and
2D-CT/MRCP images, respectively, were similar.
Among the 38 cases of Type IVa, the initial 2D-CT/
MRCP operative proposals were accepted by 3D pro-
posals in 26 cases (68.4%). In the other 12 cases
(31.6%), 3D plan changed the 2D-CT/MRCP strategy,
and the results confirmed that the 3D plans were con-
sistent with the actual finding during the operations.
These derived from the different detection rates of
IHBD anomalies between 2D-CT/MRCP and 3D
images. The stenosis detection rates at the hepatic
hilum (HH), umbilical portion (UP), and posterior
branch (POST) were 19.4%, 16.7% and 16.7% respec-
tively by 3D images, and 11.1%, 2.8% and 5.6%,
respectively, by 2D-CT/MRCP images. Moreover, sur-
gical planning based on 3D images was easy to get
agreement.
Conclusions: This study showed that 3D images were
superior to 2D-CT/MRCP in preoperative planning for
CC patients.
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PROTEOMICS-BASED
IDENTIFICATION OF A POTENTIAL
PROGNOSTIC MARKER IN HILAR
CHOLANGIOCARCINOMA
Wen-Long Yu1, Guang-Zhi Jin2, Xin-Yuan Lu2, Zong-
Ting Gu1, Sheng Xu1, Yong-Jie Zhang1 and Wen-Ming
Cong2
1Department II of Billiary Tract Sugery, Eastern
Hepatobiliary Surgery Hospital, Second Military
Medical University; 2Department of Pathology, Eastern
Hepatobiliary Surgery Hospital, Second Military
Medical University
Department of Pathology, Eastern Hepatobiliary Sur-
gery Hospital, Second Military Medical University,
Shanghai, China
The study aims to develop novel clinical immunohisto-
chemical biomarkers of prognostic markers for hilar
cholangiocarcinoma. iTRAQ-2DLC-ESI-MS/MS tech-
nique was used to screen immunohistochemical biomar-
kers between good survival group (post-operation
survival times less than 6 months) and poor survival
group (post-operation survival times longer than
3 years) of patents with hilar cholangiocarcinoma. A
total of 814 proteins were quantified, including 6 pro-
teins up-regulated and 15 proteins down-regulated in
poor survival group by at least 1.25- or 0.8-fold at
p < 0.05. The selected candidate biomarkers for poor
prognosis including Alpha-enolase which previously
reported were further verified using Western blotting
and immunohistochemistry. Finally, over expression of
alpha-enolase(ENO1) and down regulation of Annexin
A4 and KRT8 were significantly associated with poor
prognosis of hilar cholangiocarcinoma patients. ENO1,
Annexin A4 and KRT8 may serve as prognostic mark-
ers to monitor the disease progression of hilar cholan-
giocarcinoma patients.
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ENDOSCOPIC INTERVENTIONS FOR
THE IATROGENIC BILIARY
STRICTURES: A REPORT OF 41 CASES
Bing Hu, Dao-Jian Gao, Ya-Min Pan, Feng-Hai Yu,
Tian-Tian Wang and Jun Wu
Department of Endoscopy, Eastern Hepatobiliary
Hospital, The Second Military Medical University,
Shanghai, China
Background: Biliary tract injury is a common and
severe complication of abdominal surgery. The conven-
tional treatment is re-operation, usually requiring anas-
tomosis between bile duct and small bowel. The
complication rate of such operation is around 25% and
strictures recurrence occurred in 10–45% of cases.
Endoscopic management is a newly emerging minimal
invasive therapy for the benign biliary strictures,
although remains technical challenging. We report our
recent experience in endoscopic management of 41
patients with post-operation biliary strictures.
Methods: 41 cases, male 20 with mean age of
53.1  11.8 years, were enrolled in this study. The
causes of biliary injury were duo to open cholecystec-
tomy/bile duct exploration in 26, laparoscopic cholecys-
tectomy in 10, hepatectomy in 2 and others in 3. All
the patients had symptom of cholangitis and/or
obstructive jaundice and underwent ERCP for assess-
ment and treatment for the biliary stenosis. After domi-
nant narrowing was confirmed, either multiple plastic
stents or single covered metal stent were placed endo-
scopically crossing the strictures. The stents were kept
in site for at least 6–12 months before removal in
another endoscopic procedure.
Results: Balloon dilation and plastic stents placement
were performed in 28 patients with mean number of
3.4  1.1 stents used for mean duration of
13.5  11.5 months. The removable metal stent was
applied in 13 cases with stenting duration of
10.7  3.0 months. Mild complication was found in 2
and 1 cases, respectively. To date, 14 and 10 patients
underwent stents removal with stricture resolution in
14 and 9 cases, respectively. During a mean follow-up
period of 26 and 10 months, respectively, no stricture
recurrence was found.
Conclusions: It is technically feasible and safe to man-
age iatrogenic biliary stricture through endoscopic
intervention. With adequate dilation and prolonged
stenting, most strictures following surgical injury can
be resolved successfully. Further follow-up is required
to observe the long-term outcome of such endotherapy.
660
ROLE OF OVEREXPRESSION OF IL-6
IN PREDICTING PROGNOSIS AND ITS
CLOSE CORRELATION WITH
VASCULAR ENDOTHELIAL GROWTH
FACTOR IN HCC
Jie Cao1, Yao Chen2, Jing Fu2, Liang Huang1,
Cai-Feng Liu1, Feng Xu1, Meng-Chao Wu1,
Hong-Yang Wang2,3 and Yi-Qun Yan1
1Department of Hepatic Surgery I, Eastern
Hepatobiliary Surgery Hospital, Shanghai, China;
2International Cooperation Laboratory on Signal
Transduction, Eastern Hepatobiliary Surgery Institute/
Hospital, Eastern Hepatobiliary Surgery Hospital,
Shanghai, China; 3State Key Laboratory of Oncogenes
and Related Genes, Cancer Institute of Shanghai Jiao
Tong University, Eastern Hepatobiliary Surgery
Hospital, Shanghai, China
Background and aims: To evaluate the expression and
significance of Interleukin-6 (IL-6), its correlation with
vascular endothelial growth factor (VEGF) and clinico-
pathological features were studied in the tissue of hepa-
tocellular carcinoma (HCC).
Methods: IL-6 and VEGF expression was examined by
immunohistochemistry in tissue microarrays (TMAs)
containing 102 paired HCC samples and by western
blot analysis in six human hepatoma cell lines.
Results: IL-6 expression in tumor, lower compared
with that in corresponding non-tumor liver tissue
(p = 0.0007), was significantly higher than that in nor-
mal liver tissue (p = 0.0084). A close correlation
between IL-6 and VEGF expression was detected in
tumor or adjacent peritumoral liver tissue (r = 0.33784,
p = 0.0005; r = 0.47297, p < 0.0001, respectively) as
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well as in human hepatoma cell lines. High intratumor-
al IL-6 significantly correlated with vascular invasion
(p = 0.027), intrahepatic metastasis (p = 0.038) and
postoperative distant metastasis (p = 0.014). However,
neither intratumoral nor peritumoral IL-6 expression,
but the tumor/non-tumor (T/N) ratio, was associated
with the overall survival (OS) and disease-free survival
(DFS) of patients with HCC (p = 0.019 and p = 0.030,
respectively). And, more importantly, the combination
of T/N ratio of IL-6 and VEGF has more predictive
value.
Conclusions: This study on the expression of IL-6 and
its close correlation with VEGF in tissue might be use-
ful to evaluate the role of IL-6 in HCC. Overexpression
of IL-6 might promote VEGF-dependent angiogenesis
and induce more invasive and malignant tumors in
HCC.
663
RESEARCH ON HEPATIC-LIKE TISSUE
CONSTRUCTED BY USING
DECELLULARIZED SPLENIC MATRIX
IN VITRO
Rui Gao1, Wan-Quan Wu1, Jun-Xi Xiang1, Yi Lv1, Bo
Wang1 and Ya-Xiong Liu2
1Department of Hepatobiliary Surgery, The First
Affiliated Hospital, Medical School of Xi’an Jiaotong
University, Xi’an, China; 2State Key Laboratory for
Manufacturing Systems Engineering, Xi’an, China
Background and aims: Critical shortage of organs has
limited liver transplantation from being available to
patients with end-stage liver disease and liver tissue
engineering would be a potential new therapy. We
established the hepatic-like tissue by using decellular-
ized splenic matrix which reserved native extracellular
matrix and vascular network in order to be an auxiliary
transplantation method.
Methods: 1) Catheters were inserted through the rats’
spleen arteries for whole-spleen perfusion. After perfu-
sion with PBS, 0.1% SDS, 1% TritonX-100 under the
speed of 1.5 mL/min, the spleen matrix scaffolds were
observed under macroscopic and microscope with HE
staining. Dye perfusion, vessels corrosion cast and Mi-
croCT were used to evaluation the vascular network.
2) About 1 9 107 hepatocytes were cultured in splenic
decellularized scaffold to construct hepatic-like tissue.
The first group was cultured statically while the second
was cultured in dynamic perfusing system through the
vascular network of the splenic scaffold. The hepatic-
like tissue was observed under microscope and the
albumin synthesis and urea secretion was detected.
Results: 1) After 9 h perfusion, the spleen became
translucent and no cell residue was found in the scaf-
folds under microscope. The dye perfusion and vessels
corrosion cast suggested that the vascular network
remained intact. According to MicroCT, the diameter
of small measurable vessel was about 60 lm.
2) After recellularization, the presence of hepatocytes
was mainly distributed in the vasculature system when
cultured statically, while distributed in parenchyma
spaces around vasculature when cultured by perfusing
method. The amount of the hepatocytes increased dur-
ing culture. The albumin synthesis peaked in day 5 and
day 7 of the static culture and the perfusing culture
group, and then it decreased. The urea secretion
decreased with time pass in static culture, while it
peaked in day 5 in perfusing culture group, and then
decreased but the trend was gentler.
Conclusions: Fluid perfusion was an effective and reli-
able method to prepare splenic decellularized matrix
scaffold which could dislodge cells from spleen effec-
tively and preserve the native extracellular matrix and
vascular network. The splenic decellularized scaffolds
had suitable biocompatibility and accord with the cell
culture by which hepatocytes maintained cell viability
and function in vitro. It may serve as an ideal liver tis-
sue engineering scaffold.
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FAMILY HISTORY OF LIVER CANCER
IS NOT ASSOCIATED WITH
PROGNOSIS FOR PATIENTS WITH
HEPATOCELLULCAR CARCINOMA
AFTER HEPATECTOMY
Yao-Jun Zhang1,2, Mei-Xian Chen1,2, Jun-Ting
Huang1,2, Jia-Qiang Dan1,2, Zhen-Wei Peng1,2 and
Min-Shan Chen
1Department of Hepatobiliary Surgery, Sun Yat-sen
University Cancer Center, Guangzhou, China; 2State
Key Laboratory of Oncology in South China, Sun Yat-
sen University Cancer Center, Guangzhou, China
Purpose: Family history of liver cancer is a major risk
factor for hepatocellular carcinoma (HCC). In this
study, we investigated the prognoses of patients with
HCC with a family history.
Methods: Data for 1313 patients who underwent hepa-
tectomy as initial treatment for HCC between 2000 and
2008 at a tertiary cancer center hospital were retrieved
from a prospective database. A positive family history
was defined as a self-reported history of cancer in first-
degree relatives. Clinicopathologic characteristics were
compared by family history. Kaplan–Meier plots and
Cox proportional hazards regressions were applied for
overall survival (OS) and disease-free survival (DFS).
Results: Of 1,313 patients, 169 patients (12.9%) had
first-degree relatives with a history of liver cancer.
There were no significant differences between patients
with or without family history in basic clinicopatho-
logic characteristics. Either in whole group or each
stage according to TNM staging system, first-degree
family history was not associated with survival in all
patients or patients with HBV positive. Multivariate
analysis revealed that first-degree family history was
not a prognostic factor for either OS or DFS.
Conclusion: A first-degree family history of liver cancer
is not associated with prognosis for patients with HCC
after hepatectomy.
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INTRA-OPERATIVE
ULTRASONOGRAPHIC APPEARANCE
OF NEUROENDOCRINE LIVER
METASTASIS AND ASSOCIATION
WITH CLINICOPATHOLOGICAL
FACTORS
Charing Chong, Epameinondas Dogeas, Ping Xiong,
Daniel Carnegie and Michael A. Choti
Department of Surgery, The Johns Hopkins University
School of Medicine, Hong Kong S.A.R., China
Background and aims: Liver is the most common site
of metastasis of neuroendocrine tumor. Survival after
surgical intervention for neuroendocrine liver metastasis
was better than that of the non-neuroendocrine malig-
nancies of the same organ, even in metastatic stage.
Intra-operative ultrasound (IOUS) is an important tool
in liver surgery. Currently, no data exist regarding
whether IOUS findings affect overall prognosis in neu-
roendocrine liver metastasis. We sought to investigate if
echogenicity of neuroendocrine liver metastasis has a
prognostic role compared to the traditional clinicopath-
ologic factors.
Methods: Prospective data on IOUS appearance of
patients underwent IOUS and surgical intervention
(liver resection or ablation or both) for neuroendocrine
liver metastasis were collected. Images were digitally
recorded, blindly reviewed, and scored for echogenicity
and characteristics scores. Association between sono-
graphic appearance and traditional clinicopathologic
factors were analyzed.
Results: A total of 216 lesions from 65 patients
received surgical intervention were analyzed. The med-
ian tumor size was 17.2 (1–149.8) mm. The median
number of lesions per patient was 2 (range 1–11). The
median follow-up time was 45.4 (range 3.83–149.0)
months. The 1-, 3-, 5- and 10-year disease-free survivals
were 67.3%, 32.1%, 20.7% and 17.3%. IOUS identified
at least one more lesion than the most number of
metastases detected by the pre-operative imaging in 41
of our cases (63.1%) resulted in change in surgical
strategy in 14 (21.5%) of patient. Majority (n = 106,
49.1%) of the lesions were hypoechoic. Homogenous
and target or bulleye’s appearance were the commonest
sonographic characteristic. Hypoechoic lesion was asso-
ciated with poorly differentiated tumor (p = 0.005),
smaller tumor size (less than 15 mm, p = 0.004) and
more intra-hepatic recurrence (p < 0.001). Patients with
hypoechoic metastases had a significantly shorter med-
ian disease-free survival (16.4 months), compared with
patients who had either an isoechoic (30.3 months) or
hyperechoic (25.2 months) lesion (p = 0.008).
Conclusion: IOUS can detect more liver lesions com-
pared with other pre-operative imaging. In patients
with neuroendocrine liver metastasis, hypoechoic lesion
was associated with smaller and poorly differentiated
tumor. They were also associated with more intra-hepa-
tic recurrence and worse disease-free survival. Intra-
patient variability of tumor sonographic appearance
was high. Therefore, detailed IOUS examination intra-
operatively is essential.
710
SINGLE LAYERED, PARACHUTED AND
INTUSSUSCEPTED METHOD OF
PANCREATICOJEJUNOSTOMY (SPI
PJ): SINGLE SURGEON’S EXPERIENCE
Ji Woong Hwang, Jae Hoon Lee, Ki Byung Song,
Young Hwan Kim, Jeong Su Nam, Jong Hee Yoon,
Zunqiang Zhou, Song Cheol Kim and Young Joo Lee
Division of Hepatobiliary and Pancreatic Surgery,
Department of Surgery, University of Ulsan College of
Medicine, Asan Medical Center, Seoul, South Korea
Backgrounds and aims: Pancreaticojejunostomy (PJ)
has been considered as Achilles tendon in the success
of pancreato-duodenectomy (PD) or pylorus-preserving
pancreato-duodenectomy (PPPD). Although the con-
ventional methods of PJ, including duct-to mucosa
method (DTM), end-to side dunking method, have
shown acceptable rate of morbidity, the HBP surgeons
are still looking for more easy, convenient and safe
ways of PJ.
The aim of this study is to introduce the new method
of PJ, called SPI PJ. And compare its morbidity rate to
other conventional method of PJ.
Methods: Among consecutive 107 patients who under-
went PD or PPPD by single surgeon at Asan Medical
Center from January 2009 to July 2012, the SPI (single
layered, parachuted, intussuscepted) method was used
in 41 cases. The clinical data and medical records were
retrospectively analyzed compared to the other 66 con-
ventional PJ cases. The highlight of this new technique
is simply invaginating the raw end of jejunum to the
raw end of pancreas by eliminating the possibility of
minor pancreatic and lymphatic leakage from the pan-
creatic cut surface.
Results: The leakage of PJ was occurred in 5 (12.2%)
patients in SPI group; 20 (30.3%) patients in DTM
group. There was statistically significant difference
(p = 0.031). And, the occurrence rate of severe pancre-
atic leakage in SPI group (POPF B grade; 1 (9.8%),
POPF C grade; 0) was extremely lower than in DTM
group (POPF grade B; 12 (18.2%), POPF grade C; 2
(3.0%)) (p=0.058).
The mean operation time was 404.9  72.1 (270–555)
min in SPI group; 448.5  88.0 (232–677) min in DTM
group. The operation time of SPI group was signifi-
cantly shorter than the other (p = 0.009).
The serious complications related to the leakage of PJ
(ex. Pseudoaneurysmal bleeding) was occurred in 0
patients in SPI group; 4 (6.1%) patients in DTM
group. However, there was no statistically significant
difference (p = 0.108).
Conclusions: Compared with DTM group, SPI group
had excellent surgical outcome in the leakage of PJ,
operation time and serious complication. Moreover, it
is simple, convenient and easy to perform. Therefore,
we recommend the SPI method as another option of
PJ.
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LAPAROSCOPIC MAJOR
HEPATECTOMY: TECHNIQUE AND
OUTCOME
Kai-Chi Cheng, Ka-Man Chan and Yuk-Pang Yeung
Department of Surgery, Kwong Wah Hospital, Hong
Kong S.A.R., China
Introduction: Laparoscopic liver resection (LLR) is
now a well-accepted treatment option for both benign
and malignant disease of the liver. While, laparoscopic
approach is widely adopted in minor resection, the role
in major hepatectomy remains to be established. The
objective of this study is to share our institutional expe-
rience in laparoscopic major hepatectomies and the
patient outcome.
Methods: Laparoscopic liver resection was started in
our institution in 2006. All patients underwent LLR
from March 2006 to October 2012 were identified in a
prospectively collected database. Major hepatectomy
was defined as resection for more than or equal to 3
liver segments and right posterior sectionectomy. The
demographic data and operative outcome of patient
who underwent laparoscopic major hepatectomy were
collected and the result of earlier half and later half of
the period were compared.
Results: Between March 2006 and October 2012, 100
LLR was performed for 88 patients in Department of
Surgery, Kwong Wah Hospital. They were 59 (67%)
male and 29 (33%) female and the median age was
67. For final histological diagnosis, 10 were benign
disease, 14 were colorectal liver metastases, 4 were int-
rahepatic cholangiocarcinoma and 72 were hepatocel-
lular carcinoma (HCC). There were 26 laparoscopic
major hepatectomies including 11 right hepatectomies,
10 left hepatectomies and 5 right posterior sectionecto-
mies.
Patients who underwent major hepatectomies were
separated into two periods to compare the results for
early (N = 13) and later (N = 13) periods of our
patients treated. Laparoscopic-assisted procedures or
conversion were lesser performed in the later period.
The median blood loss (1200 vs. 600 mL), complica-
tion rate (61.5% vs. 38.5%), and hospital stay (12
vs. 7 days) were also significantly reduced in the later
period.
Conclusion: Totally laparoscopic major hepatectomies
are feasible with growing experience. The outcome of
patient improved over time and experience on major
LLR. Further refinements of surgical technique may be
required to further improve the outcome in major
LLR.
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SINGLE-CENTRED EXPERIENCE WITH
HEPATOPANCREATODUODEN-
ECTOMY FOR ADVANCED
HEPATOBILIARY MALIGNANCY
Jeff Dai, S. H. Chok, T. T. Cheung, A. C. Y. Chan, H.
H. Tsang, W. Sharr, S. C. Chan, R. T. P. Poon, S. T.
Fan and C. M. Lo
Department of Surgery, the University of Hong Kong,
North Point, Hong Kong S.A.R., China
Objectives: In the advanced stage of hepatobiliary
malignancies, concurrent hepatopancreatoduodenecto-
my (HPD) is necessary to accomplish curative resec-
tion. HPD remained a challenging operation and the
safety of the procedure and the long-term survival have
not been adequately analyzed. The aim of the study is
to review our single-centred experience with this proce-
dure.
Material and Methods: Respective study of a prospec-
tively collected database of patients operated at the
Department of Surgery, Queen Mary Hospital, Hong
Kong was performed. Between 1998 and 2010, 12
patients received combined hepatectomy and pancre-
atoduodenectomy and the outcome of these patients
were reviewed.
Results: Curative resection was achieved in 11 of the 12
patients (91.7%). Complications occurred in 11 (91.7%)
patients and hospital mortalities occurred in three
patients (25%), due to multi-organ failure secondary to
either pancreatic fistula or leakage from hepaticojejun-
ostomy. Six out of the nine remaining patients (75%)
developed recurrence of the disease. The median sur-
vival for those who survived the operation was 52.35
(5.42–109.1) months. The cumulative 1-, 3- and 5-year
survival rates for them were 66.7%, 55.6% and 37%,
respectively while the disease free survival was 55.6%,
44.4% and 29.6% at one year, three year and five year.
Conclusions: Hepatopancreatoduodenectomy was asso-
ciated with significant morbidities and mortalities. In
selected patients, complete surgical resection (R0) by
HPD could achieve a 5 year disease free survival and
overall survival of 29.6% and 37% respectively.
730
APPLICATION OF BIO-MESH-
REINFORCED
PANCREATOJEJUNOSTOMY AND
PANCREATOGASTROSTOMY
FOLLOWING
PANCREATICODUODENECTOMY
Xia-Fa Wang, Xin Zhong and Jun-Hai Pan
Department of Surgery, Sir Run Run Shaw Hospital,
School of Medicine, Zhejiang University, Hangzhou,
China
Background/Purpose: Pancreatic leakage is a concern
after pancreaticoduodenectomy. Our aim was to evalu-
ate the effects of bio-Mesh-reinforced pancreatojejunos-
tomy and pancreatogastrostomy.
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Methods: Sixteen patients were retrospectively ana-
lyzed who underwent bio-Mesh-reinforced pancreat-
ojejunostomy or pancreatogastrostomy from December
2011 to April 2012. Patients’ demographic data,
pathology of lesions, operative parameters, and post-
operative outcomes were analyzed. The severity of
pancreatic leak was determined according to the crite-
ria of International Study Group on Pancreatic Fistula
(ISGPF).
Results: The mean anastomosis time of Mesh-rein-
forced pancreatojejunostomy was 25 min (range, 22–
35 min). In Mesh-reinforced pancreatogastrostomy, the
mean anastomosis time was 27 min (range, 20–38 min).
Intra-operative leak tests showed all pancreatic anasto-
moses were watertight. One patient (6.3%) was recog-
nized to have pancreatic leak of grade A, one case
(6.3%) of pancreatic leakage of class B. No patient
developed pancreatic leakage of class C after operation.
No severe complications such as hemorrhage, intra-
abdominal abscess, and cholangitis were observed in
our study. All patients recovered well in one month’
follow-up after discharge.
Conclusion: This novel technique might be a simple
and feasible strategy.
745
UNILATERAL VERSUS BILATERAL
ENDOSCOPIC METAL STENTING FOR
MALIGNANT HILAR BILIARY
OBSTRUCTION
Dao-Jian Gao, Bing Hu, Ya-Min Pan, Tian-Tian
Wang, Shu-Zhi Wang, Rui Lu, Shu-Ping Wang,
Zhi-Mei Shi and Hui Huang
Department of Endoscopy, Eastern Hepatobiliary
Hospital, Second Military Medical University Shanghai,
China
Background and Aim: The extent of intrahepatic duct
drainage for palliative treatment of malignant hilar bili-
ary obstruction is controversial. The aim of this study
was to compare the outcome of endoscopic unilateral
vs. bilateral drainage using a self-expanding metal stent
(SEMS) in patients with malignant hilar biliary
obstruction.
Methods: A retrospective analysis of 69 consecutive
patients with malignant hilar biliary obstruction who
were treated by endoscopic biliary drainage using
SEMS between Jan 2007 and Jun 2011 was carried out.
The successful stent insertion, successful drainage, early
complications, stent patency, and survival rate for uni-
lateral or bilateral drainage were evaluated and com-
pared retrospectively.
Results: Unilateral metal stenting (group A) was per-
formed in 40 patients (mean age: 60  13.4 years;
male/female: 20/20; Bismuth-type II/III/IV: 2/8/30),
and bilateral metal stenting (group B) was performed
in 29 patients (mean age: 66  11.9 years; male/
female: 22/7; Bismuth-type II/III/IV: 10/4/15). There
were no significant differences between the two groups
in successful stent insertion (100% vs. 100%, respec-
tively), successful drainage (100% vs. 96.5%), early
complications (6.7% vs. 10.3%) and there was no pro-
cedure-related death in both groups. Cumulative stent
patency was significantly better in group B than in
group A (p = 0.043). However there was no differences
in cumulative survival between the two groups
(p = 0.555). But cumulative stent patency and cumula-
tive survival were significantly better for patients with
hilarcholangiocarcinoma than patients with other can-
cers (gallbladder carcinoma, primary liver carcinoma
orhilarlymph node metastasis) (p = 0.028, p = 0.001,
respectively).
Conclusions: Endoscopic bilateral drainage using
SEMS for malignant hilar biliary obstruction is more
effective than unilateral drainage in terms of cumulative
stent patency. The outcomes of endoscopic stenting is
better in patients with hilarcholangiocarcinoma than in
patients with other hilar malignancies.
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SIGNIFICANCE OF BIOELECTRICAL
IMPEDANCE IN LIVER DURING
ISCHEMIA-REPERFUSION. AND WHAT
IT CAUSES?
Sung Su Yun1,2, Hwa Kyung Jung1, Mei Lan Cui2,
Dong Shick Lee1 and Hong Jin Kim1
1Department of Surgery, HBP Division, Yeungnam
University Hospital, Daegu, South Korea; 2Research
Institute of Biomedical Engineering, Yeungnam
University Hospital, Daegu, South Korea
Background and Aims: Ischemia and reperfusion (I/R)
injury is a major cause of hepatic failure after liver
surgery, but there is no direct method to monitor or
predict it in a real-time manner during liver surgery.
We measured bioelectrical impedance (BEI) and cell
viability to assess the usefulness of BEI and clarify
correlation between BEI change and liver cell injury
during I/R in rat liver. We also evaluated the mecha-
nism underlying BEI changes. Methods: A 70% partial
rat liver ischemia model was used. Animals were allo-
cated 30, 60 and 120 min I/R group (n = 5 at each
group). BEI was measured at various frequencies
(0.12, 1.2, 12, 62.5, and 100 KHz) with a multi-fre-
quency LCR meter (GS-4311B, Ando, Japan) every
10 min. ATP contents, palmitic acid oxidation rate,
cation changes in extracellular fluid (ECF; determined
using an in vivo intracellular microdialysis technique),
hepatocyte sizes, and histological changes were exam-
ined to investigate the liver cell viability and mecha-
nism of BEI change.
Results: BEI increased during ischemia and decreased
significantly after reperfusion at low frequency. BEI
increased gradually during 60 min of ischemia and had
a tendency to plateau thereafter. The ATP content
decreased below 20% of the baseline level after 60 min
ischemia and increased after reperfusion. [Na+] in ECF
decreased from 150.4  3.8 to 97.8  10.6 mmol/L,
and [K+] in ECF increased from 7.5  0.3 to
34.3  5.5 mmol/L during the first 60 min of ischemia.
Hepatocyte diameter increased by ~20% during the first
60 min of ischemia. After 24 h of reperfusion, the ATP
contents decreased to below 50% in 30, 60 and
120 min of ischemia and the palmitic acid metabolic
rates decreased to 91%, 78%, and 74%, respectively,
compared with normal liver.
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Conclusion: BEI may be a good tool for monitoring I/
R injury during liver surgery in a real time manner.
BEI changes during I/R are probably caused by sodium
and potassium concentration changes in the ECF due
to reduced intracellular ATP contents.
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TREATMENT OF UNRESECTABLE
PANCREATIC CANCER BY
RADIOFREQUENCY ABLATION (RFA):
REPORT OF 25 CASES.
Sheng-Yang Chen and Xia-Yong Li
The Fifth Affiliated Hospital of Zhengzhou University,
Zhengzhou, China
Background: Because of lacking of typical clinical
symptoms, patients with pancreatic cancer always has
lost the chance of operation, although completely resec-
tion is the preferred treatment. In recent years, RFA
began to be used to pancreatic tumors, it had been suc-
cessfully used in other organ tumors, such as hepatic
tumor and lung cancer. The efficacy is beyond imagina-
tion.
Objective: To explore and evaluate the efficacy, safety,
short and long-term efficacy of RFA, that using in un-
resectable pancreatic cancer.
Methods: 25 patients with unresectable pancreatic can-
cer (16 pancreatic head cancers and 9 pancreatic body
and tail cancers), 18 males and 7 females, average age:
61.5 years old. Puncturing with ultrasound-guided in
laparotomy and ablating tumor as completely as possi-
ble, avoiding the main pancreatic duct. Withdraw nee-
dle and ablate approach after operation. 12 patients of
pancreatic head cancer who had jaundice accepted
choledochojejunostomy.
Results: Bilirubin in all of the 12 cases of pancreatic
head cancer had reduced to normal; Low back pain
were significantly alleviated in 15 patients; Pancreatic
fistula occurred in 4 patients and healed after unob-
structed drainage in 15 days; 4 patients occured gastro-
intestinal bleeding in 7 days, 40 days, 70 days after
operation and died. All patients had not lost, 3 cases
died in short term (less than 3 months) (12%); 10 cases
died in 6–12 months (40%); 8 cases died in 12–18
months (32%); 4 cases survived more than 18 months
(16%). 2 patients acquire long survival, the one had 28
months; the other one has survived 42 months already
and is still alive.
Conclusions: RFA is effective in relieving the clinical
symptoms for unresectable pancreatic cancer patients
efficiently, improving quality of life; Safety of body and
tail cancer is better, comparing to pancreatic head can-
cer; Temperature and time of ablating are important
factors to clinical efficacy and complication rates, more
detailed data need to be further researched and summa-
rized; Postoperative short and long-term efficacy are
worthy of recognition.
789
CLINICAL ANALYSIS ON 156 CASES OF
GALLBLADDER POLYPS TREATED
WITH MINIMALLY INVASIVE
LAPAROSCOPY COMBINED OF
CHOLEDOCHOSCOPE TO KEEP
GALLBLADDERS INTACT
Li-You Xu, Zhao Song and Zhao Liu
Department of Hepatobiliary Surgery, Clinical Hospital
of Shandong University, Jinan Central Hospital,
Shandong, Jinan, China
Objective: To discuss the adaptation methods and clini-
cal value of mini-cholecystolithotomy remaining gall-
bladder for gallbladder polyps.
Methods: We retrospectively analyzed 156 patients with
gallbladder polyps who were treated with minimally
invasive cholecystolithotomy from March 2009 to
March 2012, by using choledochoscope combined with
laparoscope, the incision on the fundus of gallbladder
was made about 10 mm, then removed gallbladder pol-
yps with hot biopsy forceps under the observation with
choledochoscope. After clearly removing all polyps, the
gallbladder was washed with metronidazole, and the
incision on gallbladder was sewed using absorptive
thread, without placement of gallbladder fistulation
tube and abdominal cavity drainage tube.
Results: With the follow-up of 3~72 months, 132
patients were examined under B ultrasound, Normal
gallbladder contractility and no relapses was shown in
those patients. The operative time was from 42 min to
126 min, average 84 min. The patients are cured without
infections. 156 patients with gallbladder polyps who were
treated with minimally invasive cholecystolithotomy.
One patient underwent laparoscopic cholecystectomy.
Conclusions: Minimally invasive choledochoscopy is
curable for treatment of gallbladder polyps. However,
the indications have to be restricted. Otherwise, laparo-
scopic cholecystectomy has to be taken.
793
RESEARCH OF THE CORRELATION
BETWEEN PANCREATICOBILIARY
MALJUNCTION AND EXTRAHEPATIC
BILIARY SYSTEM CARCINOMA
Xin Zhao, De-Chun Li and Hua Zhao
Department of General Surgery, the First Affiliated
Hospital of Soochow University, Suzhou, China
Background and aims: Pancreaticobiliarymaljunction
(PBM) was first reported as a congenital anatomical
abnormalities by Dr. Babbitt in 1969. With the wide
application of endoscopic retrograde cholangiopancrea-
tography (ERCP) and magnetic resonance cholangio-
pancreatography (MRCP) examinations, PBM
detection and diagnosis is growing increasingly. This
research is to explore the correlation between PBM and
biliary carcinoma, including gallbladder carcinoma and
extrahepatic biliary duct carcinoma.
Methods: We retrospectively analyzed the clinical data
and magnetic resonance cholangiopancreatographic
results of 857 consecutive patients who underwent mag-
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netic resonance cholangiopancreatography (MRCP) in
our hospital from January 2008 to December 2009. We
measured the length of common ducts and the conflu-
ence angle. Eventually, 67 cases were diagnosed as
PBM. In order to evaluate the correlation between
PBM and extrahepatic biliary system carcinoma, we
randomly drew 78 cases from the 790 cases without
PBM as the controls.
Results: 56.72% (38 cases) were diagnosed as biliary
carcinoma in 67 cases of PBM, while 14.10% (11 cases)
were diagnosed as biliary carcinoma in controls. The
biliary carcinoma incidence in cases with PBM was sig-
nificantly higher than that in cases without PBM
(v2 = 22.27, p < 0.05). In cases of PBM complicated
with biliary carcinoma, no correlation was found
between PBM confluence types and the differentiation
of biliary carcinoma (v2 = 2.70, p > 0.05).
Conclusions: PBM is closely related to extrahepatic bili-
ary system carcinoma, while there was no correlation
between PBM confluence types and the differentiation
of biliary carcinoma.
803
ELEVATED BLOOD EOSINOPHIL
COUNT IS A BIOMARKER FOR
PREDICTING LATE ACUTE CELLULAR
REJECTION AFTER LIVER
TRANSPLANTATION
Guo-Ying Wang, Hua Li, Yang Yang, Qi Zhang and
Gui-Hua Chen
Liver Transplantation Center of the Third Affiliated
Hospital, Sun Yat-Sen University, Guangzhou, China
Background and aims: Several studies have indicated
the value of raised blood eosinophil count in the
diagnosis of acute cellular rejection (ACR) after liver
transplantation (LT). However, all the cut-off values
have been set empirically. Furthermore, the relationship
between eosinophils and late ACR is unknown. In this
study, we determined to evaluate the predictive value
of elevated eosinophils in the diagnosis of late ACR
occurred after 6 months following LT.
Methods: The peripheral blood eosinophil count the
day before or on the day of biopsy in 185 biopsies from
161 liver transplant patients were retrospectively
analyzed. Patients were divided into ACR group and
non-acute rejection (non-ACR) group according to
histopathologic findings. The optimal cut-off value for
diagnosing ACR was determined by using a receiver
operating characteristic (ROC) curve analysis. Sensitiv-
ity and specificity was calculated.
Results: Of the 185 liver biopsies, 110 showed ACR,
including 24 cases of late ACR (21.8%). The absolute
and relative eosinophil counts were significantly higher
in the ACR group than in the non-ACR group. If
absolute eosinophil count  0.4 9 10 E9/L or relative
eosinophil count  4% was defined as elevated, 28
cases showed an elevated eosinophil count. Of the 25
biopsies with elevated eosinophil count in ACR group,
only 2 (6.3%) were in early ACR (within one month
post-transplant), with 13 in mid-term ACR (from 1 to
6 months, 24.1%) and 10 in late ACR (41.7%), respec-
tively. Relative eosinophil count was significantly
higher in the late ACR patients than those in the non-
ACR patients. ROC analysis showed that absolute
eosinophil count of 0.145 9 10 E9/L and relative eosin-
ophil count of 2.3% have the Youden index (0.333 and
0.625, respectively) with the area under the ROC curve
of 0.746 and 0.813, respectively. When absolute eosino-
phil count  0.145 9 10 E9/L or relative eosinophil
count  2.3% was defined as elevated, the sensitivity
and specificity of raised absolute and relative eosinophil
count to predict late ACR was 45.8% and 87.5%, and
75% and 87.5%, respectively. When absolute eosino-
phil count  0.285 9 10 E9/L or relative eosinophil
count  3% was defined as elevated, the sensitivity
and specificity was 25% and 100%, and 50% and
100%, respectively. All patients with absolute eosino-
phil count  0.285 9 10 E9/L have a relative eosino-
phil count  3%.
Conclusions: Eosinophil counts in peripheral blood in
ACR patients after LT are significantly higher com-
pared with those in non-ACR patients. Raised eosino-
phil count has high predictive value for diagnosing late
ACR after LT.
804
ORTHOTOPIC LIVER
TRANSPLANTATION FROM CARDIAC
DEATH DONORS IN THE MOUSE: A
NEW ANIMAL MODEL AND
EVALUATION OF THE CRITICAL
CARDIAC DEATH TIME
Qin-Long Liu, Jun Song, Ri-Xin Zhang, Rui Liang
and Li-Ming Wang
General Surgery, the Second Hospital of Dalian Medical
University, Dalian, China
Background: The availability of a model of the donor
of cardiac death (DCD) liver transplantation (LTx) in
the mouse would be an important tool for studying
injuries associated with DCD liver transplantation. The
goals of this research were: first to setup a DCD mouse
LTx model; second: to determined the security time of
the warm ischemia after cardiac death; third: to define
the injury of liver associated with this operation, and
mouse survival rate.
Methods: Mice were random divided into Sham group,
LTx group, DCD 30 min LTx group, DCD 45 min
LTx group, and orthotopic liver transplantation from
normal donors and cardiac death donors was per-
formed. The survival rate of recipients were monitored
7 days after operation, and the livers of recipients 、
serum were harvested at 6 hours after operation for
liver function and morphology evaluation.
Results: Postoperative survival rate 7 days of the recip-
ients of LTx、DCD 30 min LTx group were 100% and
75%, no significance difference between them
(p > 0.05), Postoperative survival rate of DCD 45 min
LTx group was 25%; have significance difference to
LTx group (p < 0.05); Serum alanine aminotransferase,
necrosis, and apoptosis increased after operation. DCD
45 min LTx group increased significantly compared
with normal LTx group (p < 0.05); There are no signifi-
cance between LTx、DCD 30 min LTx group
(p > 0.05); Expression of IL-6, TNF-a and iNOS
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increased significantly in DCD 45 min LTx group, but
increased slightly in DCD 30 min group (p > 0.05).
Conclusions: DCD LTx model is feasible in the mouse.
The success of the procedure relies on the availability
of an experienced and talented micro-surgeon and con-
trol the time of DCD.
806
OVERALL ANALYSIS THE SAFETY OF
DONOR IN LIVING DONOR LIVER
TRANSPLANTATION
JY Lei, LN Yan and WT Wang
Liver and Vascular Surgery, West China Hospital of
Sichuan University, Chengdu, China
Aim: To investigate the safety of donors during living
donor liver transplantation (LDLT) from every per-
spective.
Methods: This study included 283 consecutive donors
underwent operation at our center from July 2002 to
March 2012. We reviewed demographic data, operation
type, operation time, duration of hospital stay and
reviewed the abnormality of liver function after dona-
tion. All complications were recorded prospectively and
stratified by grade according to Clavien’s classification.
Laboratory tests such as liver function and blood rou-
tine were collected and evaluated; the health-related
quality of life was evaluated by using the Chinese Ver-
sion of the Medical Outcomes Study Short Form-36
tool and psychological symptoms were measured using
the Symptom Checklist-90-Revisied.
Results: The overall morbidity rate was 24.7%, most
of the complications were either grade 1 or 2, the most
common complications of living donor were the biliary
complications, and there were significantly fewer com-
plications in the later period of our experience than
that in the previous period (18.8% vs. 31.8%,
p < 0.001), the biliary complications were the most
common complications with a incidence of 4.9%, there
was no organ dysfunction and donor morbidity
(Showed in Table 1). The AST and ALT reached their
peaks on the first day after operation while the TB
reached its peak on the 3rd day after operation, the
damage of the liver function was temporal, but the
decrease of the PLT compared with pre-operation level
lasted for years and without recovery but within the
normal range, at the eight years after operation, 22
donors showed lower PLT level (189*10^9/L) than the
pre-operation level (267*10^9/L) (p < 0.05). 98.5%
donors had returned to their previous level of social
activity and an equal proportion to their pre-donation
occupation, and 88.1% donors showed their satisfac-
tion with the present capacity to work; 88.1% stated
their present health status as good to excellent; 99% of
donors would donate again if required and feasible
except two donors suffered Grade III complications
and with the recipients’ dead, almost all of the living
donor suffered no physical problem except several cases
with abdominal discomfort, fatigue, chronic pain and
scar itching, three patients were diagnosed with slight
psychiatric complication for the recipients’ dead.
Conclusions: With careful donor selection and special-
ized patient care, low morbidity rates and satisfactory
long term recovery can be achieved after hepatectomy
for living donor liver transplantation.
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LOSS OF N-CADHERIN IS ASSOCIATED
WITH LOSS OF E-CADHERIN AND
POOR OUTCOMES OF LIVER
RESECTION FOR HEPATOCELLULAR
CARCINOMA
Yang-An Liu, Zhi-Yong Huang, Bin-Yong Liang and
Xiao-Ping Chen
Research Laboratory and Hepatic Surgery Center,
Department of Surgery, Tongji Hospital, Tongji Medical
College, Huazhong University of Science and
Technology, Wuhan, China
Background and aims: Reduced E-cadherin expression
is consistently reported in numerous malignant
tumors including hepatocellular carcinoma (HCC). N-
cadherin, however, is reported upregulated in breast,
prostate and melanoma tumor, but downregulated in
osteosarcoma and ovarian epithelial tumors. Our pre-
vious study suggested that N-cadherin was downregu-
lated in HCC, and the downregulation of N-cadherin
was associated with advanced metastatic potential
and poor surgical outcomes. This study aims to
investigate the correlation between N-cadherin and E-
cadherin expression in HCC and its clinical signifi-
cance.
Methods: 86 patients with a single HCC smaller than
5 cm in diameter who underwent curative liver resec-
tion in our center between 2002 and 2009 were enrolled
in this study. N-cadherin and E-cadherin expressions in
HCC and adjacent liver tissues were studied by immu-
nohistochemistry and immunofluorescence assays, the
relationship between N-cadherin and E-cadherin
expressions of HCC was evaluated. Furthermore, the
correlation between the status of two cadherin expres-
sions and surgical outcomes was analyzed.
Results: In 23 patients with negative expression of E-
cadherin in tumors, 19 cases were also identified with
negative expression of N-cadherin. In 30 patients with
heterogeneous expression of E-cadherin in tumors, 20
cases were identified with heterogeneous expression of
N-cadherin. In 33 patients with uniformly positive
expression of E-cadherin in tumors, 19 cases were
identified with uniformly positive expression of N-
cadherin. Positive correlation was observed between
the same expression pattern of N-cadherin and E-
cadherin (p < 0.001; spearman correlation coefficient
0.744). Concurrent loss of both N-cadherin and E-
cadherin expression was significantly associated with
absence of tumor capsule (p = 0.014), vascular inva-
sion (p < 0.001) and poor differentiation (p < 0.001).
Moreover, the 1- and 3- year disease-free and overall
survival rates were 27% and 18%, respectively, and
64.3% and 14.3%, respectively, in the patients with
concurrent loss of both N-cadherin and E-cadherin
expression, which were significantly worse than those
with concurrent preserved expression or heteroge-
neous expression of N-cadherin and E-cadherin
(p < 0.001).
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Conclusions: Loss of N-cadherin expression is posi-
tively correlated with loss of E-cadherin in HCC. The
concurrent loss of both N-cadherin and E-cadherin
expression is associated with poor surgical outcomes of
liver resection in HCC patients.
810
COMPARISON OF THE OUTCOMES OF
PATIENTS WHO UNDERWENT
DECEASED-OR LIVING-DONOR LIVER
TRANSPLANTATION AFTER
SUCCESSFUL DOWN-STAGING
THERAPY
JY Lei, LN Yan and WT Wang
Liver and Vascular Surgery, West China Hospital of
Sichuan University, Chengdu, China
Background and Aims: Down-staging therapy has been
introduced to treat patients with advanced hepatocellu-
lar carcinoma (HCC) before they receive a liver trans-
plantation. We aimed to determine the difference in
outcomes between patients who underwent deceased-
donor or living-donor right-lobe liver transplantation
after successful down-staging therapy.
Patients and methods: From July 2002 to August 2009,
83 adult patients were diagnosed with advanced HCC
and received a liver transplantation (LT) after various
successful down-staging therapies. All of the patients
met the UCSF criteria. Of these patients, 31 patients
(Group 1) underwent living-donor, right-lobe liver
transplantation, and 52 patients (Group 2) underwent
deceased-donor liver transplantation. We compared the
two groups by evaluating the differences in post-opera-
tive complications, tumor recurrence, survival rate and
hepatitis B virus recurrence.
Results: No significant differences were observed
between the LDLT and DDLT groups with respect to
the down-staging protocol, tumor characteristics, base-
line recipient and donor characteristics, overall compli-
cation rate (LDLT recipients: 48.4%, DDLT recipients:
46.1%, p = 0.883) and mortality rate (LDLT group:
9.7%, DDLT group: 7.7%, p = 0.754). The overall 1-,
3- and 5-year recurrence-free rates were 77.4%, 71%
and 62.7% after LDLT and 80.7%, 69.2% and 60.5%
after DDLT (p = 0.771) (Showed in Fig. 1). The overall
patient survival rates at 1-, 3- and 5-years were 90.3%,
74.2% and 71% after LDLT and 90.4%, 71.2% and
67.3% after DDLT (p = 0.860) (Showed in Fig. 2). The
1-, 3-, and 5-year post-transplant HBV recurrence rates
were 4%, 5% and 10.5%, respectively, for the patients
who underwent LDLT and 2.6%, 6.7% and 10.7%,
respectively, for the patients who underwent DDLT
(p = 0.918)
Conclusions: These data strongly suggest that no signif-
icant differences in postoperative complications, tumor
recurrence rate, survival rate and HBV recurrence exist
between DDLT and LDLT patients.
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MIR-3188 PROMOTES PROLIFERATION
AND METASTASIS OF
HEPATOCELLULAR CARCINOMA BY
DOWN-REGULATING KLF17 AND
UP-REGULATING SNAIL GENE
EXPRESSION
Fu-Yao Liu, Zhi-Yong Huang and Xiao-Ping Chen
Research Laboratory and Hepatic Surgery Center,
Department of Surgery, Tongji Hospital, Tongji Medical
College, Huazhong University of Science and
Technology, Wuhan, China
Background and Aims: miRNAs, critical mediators in
post-transcription stage, have been reported to be
involved in tumorigenesis nearly in all types of tumors.
This study aims to investigate the expression status of
miRNAs in hepatocellular carcinoma (HCC) and the
correlation between miRNAs expression and prolifera-
tion as well as metastasis potential of HCC.
Methods: Expression profile of miRNAs in serum of
peripheral blood between HCC patients with HCC
family history and healthy people was contrasted by
microarray. 14 miRNAs were found with expression
difference bigger than 20 folds between two cohorts
and had never been reported in HCC. By using real-
time-PCR, the expressions of the 14 miRNAs were ver-
ified in paired tissues from 50 HCC patients. MiR-
3188, miR-216b, and miR-138-2-p were selected for fur-
ther study as they have the same variation trend with
serum micro-arrays result. Their expression status and
the clinicopathological features of HCC were evaluated.
By using RNA interference technique, the correlation
of miRNA expressions and metastatic potential was
investigated by downregulating or upregulating expres-
sion in several HCC cell lines including SMMC-7721,
MHCC-97H, HepG2 and PLC/PRF/5 cell lines. The
cell proliferation, apoptosis, aggregation, migration and
invasion were then analyzed. Furthermore, the correla-
tion between the expressions of these miRNAs and the
proteins related to these biological characters were
extensively investigated by western blotting.
Results: The expressions of miR-3188, miR-216b and
miR-138-2-p* were significantly different between tumor
and its adjacent liver tissues. Of 50 HCC, 34 (68%)
tumors showed increased miR-3188 expression compar-
ing with their adjacent liver tissues. MiR-216b (78%)
and miR-138-2-p* (74%) showed reduced expression in
tumor tissues comparing with liver tissues. The increased
expression of miR-3188 were significantly correlated
with poorer tumor differentiation (p = 0.038) and vascu-
lar invasion (p = 0.034). Knockdown of miR-3188 in
SMMC-7721 and PLC/PRF/5 cells resulted in decreased
cell proliferation, aggregation, cell migration and inva-
sion. In PLC/PRF/5 cells, miR-3188 inhibited apoptosis
as well. Moreover, the KLF17 expressions in HCC cell
lines following knockdown miR-3188 were significantly
increased; and snail expression were decreased.
Conclusions: miR-3188 expression is increased in HCC,
which is associated with the proliferation and meta-
static potential of HCC. miR-3188 may promote tumor
progression by down-regulating KLF17 and up-regulat-
ing snail expressions.
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MAGNETIC BILIARY-ENTERIC
ANASTOMOSIS CAN PROMOTE
STOMA HEALING UNDER
INFLAMMATION: A HISTOLOGICAL
RESEARCH
Jian-Hui Li1, Yi Lv, Long Guo2, Zhi-Yong Zhang1,
Wei-Jie Yao1, Shan-Pei Wang2, Shi-Qi Liu2 and
Zhi-Min Gen2
1Department of Oncology Surgical, The Third Affiliated
Hospital, School of Medicine, Xi’an Jiaotong University,
Xi’an, China (Shaanxi Provincial People’s Hospital);
2Department of Hepatobiliary Surgery, The First
Affiliated Hospital, School of Medicine, Xi’an Jiaotong
University, Xi’an, China; 3Materials Science and
Engineering Postdoctoral Research Station, Xi’an
Jiaotong University, Xi’an, China; 4XJTU Research
Institution of Surgical Advanced Technology and
Engineering, Xi’an, China
Background and aims: Reconstruction of bile duct
under severe inflammation is usually difficult and dis-
satisfatory when using traditional ways. We are aimed
to evaluate applying magnetic biliary-enteric anastomo-
sis stent to reconstructing the biliary-enteric continuity
can promote stoma healing in this situation.
Methods: Acute bile duct injury and bile peritonitis
were constructed in canine models. The sutureless mag-
netic biliary-enteric anastomosis stents and traditional
suture anastomosis were both used to reconstruct the
biliary-enteric continuityin one stageunder the circum-
stance of severe inflammation. The histological healing
effects of two kinds of methods were observed through
light microscope and electron microscope in order to
contrast with each other.
Results: Compared with traditional manual anastomo-
sis, less inflammatory reaction and more regular
arrangement of collagen were observed at the stoma of
the biliary-enteric continuity reconstruction in one stage
using magnetic biliary-enteric anastomosis stents.
Conclusions: Magnetic anastomosis stent has a better
stoma healing even under a circumstance of severe
inflammation. It can promote the stoma healing and
decrease the scar formation.
837
IMPROVEMENT IN LONG-TERM
SURVIVAL AFTER MAJOR HEPATIC
RESECTION FOR SMALL SOLITARY
HEPATOCELLULAR CARCINOMA IN
CIRRHOTIC PATIENTS
TCL Wong, TT Cheung, KS Chok, AC Chan, SH
Tsang and RT Poon
Queen Mary Hospital, The University of Hong Kong,
Pokfulam Road, Hong Kong, Hong Kong S.A.R., China
Background & Aims: Extend of liver resection for soli-
tary hepatocellular carcinoma less than 5 cm is contro-
versial.
Methods: This is a retrospective review of patients with
solitary HCC less than 5 cm, who have undergone liver
resection in a tertiary referral centre in Hong Kong, from
January 1989 to December 2009. Baseline demographics,
liver function, perioperative outcomes and overall sur-
vival were compared.
Results: 348 cirrhotic patients with a solitary HCC less
than 5 cm have undergone either major hepatectomy
(n = 93) or a minor hepatic resection (n = 255). The
Child’s status were not different, 98.9% vs. 96.1%
(p = 0.319) patients who underwent major and minor
liver resection were Child’s A. Patients who underwent
minor liver resection had a more severe degree of cir-
rhosis as suggested by a lower platelet count (131.0 vs.
146 9 103/uL, p < 0.001) and a worse indocyanine
green retention at 15 mins (13.3 vs. 10.4%, p < 0.001).
The median tumor size was larger for those who
received major hepatectomy (4.0 vs. 2.5 cm,
p =< 0.001) and they also had more advanced stage of
disease (stage I:II:IIIA, 10.8: 55.9: 33.3% vs. 26.7: 52.9:
20.4%, p = 0.002). The median operative time for
major hepatectomy was significantly longer (415 vs.
248 min p < 0.001) and with more blood loss (0.9 vs.
0.5L, p < 0.001). Despite larger tumor and more
advance stage of disease in major hepatectomy group,
hospital mortality (5.4% vs. 2.0%, p = 0.185), post-
operative complications rate (30.1 vs. 23.1%,
p = 0.234) and transfusion rate (10.8 vs. 11.4%,
p = 0.862) were the same between the 2 groups.
The risk of intrahepatic recurrence was 30.1 vs. 45.1%
(p = 0.012) after major hepatectomy and minor liver
resection respectively. In the latter group, majority
(45.2%) of these patients developed solitary recurrence
in same liver lobe where previous tumor was located.
The overall survival was significantly better for those
who underwent major hepatectomy (147.52 vs.
92.05 months, p = 0.043) and they have better 5- and
10-year disease free survival rate (57.3 vs. 40.2%, 38.1
vs. 18.9%, p = 0.003).
Conclusions: In well-selected patients, major hepatec-
tomy for cirrhotic patients with small solitary HCC
<5 cm is safe. As most intrahepatic recurrences were
solitary and in the same lobe where previous tumor
was located, a major hepatic resection might have pre-
vented such recurrence. This might explain why despite
larger tumor size and more advanced stage of disease,
patients received major hepatectomy have better overall
and disease-free survival.
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RISK ASSESSMENT IN LIVER
TRANSPLANTATION AFTER CARDIAC
DEATH - WHICH RECIPIENT SHOULD
BE SELECTED?
Schlegel Andrea1, Dutkowski Philipp1, DeOliveira
Michelle1, M€ullhaupt Beat2 and Clavien Pierre-Alain1
1Swiss HPB and Transplant Center, Department of
Surgery, University Hospital Zurich, Zurich,
Switzerland; 2Department of Gastroenterology and
Hepatology, University Hospital Z€urich, Zurich,
Switzerland
Background and aims: We recently developed a score
system from the US database (balance of risk, BAR
score) to predict patient survival after orthotopic liver
transplantation (OLT). The aim of this study was to
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identify, donor, graft and recipient combinations for an
acceptable outcome in liver transplantation donated
after cardiac death.
Methods: According to the UNOS database, contain-
ing 11,942 patients, in a first step, we generated and
compared two groups of liver transplantations, donated
after brain death (DBD) and after cardiac death
(DCD). In a next step all DCD liver transplants from
UNOS database were evaluated in one survival analysis
in relation to the 3 risk classes of the BAR score and
compared to the DBD liver transplantations.
Results: Liver grafts donated after cardiac death (med-
ian asystolic warm ischemic time of 14 minutes) achieve
acceptable 5 - year graft survival rates between 60 and
65 % only up to a BAR score of  9. Implantation of
liver grafts, which suffered from warm ischemia result
in significantly decreased graft survival when trans-
planted into higher BAR risk classes (BAR > 9).
Conclusions: Using the UNOS database, we show that
liver grafts donated after cardiac death can be used
with risk adjustment, i.e. up to BAR  9, while DCD
liver transplantation above BAR 9, result in significant
decreased recipient survival.
846
RESCUE OF LIVER GRAFTS AFTER
CARDIAC ARREST: FIRST STUDY
COMPARING WARM VS. COLD
MACHINE PERFUSION IN LIVER
TRANSPLANTATION
Schlegel Andrea, Graf Rolf, Brockmann Jens,
Dutkowski Philipp and Clavien Pierre-Alain
Department of Surgery, Laboratory of the Swiss HPB
and Liver Transplantation Center, University Hospital
Zurich, Zurich, Switzerland
Background and aims: The use of livers from donors
after cardiac arrest (DCD) is increasing in many coun-
tries to overcome organ shortage. Due to an inherent
period of warm ischemia before preservation, those
grafts are at higher risk of failure or bile duct injury.
Rescue strategies with machine perfusion have been
developed with two competing concepts: continuous
normothermic oxygenated perfusion vs. end-ischemic
Hypothermic Oxygenated PErfusion (HOPE), applied
only 1 h prior to graft implantation. While several
groups have claimed success with either technique, no
comparison is currently available.
Methods: Rat livers were subjected to 30 or 60 min in
situ warm ischemia, followed by subsequent 4 h cold
storage, mimicking DCD-organ procurement followed
by conventional organ transport. After warm ischemia,
animals in the normothermic group received a 4 h nor-
mothermic oxygenated perfusion through both the por-
tal vein and hepatic artery, while in the HOPE group,
livers underwent passive cold storage for 4 h followed
by 1 h HOPE. Outcome after reperfusion was tested in
isolated rat liver perfusion (IPRL) and liver transplan-
tation (LT) models.
Results: All control animals died after transplantation
of a liver graft subjected to 60 min warm ischemia fol-
lowed by 4 h cold storage. Consistent with this obser-
vation, those livers disclosed very poor function in the
IPRL. Normothermic oxygenated perfusion after
60 min warm ischemia failed to prevent lethal injury.
In contrast, 1 h HOPE after cold storage was associ-
ated with 70% animal survival after transplantation
with good function in the IPRL. Reduction of warm
ischemia to 30 min resulted in survival in all groups,
with again significantly reduced injury for HOPE trea-
ted grafts. Graft subjected to HOPE were also pro-
tected against later biliary injury.
Conclusions: This is the first study comparing cold vs.
normothermic machine perfusion. The impressive supe-
riority of the HOPE technique can now be tested in
human trials.
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MITOCHONDRIAL FUNCTION IN
STEATOTIC LIVERS SUBJECTED TO
COLD PRESERVATION AND ISCHEMIC
PRECONDITIONING
Michael J. J. Chu1, Anthony Hickey2, Adam
Bartlett1,3-4 and Anthony R. J. Phillips1-4
1Department of Surgery, University of Auckland,
Auckland, New Zealand; 2School of Biological Sciences,
University of Auckland, Auckland, New Zealand;
3Maurice Wilkins Centre for Biodiscovery, University of
Auckland, Auckland, New Zealand; 4New Zealand Liver
Transplant Unit, Auckland City Hospital, Auckland,
New Zealand
Introduction: Hepatic steatosis is associated with pri-
mary graft non-function following liver transplantation.
Mitochondrial dysfunction is thought to contribute to
the increased susceptibility of steatotic livers to cold
ischemia. Ischemic preconditioning (IPC) has been
shown to improve outcome in some clinical studies of
transplantation. The impact of IPC and hepatic steato-
sis on mitochondrial function during cold ischemia has
yet to be well-described.
Aims: To assess mitochondrial function during cold
ischemia of a rodent model of hepatic steatosis previ-
ously subjected to IPC (10 min ischemia, 10 min reper-
fusion).
Methods: Three week-old male Sprague-Dawley (SD)
rats were fed a high fat/high sugar diet (HFSD) for 1–
4 weeks to induce hepatic steatosis while aged-matched
controls were fed control chow. Liver samples (IPC- or
IPC+) were collected from obese (n = 8/group) and lean
rats (n = 8/group) at 1, 2 and 4 weeks of feeding; and pre-
served in ice-cold University ofWisconsin (UW) solution.
Mitochondrial function of homogenized liver samples
was measured by high resolution respirometryoxygraphs
using a multiple substrate and inhibitor protocol after
1.5, 4, 8, 12, 18 and 24 h of cold storage respectively.
Results: SD rat livers showed mild (<30%), moderate
(30–60%) and severe (>60%) macrovesicularsteatosis
after 1, 2 and 4 weeks of HFSD feeding, respectively.
Steatotic livers (IPC-) at all age groups showed
increased proton leak at Complex I (60%–200%) and
lower respiratory control ratios (RCR, 52%–75%) dur-
ing cold ischemia compared to aged-matched controls.
Mildly steatotic livers (IPC+) showed a 27-39%
improvement in RCR throughout cold ischemia com-
pared to IPC- mild steatotic livers; and had similar
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RCR to aged-matched lean livers up to 4 h of cold
ischemia. IPC had no apparent impact on mitochon-
drial function in moderate or severe hepatic steatosis.
Conclusions: This study showed that steatotic livers
have impaired Complex I function and 52%–75%
Complex I efficiency compared to aged-matched con-
trol livers, even in mild hepatic steatosis. IPC improved
Complex I efficiency in mild hepatic steatosis but did
not have an apparent effect on mitochondrial function
in moderate or severe hepatic steatosis. These data indi-
cate that steatotic livers are more susceptible to pro-
longed cold ischemia but that IPC was beneficial in
mild hepatic steatosis restoring aspects of mitochon-
drial function back toward those in normal livers. It is
recommended that shorter cold ischemia should still be
utilized for preconditioned steatotic donor livers.
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EFFECT OF ISCHEMIC
PRECONDITIONING ON
MITOCHONDRIAL FUNCTION OF
STEATOTIC LIVERS SUBJECTED TO
WARM ISCHEMIA-REPERFUSION
INJURY
Michael J. J. Chu1, Rakesh Premkumar1, Anthony
Hickey2,3, Anthony R. J. Phillips1-4 and Adam
Bartlett1,3-4
1Department of Surgery, University of Auckland,
Auckland, New Zealand; 2School of Biological Sciences,
University of Auckland, Auckland, New Zealand;
3Maurice Wilkins Centre for Biodiscovery, University of
Auckland, Auckland, New Zealand; 4New Zealand Liver
Transplant Unit, Auckland City Hospital, Auckland,
New Zealand
Introduction: Hepatic steatosis is a major risk factor
for liver resection. The increased susceptibility of fatty
livers to ischemia-reperfusion injury (IRI) is associated
with mitochondrial dysfunction. Ischemic precondition-
ing (IPC) protects steatotic livers against ischemia and
have been thought to preserve ATP content but the
effect of IPC on mitochondrial function (MF) is not
well described.
Aims: To assess effect of IPC on MF in steatotic livers.
Methods: Three week-old male Sprague-Dawley rats
(n = 30) were fed a high fat/high sugar diet for 8 weeks
to induce >60% macrovesicularsteatosis while another
cohort (n = 30) was fed control chow. Three groups
(n = 10) were tested. The IR group was subjected to a
standard IR injury of 60 min partial hepatic ischemia
and 4 h reperfusion. The IPC group was subjected to
10 min ischemia followed by 10 min reperfusion, prior
to the same standard IR injury. The sham group
underwent the same surgery but no ischemia was
induced. Liver samples were taken at various time-
points for hepatic MF analysis: i) t = 0 (baseline), ii)
t = 10 (10 min ischemia), iii) t = 20 (end of IPC), iv)
t = 80 (60 min ischemia), and v) t = 320 (end of 4 h
reperfusion). MF of homogenized liver samples was
measured by high resolution respirometryoxy graphs
using a multiple substrate and inhibitor protocol.
Results: Repeated liver sampling had no effect on MF
over the duration of the study. Steatotic livers showed
impaired basal respiratory control ratios (RCR) due to
increased proton leak at Complex I compared to lean
livers. Following IRI, MF in lean livers returned to pre-
ischemic levels whereas steatotic livers showed impaired
Complex I-fuelled oxidative phosphorylation and lower
RCR compared to lean livers. IPC had no effect on lean
liver MF. However, oxidative phosphorylation in the
IPC-steatotic livers showed a small improvement com-
pared to IR-steatotic livers (p = 0.08). Complex II func-
tion in both liver types was not affected by IRI.
Conclusions: This study showed that steatotic livers
have impaired basal Complex I function and phosphor-
ylation efficiency. Warm IRI led to further derangement
of Complex I function and decreased phosphorylation
efficiency in steatotic livers. IPC had a trend toward
improving these features in steatotic liver but had no
effect in lean livers. These data confirmed that steatotic
livers have decreased tolerance to warm IRI compared
to lean livers and may be mediated through Complex I
impairment. The protective effect of IPC in steatotic liv-
ers may not be mediated through the mitochondria.
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ANTIGEN PRESENTING CELLS IN
NORMAL HUMAN LIVER: A
SYSTEMATIC REVIEW
Otto Strauss1,2, Rod Dunbar2,3, Anthony Phillips2,3
and Adam Bartlett1,2
1Department of Surgery, Faculty of Medical Health
Sciences, University of Auckland, Auckland, 1142, New
Zealand; 2Maurice Wilkins Centre for Molecular
Biodiscovery, University of Auckland, Auckland, 1142,
New Zealand; 3School of Biological Sciences, Faculty of
Science, University of Auckland, Auckland, New
Zealand
Background: The liver is an immunologically unique
organ. Although normally hyporesponsive and tolero-
genic, it can initiate robust immune responses in certain
conditions. Antigen presenting cells (APC) are the or-
chestrators of the immune system, and are seen as
potential therapeutic targets in a variety of diseases
from cancer to transplant rejection. However the phe-
notype of these cells in the liver is not well defined.
Methods: A systematic review was conducted to iden-
tify the current experimental evidence describing the
immunophenotype of non-parenchymal APC in normal
human liver.
Results: Using well defined selection criteria, a search
of MEDLINE and EMBASE databases identified 57
studies. The majority (n = 51) describe Kupffer Cells
(KC), with only 10 looking specifically at dendritic cells
(DC). Two studies used flow cytometry in KC and in
these the data was limited. The majority of papers
described the roles of these cells in the acquired
immune response, but some other functions in the
innate immune and metabolic systems were highlighted.
Conclusions: It is apparent that despite the phenotypes
and functions being well described in animal models,
the data in humans is surprisingly limited. A study
undertaken using modern immunological techniques to
better characterise these cell populations in human liver
is long overdue.
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A SYSTEMATIC REVIEW OF THE
EXTRA-PANCREATIC INFECTIOUS
COMPLICATIONS IN ACUTE
PANCREATITIS
Lisa Brown, John Windsor and Max Petrov
Pancreas Research Group, Department of Surgery,
University of Auckland, Auckland, New Zealand
Background and Aims: Infectious complications, espe-
cially of pancreatic necrosis, are an important cause of
morbidity and mortality in acute pancreatitis. The fre-
quency and relative importance of extra-pancreatic
infection has not been systematically reviewed. This
review aims to determine prevalence of different extra-
pancreatic infectious complications in acute pancreati-
tis, and relationship of the timing of these infections to
the onset of acute pancreatitis.
Methods: Search performed of Ovid MEDLINE (1946
to present), Embase (1980 to present) and Cochrane
Libraries. Search terms used “Pancreatitis” AND
“Infection” AND (“Complication” OR “Outcome”).
Interventional clinical studies were included, except
those groups that commenced antibiotics prophylacti-
cally from admission.
Results: A total of 907 papers were screened, with 17
studies included in the final analysis. The studies con-
sisted of one prospective non-randomized trial and 16
randomized control trials. A total number of 1,323
patients with confirmed acute pancreatitis were
included in the review, with a combined mortality of
138 deaths (10.8%). The total number of extra-pancre-
atic infections was 400 (30%) cases, with pneumonia
(and other respiratory infections) the most common at
166 (42%) cases; blood-borne 150 (38%); urinary tract
44 (11%); “superinfection” 19 (5%); and others 21
(5%). Six papers reported length of time from admis-
sion to occurrence of extra-pancreatic infection, with
median time of 8 days (range 4–33 days).
Conclusions: Extra-pancreatic infection is a common
complication of acute pancreatitis with respiratory,
blood-borne, and urinary infections being the most pre-
valent. The extra-pancreatic infectious complications
are most likely to occur relatively early in the course of
acute pancreatitis. Recognition should be made of the
common occurrence of extra-pancreatic infectious com-
plications in acute pancreatitis, with prevention/treat-
ment modalities administered early to curb morbidity
and mortality.
868
PRO-METASTATIC EFFECTS OF
ERADICATION THERAPIES FOR
HEPATOCELLULAR CARCINOMA AND
THEIR INTERVENTION
Zhao-You Tang
Liver Cancer Institute & Zhongshan Hospital, Fudan
University, Shanghai, China
In the 20th century, substantial progress has been made
to eradicate cancer using surgery, radiotherapy, chemo-
therapy and regional cancer therapies. Unfortunately,
the overall prognosis of patient with hepatocellular
carcinoma (HCC) remained unsatisfactory. The effect
and side effect of eradication therapies have been well
acknowledged. However, little was known about their
“opposite effect”, therefore, study on the mechanism
and intervention of the “opposite effect” will help to
further improve their effectiveness. In author’s institu-
tion, experimental studies using human HCC nude mice
model with high metastatic potential indicated that pal-
liative resection, radiotherapy, chemotherapy, hepatic
artery ligation and molecular targeted therapies that
target to VEGF (e.g. Sorafenib) promoted the meta-
static potential of residual cancer mainly via inflamma-
tion, hypoxia and immuno-suppression with different
molecular alteration. And epithelial-mesenchymal tran-
sition (EMT) was commonly found. For example, we
found that Palliative resection-stimulated HCC metas-
tasis, in part, by up-regulation of VEGF and MMP2/
TIMP2. Radiation enhances long-term metastasis
potential of residual HCC through TMPRSS4-induced
EMT. The underlying proinvasive mechanism of hepa-
tic artery ligation (HAL) appeared to be associated
with enhanced intratumoral hypoxia and EMT due to
hypoxia. We found that activation of b-Catenin by
hypoxia contributes to the enhanced metastatic poten-
tial (Clin Cancer Res 2010). We demonstrated that so-
rafenib down-regulates expression of HTATIP2 via
JAK-STAT3 signaling to promote metastasis of HCC.
Interestingly, effective intervention has been found
using clinical available drugs. (1) Cytokines such as
interferon alfa prolonged survival after palliative resec-
tion. (2) Anti-inflammatory such as zoledronic acid was
found to enhance the effect of sorafenib via depletion
of tumor-associated macrophage. (3) Traditional medi-
cine also played a role for intervention. We found that
“Song-You Yin” (SYY, herbal compound with 5 herbs)
inhibited tumor growth and prolonged survival via
inducing apoptosis and down-regulation of MMP2 and
VEGF; we demonstrated that residual HCC after oxa-
liplatin treatment has increased metastatic potential
and is attenuated by SYY; we reported that SYY rein-
forced the ability of interferon-alfa to inhibit the
enhanced metastatic potential induced by palliative
resection of HCC. Tanshinone IIA (one of the compo-
nents of SYY, an herbal monomer with a clear chemi-
cal structure, isolated from Salvia miltiorrhiza) inhibits
metastasis after palliative resection of HCC and pro-
longed survival in part via vascular normalization, and
improved hypoxia. (4) A novel tripeptide, tyroserleu-
tide, inhibits irradiation-induced metastasis of HCC.
All of these have provided potential clinical implication
to improve the outcome after eradication therapies.
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A KOREAN 11 YEAR SINGLE CENTER
EXPERIENCE OF LIVER INJURY DUE
TO TRAUMA
Dong Do You, Il young Park, Dong Gu Kim and
Yong Sugn Won
Department of Surgery, College of Medicine, the
Catholic University of Korea, Suwon, South Korea
Background: In the past surgery has played a major
role in treating liver injury yet recently conservative
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treatment has been reported for the first line treatment
of hemodynamically stable patients. The aim of this
study was to compare factors and outcome concerning
surgical and conservative treatment in patients with
traumatic liver injury.
Methods: A retrospective study of 91 patients who
were treated in Saint Vincent Medical Hospital from
April 2000 between July 2012 for liver injury due to
trauma were reviewed retrospectively
Results: Among the 91 patients confirmed in our center
74 patients were treated non-surgically and 17 patients
with surgery. In the surgically treated group there were
3(17.6%) mortalities compared to 3(4.0%) in the non-
surgical treated group in which the mortality cause was
not from liver laceration but from spleen rupture,
External iliac artery bleeding and IVC bleeding com-
bined with multiple fracture. The surgically treated
group had a higher mean Injury severity score (ISS 39
vs. 15), mean liver injury score (3 vs. 2), extravastion
rate of contrast on initial Abdominal pelvis CT scan
(52.9% vs. 6.7%), decrease of hemoglobulin (1.7 vs.
0.6) during the initial 4 hours of admission and a.
lower GCS (11 vs. 14), initial Systolic blood pressure
(85.1 vs. 96) compared to the non-surgically treated
group. In the surgical treated group when only con-
cerning liver injury there were 5 cases of hepatorraphy,
3 of packing, 2 of hepatectomy and 2 of hepatic artery
ligation. In 3 cases only irrigation and hematoma evac-
uation was done and in other 3cases other abdominal
surgery without procedures concerning the liver was
done. In the 3 cases of mortality in the surgically trea-
ted group due to more serious associated injuries the
mean ISS score was higher compared to the other sur-
gically treated group (57 vs. 35).
Conclusions: Injury severity score, Liver injury score
and systolic blood pressure and decreasing hemoglobu-
lin change must be considered when deciding operation
or conservative treatment for patients with traumatic
liver injury. In predicting outcome associated injuries
are an important factor. A multimodal therapy is cru-
cial to improve outcome.
877
LONG TERM SURVIVAL AFTER
LAPAROSCOPIC RESECTION OF
COLORECTAL LIVER METASTASES
Joel Lewin, Richard Bryant, Ian Martin, Les
Nathanson, George Fielding and Nicholas O’Rourke
Royal Brisbane Hospital, Wesley Hospital, Brisbane/
Queensland, Australia
Backgrounds: The laparoscopic approach to liver resec-
tions in benign and malignant conditions has now been
widely reported, although there is still little data avail-
able on long term survival after laparoscopic resection
for malignant disease. This paper reports the long term
follow up of patients undergoing laparoscopic liver
resection for colorectal liver metastases.
Methods: Patients undergoing laparoscopic liver resec-
tion for colorectal liver metastases by 5 surgeons in 2
institutions between 1998 and 2012 were collected in a
prospective database. Follow up data were confirmed
by telephone contact and chart review.
Results: 132 laparoscopic liver resections were per-
formed in 127 patients. 74 patients were male and 55
female, with a median age of 64 (range 25–86). 93
patients had a single lesion, 27 patients 2 lesions, and
12 patients 3 or more lesions. 2 patients had a second
laparoscopic resection for further metastases and 1 had
a total of 4 resections. The median lesion size was
26 mm (range 6–92). The median Clinical Risk Score
was 1 (range 0–4) and the median Basingstoke Prog-
nostic Index preoperative score was 5 (range 0–15). 110
procedures were completed purely laparoscopically.
There were 10 conversions and 12 hybrid procedures.
There were 33 major hepatectomies ( 3 segments).
Median blood loss was 200 mL (0–1500) and median
operation time 120 min (20–367). Mean patient follow
up was 33 months. 5-year overall actuarial survival was
64% (CI 54%–78%) and 5-year disease-free actuarial
survival 44% (CI 33%–58%). Stratifying according to
the risk scores did not demonstrate a statistically signif-
icant difference in survival.
Conclusions: Long term survival after laparoscopic
liver resection for colorectal liver metastases is equiva-
lent to reported outcomes in open surgery.
878
ACUTE VERSUS INTERVAL
CHOLECYSTECTOMY FOR ACUTE
CHOLECYSTITIS: A COST-ANALYSIS
STUDY
Malwaththe Hettige Asela Jayathilaka, Cindy Siaw Lin
Goh, Winston Wei Liang Woon, Jee Keem Low and
Sameer Padmakumar Junnarkar
Hepatobiliary Unit, Department of General Surgery, Tan
Tock Seng Hospital, Singapore, Singapore
Background and aims: Biliary symptoms whilst await-
ing elective cholecystectomy are common, resulting in
hospital admission, further investigation and increased
hospital costs. Immediate cholecystectomy during the
first admission is safe and effective, even when per-
formed laparoscopically. This study was designed to
compare the costs of performing acute vs. interval cho-
lecystectomy for acute cholecystitis in the Department
of General Surgery, Tan Tock Seng Hospital, Singa-
pore.
Methods: The case notes of all patients undergoing
elective or emergency cholecystectomy in our hospital
between April 2011 and March 2012 were retrospec-
tively reviewed. Data was collected on the indications
for surgery, details of associated hospital admissions
between point of diagnosis and surgery, operative time,
conversion rates, complication rates and overall hospi-
tal charges for each patient.
Results: Over the 12-month study period, 460 patients
underwent cholecystectomy (398 laparoscopically).
Indications for surgery were symptomatic gallstones
(208), choledocholithiasis (35), acute cholecystitis (187),
biliary pancreatitis (24), gallbladder polpys (5) and por-
celain gallbladder (1). Cholecystectomy was elective in
70% of cases (322). Index admission cholecystectomy
for acute cholecystitis was performed in 138 patients,
of which 125 patients underwent laparoscopic cholecys-
tectomy, with 21 cases being converted to open proce-
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dure. 52 patients were managed conservatively with
interval cholecystectomy being performed on a later
date. Of these, 16 patients were readmitted 24 times
overall during the interim period for gallstone-related
complications. For the patients who had index admis-
sion cholecystectomy, mean operative time was
128 min, conversion-to-open rate was 16.8% and mean
hospital bed occupancy duration was 5 days. Corre-
spondingly, the figures obtained for the interval chole-
cystectomy group were 96 min operative time, 7.5%
conversion-to-open rate and 8 days average hospital
stay. The total average cost for all hospital admissions,
investigations and procedures were calculated for each
group. The mean cost for the index admission cholecys-
tectomy group was S$8750, interval cholecystectomy S
$15600 and routine symptomatic gallstones S$4500.
Within the interval cholecystectomy group, the average
cost was almost double for the group of patients who
were readmitted whilst awaiting surgery (S$21500 vs. S
$12050). No bile duct injuries and no mortalities
occurred in both groups, but the rate of subtotal chole-
cystectomy in the emergency cholecystectomy group
was 8%.
Conclusions: Although conversion rate was higher and
operative time greater for index admission cholecystec-
tomy, our findings suggest that performing cholecystec-
tomy during the index admission for acute cholecystitis
will result in substantial cost savings for both trust and
patient, reduced operative waiting times and increased
tariff income.
881
LOCO-REGIONAL TREATMENT OF
HCC
Yonson Ku and Takumi Fukumoto
Division of Hepato-Biliary-Pancreatic Surgery,
Department of Surgery, Kobe University Graduate
School of Medicine, Hyogo, Japan
Background: According to Barcelona Clinic Liver
Cancer staging system, patients with intermediate-
stage HCC refractory or unsuitable for transarterial
chemoembolization (TACE) and those with advanced-
stage are all candidates for sorafenib. However, the
5-year survival rates of these patients remain low
(0%–10%).
Methods: As an ultimate loco-regional chemotherapy
of the liver, we have developed percutaneous isolated
hepatic perfusion (PIHP). PIHP is a novel and simple
hepatic venous isolation system that enables adminis-
tration of cytotoxic agents at a dose of up to 10 times
the maximally tolerated dose, while reducing exposure
of the entire body to the major side effects of the
agents. Major cytotoxic agents including doxorubicin,
MMC, cisplatin and melphalan can be effectively elimi-
nated by PIHP system when administered via the hepa-
tic artery. In 1998, we first reported the long-term
results of PIHP in 28 patients with intermediate-stage
HCC refractory or unsuitable for TACE and
advanced-stage HCC with doxorubicin-based regimen.
After that, to enhance the antitumor effects of PIHP,
we have started the use of PIHP in combination with
reductive surgery. This dual treatment strategy has
several oncologic advantages: i) A large HCC fre-
quently accompanies arterial collaterals from adjacent
organs, which may reduce the effect of trans-arterial
chemotherapy, and these arterial collaterals could be
eliminated at the time of first-line surgical resection; ii)
reductive hepatectomy reduces the vascular bed of the
liver, which is theoretically beneficial to increasing the
relative dose rate to the residual tumors.
Results: Until December 31, 2011, we have treated 171
HCC patients with PIHP and obtained objective
response rate of 60%. The 1-year and 5-year survival
rates of PIHP were 67 and 17%, respectively. Ninety
of 171 patients underwent dual treatment and 1-year
and 5-year survival rates were 73 and 22 %, respec-
tively.
Conclusions: Long-term survival of HCC patients with
an extensive disease treated by palliative loco-regional
treatments is not satisfactory because complete
responses are rarely achieved. Sorafenib represents an
important advance in the systemic chemotherapy of
advanced HCC. However the survival benefit of so-
rafenib is limited. A substantial improvement in the
outcomes of advanced HCC is expected with the
advent of new therapeutic approaches as represented
by PIHP.
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INCREASED CIRCULATING
REGULAORY T CELL PREDICTS POOR
HEPATOCELLULAR CARCINOMA
PROGNOSIS
Xi Feng, Bo Li, Hui Ye, Yong-Gang Wei, Sheng-fu Li
and Yin-Qiu Mao
West China Hospital, Sichuan University, Chengdu,
China
Regulatory T cells (Treg) correlate with impaired anti-
tumor response. However, the impact of circulating
Treg on the prognosis of hepatocellular carcinoma
(HCC) has not been well studied. The aim of this study
is to investigate the prognostic impact of circulating
Treg in HCC patients who received liver resection. Treg
level, serum IL-2 and TGF-b1 levels were measured
among 42 HCC patients. All subjects were followed up
for 2 years. Compared with patients with low Treg
level, serum IL-2 (7.80 vs. 6.42 ng/mL, p = 0.03) and
TGF-b1 (139.42 vs. 114.14 pg/mL, p = 0.02) levels
were significantly increased in patients with high Treg
level. Furthermore, the Kaplan–Meier survival analysis
demonstrated that patients with high Treg level showed
a worse overall survival (23 vs. 17 months, p = 0.027)
and disease-free survival (20 vs. 13 months, p = 0.043)
than patients with low Treg level. Cox’s proportional
hazards regression model confirmed that only Treg
level and tumor differentiation were two independent
prognostic factors among all clinicopathological factors
in patients with HCC. In conclusion, this study showed
increased circulating Treg frequency and elevated IL-2
and TGF-b levels correlated with poor prognosis in
HCC, which suggests measuring circulating Treg level
may identify HCC patients with poor prognosis and
down-regulating IL-2 and TGF-b levels may affect
antitumor response.
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LIVING DONOR LIVER
TRANSPLANTATION FOR
HEPATOCELLULAR CARCINOMA IN
SINGLE CENTER EXPERIENCE AND
IMPACT TO THE VARIOUS CRITERIA
Ho Joong Choi, Dong Goo Kim, Eun Young Kim,
Gun Hyung Na, Jae Hyun Han, Tae Ho Hong and
Young Kyoung You
Hepatobiliary-pancreas surgery & Liver Transplantation
division, Department of Surgery, Seoul St. Mary’s
Hospital the Catholic University of Korea, Seoul, South
Korea
Background and aims: Liver transplantation (LT) as
treatment for hepatocellular carcinoma (HCC) is
known to be the best therapeutic option. To obtain
good result, it is important to select appropriate LT
candidates among HCC patients. Up to now, there are
various selection criteria. Many centers have their own
criteria, which is from the influencing factors to sur-
vival. Especially in living donor liver transplantation
(LDLT), it is significant to investigate such criteria
whether the effect is.
Methods: From October 2000 to November 2011, we
retrospectively analyzed 233 patients who had under-
gone LDLT for HCC. To identify risk factors for
recurrence, we provided our own criteria from the
patient’s and tumor characteristics based on the recur-
rence. And then, we compared our selection criteria
with various tumor grading scales, such as Milan crite-
ria, UCSF criteria, TNM stage, BCLC stage and CLIP
scoring system. The median follow-up was 68 (6~139)
months.
Results: In 233 patients who received LDLT for HCC,
we experienced 37(15.9%) recurrences. The 5 year dis-
ease free survival (DFS) and overall survival rates after
LDLT in patients with HCC were 80.9% and 74.4%
respectively. On multivariate analysis, largest tumor
diameter and alphafetoprotein (AFP) had significant
influence on HCC recurrence after LDLT. Therefore,
only 2 factors included in our scoring system; largest
tumor diameter ( 5 cm) and AFP ( 100 ng/mL).
Within our new scoring system, 1, 3, 5 years DFS and
overall survival rates were 93.9%, 89.8%, 88.5% and
89.0%, 82.2%, 80.1%. Our scoring system (p < 0.001),
Milan criteria (p = 0.009), UCSF criteria (p = 0.001),
BCLC stage (p < 0.001) and CLIP scoring system
(p = 0.011) showed significant difference in DFS. And
our scoring system (p = 0.001), UCSF criteria
(p = 0.004) and BCLC stage (p = 0.024) showed signifi-
cant difference in overall survival rate.
Conclusions: LT is considered as the preferred thera-
peutic option in such patients who have
AFP  100 ng/mL and tumor diameter  5 cm.
Milan criteria, UCSF criteria, BCLC stage are also
good therapeutic guide lines. Further verification of
these findings by a prospective study is required for
clinical application of our new scoring system.
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PANCREATIC TRAUMA – A SINGLE
CENTER EXPERIENCE
Borgaonkar Vijay, Deshpande Sushil, Goklani Mayur
and Vanzar Prashant
Seth Nandlal Dhoot Hospital, Aurangabad,
Maharashtra, India
Pancreatic injury is not very common in abdominal
trauma cases. The retroperitoneal position of the organ
itself is the main reason for this. Penetrating as well as
blunt abdominal injuries can lead to injury to pancreas.
The possibility of the injury to pancreas must always
be kept in mind while dealing with such type of acci-
dents. Due to the fact that abdominal signs and symp-
toms may develop very late, these injuries are often
missed. These injuries are sometimes associated with
major vascular injuries. The standard protocol of doing
abdominal C. T. helps in detecting pancreatic injuries
which otherwise may be missed on ultrasound examina-
tions. The treatment options are
• Only supportive treatment
• Drainage only
• Drainage with surgical bypass
• Distal pancreatectomy
• Pancreatico-duodendectomy.
Presenting herewith a single center experience of manag-
ing Pancreatic trauma cases. We managed eleven cases of
Pancreatic trauma in our center. The patients were
referred after varying duration since the time of injury.
All patients were thoroughly investigated and managed
as per standard protocol. We found that surgical inter-
vention with bypass procedure for ductal disruption,
when done at earliest possible time, gives best results.
956
THE NATURAL COURSE OF THE
PATIENTS WITH HIGH COMORBIDITY
WHO UNDERWENT PERCUTANEOUS
CHOLECYSTOSTOMY (PC) FOR ACUTE
CHOLECYSTITIS
Ye Rim Chang, Jin Young Jang, Wooil Kwon, Jae
Woo Park, Mee Joo Kang and Sun Whe Kim
Departments of Surgery, Seoul National University
Hospital, Seoul, South Korea
Background and aims: Controversies exist regarding
treatment options in high-risk and unfit for surgery
patients with acute cholecystitis (AC) and few studies
show long term follow-up results. The purpose of this
study is to analyze the natural course after removal of
PC catheter in high-risk patients with AC, the time
interval of relapse, and factors influencing relapse of
AC.
Methods: From 2000 to 2011, 186 patients underwent
PC for AC and removed the drainage in Seoul
National University Hospital and Borame Hospital,
Korea. Excluding cases with intended interval cholecys-
tectomy, malignant biliary obstruction, and follow-up
period shorter than 12 months, total 60 cases were ret-
rospectively reviewed.
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Results: Mean age was 68.6  13.8, and mean Kar-
nofsky performance score was 24.8  9.7. After PC
insertion, symptom resolution and improvement on
imaging were achieved in 95% and 96.7%, respec-
tively. Laboratory values were also improved
(p < 0.01). There was no mortality during admission
and 2 cases (3.3%) of complication during removal of
PC catheter. Median follow-up was 38.1 months.
Among 60 patients, relapse was observed in 7 patients
(11.7%). The median time interval to relapse was
14.1  14.8 months. There were no differences on clin-
ical, laboratory or imaging finding such as gallbladder
wall edema, necrosis, and perforation between relapse
and non-relapse patients. Therefore, prediction of
relapse was not possible.
Conclusions: Among high-risk patients with AC, 88.3%
were managed with PC without relapse within 38.1
median follow-up period in spite of radiologically
severe acute cholecystitis in some patients. Therefore,
considering high operative mortality and morbidity in
the patients with severe comorbidity, temporary PC
can be a first-line treatment for AC without interval
cholecystectomy. Surgical intervention can be post-
poned until relapse, however, long-term follow-up is
needed.
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THE PREVALENCE OF CYSTIC
NEOPLASM OF THE PANCREAS IN
NORMAL HEALTHY POPULATION
Ye Rim Chang1, Jin Young Jang1, Mee Joo Kang1,
Joo Kyung Park2, Jeong-Hee Yoon3, Jeong Min Lee3,
Ji Won Park4 and Sun-Whe Kim1
1Departments of Surgery, Seoul National University
Hospital, Seoul, South Korea; 2Center for health
promotion and optimal aging, Seoul National University
Hospital, Seoul, South Korea; 3Department of
Radiology, Seoul National University Hospital, Seoul,
South Korea; 4Medical Research Collaborating Center,
Seoul National University Hospital, Seoul, South Korea
Background and aims: The prevalence of cystic neo-
plasm of the pancreas is not known, but asymptomatic
pancreatic are diagnosed with increasing frequency.
Few reports in regard to prevalence among asymptom-
atic normal healthy population are published except
data from small number of subjects. Therefore, the pur-
pose of this study is to investigate the crude prevalence
of pancreatic cyst in normal healthy population and to
estimate age, sex-matched nationwide prevalence of
cystic tumor of the pancreas in Korea.
Methods: From 2003 to 2008, 61,280 individuals were
screened using abdominal imaging modalities including
ultrasonography (USG), computed tomography (CT),
magnetic resonance (MR) imaging, and high-resolution
ultrasound (HRUS) in the Center for health promotion
and optimal aging, Seoul National University Hospital,
Korea. Demographic data including age and sex were
collected and imaging findings were reviewed for differ-
ential diagnosis by 1 specialized radiologist. Nationwide
population data were collected from National Statisti-
cal Office, Korea for calculation of expected preva-
lence.
Results: Among 61,280 cases, cystic tumor was found
in 118 cases (0.19%). The number of intraductal papil-
lary mucinous neoplasm (IPMN), mucinous cystic neo-
plasm (MCN), serous cystic tumor (SCT) were 94, 11,
and 9, respectively. Pseudocysts were found in 6 cases.
Crude prevalence from the Center for health promotion
and optimal aging was 192 per 100,000 and expected
nationwide prevalence was 231 per 100,000. Prevalence
of cystic tumor of the pancreas increased with age
(p = 0.045, R2 = 0.124).
Conclusions: Crude and expected prevalence rate of
cystic neoplasm of the pancreas were 0.19% and
0.23%, respectively. Prevalence increased with age espe-
cially over 40 year-old, therefore, surveillance for pan-
creatic lesions which might be precursor for pancreas
cancer is strongly recommended.
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LONG-TERM OUTCOMES OF LIVER
TRANSPLANTATION FOR COMBINED
HEPATOCELLULAR CARCINOMA AND
CHOLANGIOCARCINOMA
Yo-Han Park, Shin Hwang, Chul-Soo Ahn, Ki-Hun
Kim, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song,
Dong-Hwan Jung and Gil-Chun Park
Division of Hepatobiliary Surgery and Liver
Transplantation, Department of Surgery, Asan Medical
Center, University of Ulsan College of Medicine, Seoul,
South Korea
Purpose: Combined hepatocelluar carcinoma and cho-
langiocellular carcinoma (HCC-CCC) is a rare intrahe-
patic malignancy. Differential diagnoses among HCC,
CCC and combined HCC-CCC are occasionally diffi-
cult, thus malignancies other than ordinary HCC are
unexpectedly found at the explant liver specimens. This
study was conducted to analyze the long-term out-
comes of liver transplantation (LT) in patients having
combined HCC-CCC.
Methods: From January 1999 to December 2009, 2137
cases of adult LT operations were performed in our
institution. Fifteen cases of pathologically confirmed
combined HCC-CCC were identified. All of them
underwent LT operation under the pretransplant diag-
nosis of HCC. Their medial record was reviewed retro-
spectively.
Results: Mean patient age was 58.9  7.2 years. Med-
ian preoperative alpha-fetoprotein level was 32.6 ng/
mL. LT types were living-donor LT in 14 and
deceased-donor LT in 1. Milan criteria were met in 12.
Tumor number was single in 8 and multiple in 7. Maxi-
mal tumor diameter was 2.9  1.7 cm. Seven patients
showed tumor recurrence, in which 6 occurred within
the first 12 months. All recurrent cases died at a med-
ian period of 4 months after diagnosis of tumor recur-
rence. The overall patient survival rates were 66.7% at
1 year and 60.0% at 3 and 5 years. Disease-free patient
survival rates were 60.0% at 1 year and 53.3% at 3
and 5 years.
Conclusions: Combined HCC-CC showed a high early
recurrence rate especially within the first year, thus
strict tumor surveillance is necessary to detect and
manage recurrence in time.
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SYNCHRONOUS VERSUS
METACHRONOUS RESECTION IN
PATIENTS WITH COLORECTAL
CANCER WITH SYNCHRONOUS LIVER
METASTASIS
Tay Chee Wei, Iyer Shridhar, Kow Wei Chieh Alfred,
Chang Kin Yong Stephen and Madhavan
Krishnakumar
National University Health System, Singapore,
Singapore
Background: About 20% of patients with colorectal
cancer (CRC) have liver metastasis (LM) at diagnosis,
liver and colorectal resection remains the only curative
option now. Various strategies such as neoadjuvant
chemotherapy, portal vein embolization have been used
to increase the resectability of LM with good results.
In addition widespread adoption of minimally invasive
techniques for colorectal cancer and liver surgery intro-
duces more variability. However, there is no evidence
up to date to support whether synchronous or meta-
chronous resection of LM during the time of colorectal
surgery have better oncologic outcomes. Our study
aims to compare the outcomes between patients under-
going synchronous and metachronous resection of colo-
rectal liver metastasis.
Methods: We retrospectively reviewed 22 patients who
had CRC with synchronous LM at diagnosis and
underwent either synchronous (Group 1) or metachro-
nous (Group 2) resection of their LM from 2006 to
2012 at our institute. Patients’ demographic characteris-
tics, type of colorectal surgery, extent of liver resection
as well as intra- and post- operative data were col-
lected. Oncologic data such as tumor characteristics,
further treatment, recurrence rate and survival data
were analyzed.
Results: 22 patients were studied, 11 in each group.
There is no statistical difference in patients’ baseline
demographic characteristics. There was no significant
difference in the CRC or liver tumor characteristics. 12
patients had major liver resections, 5 in Group 1 and 7
in Group 2 (p = 0.67). There was no statistical differ-
ence in total operating time, blood loss, blood transfu-
sion, complication rate. There were no perioperative
deaths in this study. 14 patients had open surgery for
both colon and liver, 8 patients had minimally invasive
surgery for either CRC of liver or both. The mean
operative time was 354 minutes in Group 1 vs. 450 min
in Group 2 (p = 0.024). The median hospital stay was
10 days and 13 days (p < 0.05). The 3 year recurrence
free survival was 35% in Group 1 and 3 year and
5 year recurrence free survival were 52% and 36% in
Group 2 (p = 0.46). The 3 year overall survival was
80% in Group 1, 3 year and 5 year survival were 76%
and 50% in Group 2 (p = 0.8).
Conclusions: Synchronous liver resection including
major liver resections for CLC liver metastasis can be
safely performed with no increased morbidity and mor-
tality. Synchronous resection offers advantage in terms
of lower hospital stay and operative time without com-
promising oncologic outcomes.
978
LONG-TERM SURVIVAL OUTCOMES
FOR LIVING-DONOR LIVER
TRANSPLANT RECIPIENTS WITH
PATHOLOGICALLY NON-VIABLE
HEPATOCELLULAR CARCINOMA
Hyung-Woo Park, Shin Hwang, Chul-Soo Ahn, Ki-
Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Gi-Won
Song, Dong-Hwan Jung and Gil-Chun Park
Division of Hepatobiliary Surgery and Liver
Transplantation, Department of Surgery, Asan Medical
Center, University of Ulsan College of Medicine, Seoul,
South Korea
Purpose: Complete necrosis of hepatocellular carci-
noma (HCC) lesions has occasionally been found by
explant pathology after pretransplantneoadjuvant treat-
ment. This study sought to investigate the long-term
prognostic effect of loss of tumor viability after HCC
treatment in living-donor liver transplantation (LDLT)
recipients.
Methods: Thirty-seven patients who demonstrated non-
viable HCC on explant pathology were followed up for
more than 5 years. Patient medical records were
reviewed retrospectively.
Results: The most common primary disease was hepa-
titis-B-virus-associated liver cirrhosis (n = 34). Single
explant tumors were found in 29 patients, and the
mean maximal tumor size was 2.1  0.9 cm (range: 0.8
–4.0). No patients showed microvascular invasion. The
median level of alpha-fetoprotein was 12 ng/mL (range:
1–1,160). Only one patient showed recurrence at
20 months, but remains alive more than 6 years after
adrenalectomy and repeated pulmonary metastasecto-
my. The 5-year HCC recurrence rate was thus 2.1%.
There were two late mortality cases, each due to graft
failure and recurrence of gastric cancer. The overall
patient survival rate was 97.3% at 5 years and 92.7%
at 10 years.
Conclusions: The results of this study reveal that the
loss of tumor viability induced by pretransplantneoadju-
vant treatment definitely decreased the risk of posttrans-
plant HCC recurrence. Therefore, patients with non-
viable HCC can be regarded as members of a super-
selection group with minimal risk of HCC recurrence,
and who are exempt from routine HCC screening.
981
DIFFERENT EXPRESSION PATTERNS
OF HEPATOCELLULAR CARCINOMA
TUMOR MARKERS BETWEEN VIRAL
HEPATITIS B AND C PATIENTS
Shin Hwang, Chul Soo Ahn, Ki-Hun Kim, Deok-Bog
Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan
Jung, Gil-Chun Park and Jung-Man Namgoong
Division of Hepatobiliary Surgery and Liver
Transplantation, Department of Surgery, Asan Medical
Center, University of Ulsan College of Medicine, Seoul,
South Korea
Background: This study was conducted to compare
the expression patterns of serum alpha-fetoprotein
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(AFP) and des-gamma-carboxyprothrombin (DCP) in
hepatocellular carcinoma (HCC) patients undergoing
LT and resection by using high-volume single institu-
tion data.
Methods: In part 1 study, 663 liver transplant recipi-
ents were selected. They were divided into HBV group
(n = 628) and HCV group (n = 35). Their medial
record was reviewed retrospectively. In part 2 study, a
cohort of patients who underwent HCC resection con-
sisted of 618 HBV and 206 HCV patients.
Results: In the part 1 study, mean and median pre-
transplant AFP levels were 54.5  123.4 ng/mL and
9.8 ng/mL in HBV group and 65.1  163.7 ng/mL and
21.9 ng/mL in HCV group respectively. Pretransplant
AFP > 20 ng/mL was observed in 42.5% of HBV and
60% of HCV patients (p = 0.042). Mean and median
pretransplant DCP levels were 57.8  114.6 mAU/mL
and mAU/mL in HBV group and 79.8  115.1 mAU/
mL and 28.0 mAU/mL in HCV group, respectively.
Pretransplant DCP > 40 mAU/mL was observed in
30.6% of HBV and 42.9% of HCV patients
(p = 0.127). In the part 2 study, pretransplant
AFP > 20 ng/mL was observed in 51.9% of HBV and
57.8% of HCV patients (0.289). DCP > 40 mAU/mL
was identified 29.1% of HBV and 51.5% of HCV
patients (p = 0.000).
Conclusions: This study implicates that serum AFP and
DCP may be differently expressed according to the
types of background liver diseases. Further large-vol-
ume multicenter study is necessary to validate this pos-
sibility of etiology-dependent expression of tumor
markers.
986
RECURRENCE PATTERN OF
HEPATOCELLULAR CARCINOMA
AFTER PARTIAL HEPATECTOMY:
ANALYSIS OF
CLINICOPATHOLOGICAL
CHARACTERS
Ming-Chin Yu, Chao-Wei Li, Tsung-Han Wu,
Wei-Chen Lee and Miin-Fu Chen
Department of Surgery, Chang Gung Memorial
Hospital, Linkou Branch, Chang Gung University,
Taoyuan, Taiwan
Background and aims: Surgical resection remains the
first line of treatment for earlier stages of hepatocellular
carcinoma (HCC). However, the recurrent rates in
hepatocellular carcinoma after radical resection are still
high. The risk factors for the intrahepatic pattern
recurrence pattern of HCC after resection and the
long-term survival rate were not studied in detail.
Therefore, the clinical correlation with recurrence pat-
tern was analyzed to select the patients who need the
salvage therapy to improve the outcome.
Methods: In the period from 2001 to 2005, 614 patients
who underwent hepatectomy and mean follow-up time
was 57.2 months. According to the site of the recur-
rence and the number of recurrent tumors, we defined
groups A as recurrence at the primary tumor margin or
adjacent lobules, nodule < 3 and group B as multiple
intrahepatic recurrence, nodule  3. These data were
retrospectively reviewed for analysis of clinicopatholog-
ical characters.
Results: Intrahepatic recurrence was noted in 367
patients (59.8%). Disease free survival rate and overall
survival rate in Group A was better than that in Group
B. Besides, platelet count, liver function, hepatitis C
and cirrhosis were factors to predict recurrence in
Group A, compared with no recurrence group. In
Group B, factors as symptoms, liver function, higher a-
fetoprotein, large tumor size, vascular invasion, throm-
bus, daughter nodule, margin, cirrhosis, necrosis and
stage were poor predictors. Cirrhosis and daughter
nodule were independent prognostic factors in general-
ized linear model for multivariate analysis. For salvage
treatment, RFA and repeated resection showed better
outcome for group A recurrence (p < 0.05).
Conclusions: Multiple intrahepatic recurrence has poor
outcome. Cirrhosis and daughter nodule were indepen-
dent factors to predict recurrence. We should identify
patients who required intervention after initial hepatec-
tomy and provide aggressive management of postopera-
tive recurrence for them to improve outcome.
990
VALIDATION OF THE UPDATED
KOREAN PRACTICAL GUIDELINES
FOR SURGICAL TREATMENT OF THE
GALLBLADDER CANCER
Gil-Chun Park, Shin Hwang, Ki-Hun Kim, Young-Joo
Lee, Chul-Soo Ahn, Deok-Bog Moon, Kwang-Min
Park, Tae-Yong Ha and Gi-Won Song
Department of Surgery, Asan Medical Center,
University of Ulsan College of Medicine, Seoul, South
Korea
Background: Surgical treatment of the gallbladder can-
cers has not been reliably standardized yet due to
diverse oncologic features, thus the Korean practical
guidelines are updated in year 2012/2013. Since they
were prepared with extensive literature review, it is
worthy of validating them with clinical data of large-
volume single-center experience.
Methods: The draft concepts of Korean practical guide-
lines for surgical treatment of the gallbladder cancer
were validated by analyzing the profiles of 500 gallblad-
der cancer patients undergone surgical resection in Asan
Medical Center. Their medical records were reviewed
retrospectively according to the guideline suggestions.
Results: Median patient age was 63 years and the
upper quartile was 70 years. R0 resection was achieved
in 73%. During postoperative follow-up, 21% of
patients were lost at a median follow-up period of
21 months with a lower upper quartile of 4 months.
For pT1aNx lesions, the 5-year survival rate (5-YSR)
was 91%, which was not different in both open and
laparoscopic cholecystectomy groups. For pT1bNx
lesions, 5-YSR was around 70%, which was not differ-
ent in both open and laparoscopic cholecystectomy
groups, but that of extended cholecystectomy group
was 78%, which implicating the potential benefit of re-
do resection. Lymph node metastasis was identified in
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11% of pT1b lesions. For pT2N0 lesions, 5-YSR was
62% after R0 resection, showing no survival difference
depending on concurrent resection of the extrahepatic
bile duct. For stage 3 lesions, 5-YSR was 32% after R0
resection and 11% after R1 resection. For stage 4
lesions, 5-YSR was 26% after R0 resection and 0%
after R1 resection.
Conclusions: The results of this validation study impli-
cate that the updated Korean practical guidelines for
surgical treatment of the gallbladder cancer reflect the
resection extent-related benefit logically. However, con-
sidering that a considerable proportion of very old-aged
patients showed a lower compliance on long-term fol-
low-up as well as a higher incidence of cancer-unrelated
death in such age group, the overall survival outcome
should be adjusted especially in patients with T1 and T2
lesions. The main pathways of lymph node metastasis
and prognostic significance of lymphovascular and neu-
ral invasion should be taken into account prudently dur-
ing individualized planning for surgical treatment.
992
ROLE OF HAND-ASSISTED
LAPAROSCOPIC SURGERY (HALS) FOR
LIVING DONOR RIGHT LOBE
HARVEST
Tae Yong Ha, Shin Hwang, Chul Soo Ahn, Ki Hun
Kim, Deok Bog Moon, Gi Won Song, Dong Hwan
Jung, Gil Chun Park and Jung Man Namgoong
Division of Hepatobiliary Surgery and Liver
Transplantation, Department of Surgery, Asan Medical
Center, University of Ulsan College of Medicine, Seoul,
South Korea
Purpose: Cosmetic aspect of abdominal skin incisions
is the matter of concern for both liver living donors
and surgeons. We performed a prospective comparative
study on mini-laparotomy for right liver graft harvest
with and without hand-assisted laparoscopic surgery
(HALS).
Methods: Young donors were indicated for mini-lapa-
rotomy with or without HALS. In non-HALS group
(n = 20), a 10 to 12 cm-long right subcostal incision
was applied for right liver graft harvest. In HALS
group (n = 20), an 8 cm-sized right subcostal incision
was applied for hand assistance and 3 laparoscopic
holes are made for manipulation. The retrohepatic infe-
rior vena cava (IVC) was initially dissected laparoscopi-
cally under air inflation. The skin incision was extended
to 10 to 12 cm, and then hilar dissection and hepatic
transection were performed through the skin incision.
Results: In all 40 donors, safe uneventful harvest of the
right liver grafts was successfully achieved through
mini-laparotomy incisions. HALS group required addi-
tional 30 min for laparoscopic preparation and dissec-
tion than non-HALS group. HALS facilitated
retrohepatic IVC dissection, and the remaining part of
surgery was the same as that for minimal-incision sur-
gery. The minimal skin incision for delivery of liver
from the abdomen was average 10 cm for graft of
500 g and 12 cm for graft of 700 g or more. In com-
parison of the patient profiles, there were no differences
in donor age, body mass index, graft weight, intraoper-
ative blood loss, postoperative rise of peak liver
enzymes, total hospital stay and incidence of postoper-
ative complications
Conclusions: We concluded that HALS facilitates per-
formance of donor hepatectomy using a minimal inci-
sion, probably permitting wider selection of living
donors for minimal-incision approach.
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SURGICAL RESECTION VS. BIOPSY;
THE APPROACH TO
HEPATOCELLULAR ADENOMAS
WHILST UNCLEAR OF MALIGNANT
TRANSFORMATION RISK
Bavahuna Manoharan1, Nicholas O. Rourke1, Ian
Martin2, Richard Bryant1 and Andrew Clouston3
1Royal Brisbane and Women’s Hospital, Herston, Qld,
Australia; 2Wesley Hospital, Auchenflower, Qld,
Australia; 3Envoi Specialist Pathologists, Herston, Qld,
Australia
Background and Aims: Hepatocellular adenomas
(HCAs) are a diagnostic challenge due to ambiguous
histological and radiological profiles and potential for
malignant transformation. Recent genotyping work
using Quantitative Reverse Transcriptase Polymerase
Chain Reaction has lead to a new HCA classification
(Bordeaux Classification) of four main subtypes with
different phenotypes and malignant risk. The indication
and implication of trucut biopsies and resection for
these lesions is uncertain. This paper aims to present
the surgical experiences in stratifying risk of HCA
malignant transformation into Hepatocellular Carci-
noma (HCC).
Methods: Patients with HCA diagnosis and stored
tumour tissue were identified via a HPB database at
the Royal Brisbane and Wesley Hospital(s) between
2000 and 2012. New immunohistochemical techniques
for identifying LFABP inactivation, nuclear beta-cate-
nin activation, Glutamine Synthatase, Serum Amyloid
A and C-Reactive Protein were applied to biopsied and
surgically resected specimens prior to being interpreted
by specialist liver pathologists. Data was obtained from
patient charts, operative notes, radiological reports and
pathology reports.
Results: 46 patients (89% Female; Mean Age 45 years;
70% female < 50 years), were identified. 53 HCA speci-
mens, from either surgical resection (25 laparoscopic, 1
open), wedge or core biopsies (27 total, 3 laparoscopic)
were re-classified according to the Bordeaux classifica-
tion. Multiple subtypes verified the presence of a heter-
ogeneous adenoma group with multiple subtypes;
Inflammatory (44%), HNF-1 Alpha (32%) and beta-
catenin (24%; 50% biopsy, 50% resection) and unclas-
sifiable (15%).
Conclusions: Literature suggests beta-catenin mutants
can predispose to malignant change (10%–15% of all
HCAs transform) and our data verifies the presence of
beta-catenin mutations in HCAs, showing a heteroge-
neous group of tumours, however further validation
required to assess HCA transformation to HCC and if
a new diagnostic approach is warranted.
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EXTENSIVE DISTAL
PANCREATECTOMY (EXDP) FOR
PANCREATIC BODY CANCER
ADJACENT TO PV/SMV
Masafumi Nakamura1, Takao Ohtsuka2, Hiroshi
Nakashima1, Kousuke Tsutsumi1, Shunichi Takahata2
and Masao Tanaka2
1Department of Digestive Surgery, Kawasaki Medical
School, Kurashiki, Japan; 2Department of Surgery and
Oncology, Graduate School of Medical Sciences, Kyushu
University, Kurashiki, Japan
Background: Distal pancreatectomy (DP) is a reason-
able surgical treatment for pancreatic body cancer,
because cancer of the pancreatic body tends to invade
the neural plexus and lymphatic tissue around the sple-
nic artery. However, since the right border of transection
in DP is limited by the gastroduodenal artery (GDA) or
the superior pancreaticoduodenal arteries (SPDAs),
total pancreatectomy and pancreaticoduodenectomy are
often performed for pancreatic cancer between PV and
splenic artery. We report our experience of a novel surgi-
cal method, extensive distal pancreatectomy (ExDP). In
ExDP, we transected the pancreas at the right side of the
GDA after cutting the GDA or SPDAs.
Methods: We retrospectively analyzed our experience
of 13 patients who underwent ExDP as a curative sur-
gical operation for pancreatic tumor.
Results: Perioperative outcome of ExDP was as fol-
lows, median blood loss 368 g, median operation time
280 min, median hospital stay 20 days and pancreatic
fistula of grade B defined by ISGPF in two patients. In
terms of curability, 12 out of 13 patients underwent R0
resection. Negative intraoperative frozen section diag-
nosis changed to positive by permanent section histol-
ogy in a patient. Diabetes was not deteriorated in 12 of
the 13 patients.
Conclusions: ExDP is a function-preserving operation
for the treatment of pancreatic body cancer adjacent to
PV/SMV with favorable curability.
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THE RESEARCH OF HEPATOCYTES’
CULTURE WITH SILK FIBROIN/
GELATIN SCAFFOLD
Wan-Quan Wu, Rui Gao and Yi Lv
The First Affiliated Hospital, Medical college of Xi’an
Jiaoton University, Xi’an, China
Background and aims: Liver transplantation is the only
definitive treatment for end-stage liver disease. How-
ever, critical shortage of organs, the need for taking
immunosuppressive drugs and high costs of follow-up
treatment restrict the liver transplantation seriously.
Hence there is an urgent need for the alternative treat-
ment. Tissue engineering approaches can improve cell
engraftment in animal models by enhancing
celltocell contact and providing nonimmunogenic
matrices before transplantation. However, it has been
limited by oxygen and nutrient. This paper aims to
enable the substitution of hepatocytes’ liver function
into a scaffold with threedimensional structure.
Methods: We design the scaffold according to the data
of the hepatic portal vein cast, and choose silk fibrion
and gelatin which has good biocompatibility as the
scaffold materials. After finishing the scaffold’s fabrica-
tion, we do some study to evaluate the histocompatibil-
ity of the scaffold. Then the rat hepatocytes are
isolated and cultured with the bionic silk fibroin/gelatin
scaffold. In order to evaluate the cell compatibility and
culture efficiency of hepatocytes with the biomimetic
scaffold, we study on the activity, morphology and
function of hepatocytes.
Results: In this research we successfully fabricate three-
dimensional porous silk fibroin/gelatin scaffold with bi-
omimetic channel structure .The silk fibroin/gelatin
scaffold has better histocompatibility than chitosan/gel-
atin scaffold when implanted into rat subcutaneous.
The results of being implanted into rat abdominal
omentum demonstrates that the silk fibroin/gelatin
scaffold has slight inflammatory response. The rat he-
patocytes are cultured in biomimetic silk fibroin/gelatin
scaffold and show a good culture efficiency: Scanning
electron microscope demonstrates that three-dimen-
sional porous scaffold benefits colonization of the he-
patocytes, the hepatocytes maintain good morphology
during 14 days; ALB secretion and BUN synthesis
increase in the early stage and then decrease in the later
stage in the biomimetic scaffold, and the biomimetic
scaffold has better culture efficiency than non-channels
scaffold and culture plate (p < 0.05).
Conclusions: Hepatocytes are cultured in biomimetic
silk fibroin/gelatin scaffold. It demonstrates that three-
dimensional porous scaffold benefits colonization of the
hepatocytes, has low cytotoxicity and good culture effi-
ciency. The presence of biomimetic channels are more
conducive to maintain the proliferation and function of
hepatocytes than non-channels.
1025
PERI-TRANSPLANT AFP LEVELS:
USEFUL MARKERS IN PREDICTING
RECURRENCE AFTER LIVER
TRANSPLANTATION FOR
HEPATOCELLULAR CARCINOMA
Tae Suk You, Kyung Suk Suh, Kwang Woong Lee,
Nam Joon Yi, Geun Hong, Young Rok Choi,
Hyeyoung Kim, Min Su Park and Sukwon Suh
Department of Surgery, Seoul National University
College of Medicine, Seoul, South Korea
Aims: To investigate the clinical significance of the
peri-transplant Alphafetoprotein (AFP) levels for pre-
dicting recurrence in hepatocellular carcinoma (HCC)
patients who underwent liver transplantation.
Methods: We retrospectively reviewed the data from
231 HCC patients who underwent liver transplantation
between February 2000 and December 2010. Peri-trans-
plant AFP levels (pre-transplant level, 1 month post-
transplant level and level at recurrence) were analyzed
for patient distribution and recurrence free survival.
Results: Before liver transplantation, there were 125
patients who had high AFP levels and 106 who had
normal levels. Of 125 patients with high pre-transplant
AFP levels, 101 had normal AFP levels after transplan-
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tation and 28 had persistently high levels. Of 101
patients with normalized post-transplant AFP levels, 23
showed recurrence, of whom 15 had high AFP levels
and 8 had normal levels. Of 106 patients with normal
pre-transplant AFP levels, 8 showed recurrence, of
whom 3 had high AFP levels and 5 had normal levels.
Pre-transplant AFP levels <20 ng/mL (p < 0.001), and
normalized post-transplant AFP levels (p < 0.001)
showed significantly better recurrence free survial
(RFS) rates. Also, in 125 patients with high pre-trans-
plant AFP, post-transplant AFP levels (HR = 14.4,
p < 0.001) as well as sex (HR = 3.2, p < 0.032), tumor
size (HR = 1.1, p = 0.001), microvascular invasion
(HR = 2.6, p = 0.005) were independent risk factors for
RFS in multivariated analysis. We compared clinical
factors according to post-transplant AFP (normalized
post-transplant AFP vs. persistently elevated AFP) in
elevated pre-transplant AFP patients. Pre-transplant
AFP, tumor size & number, microvascular invasion
had significant difference between two groups. More-
over, even if patients with very high pre-transplant
AFP (>200) had normalized post-transplant AFP, these
patients had good RFS as patients with normalized
post-transplant AFP level. However, if patients with
not so high pre-transplant level (20 < pre-transplant
AFP  200) had persistently high post-transplant
AFP, they had poor outcomes as patients with persis-
tently elevated post-transplant AFP level.
Conclusions: Not only pre-transplant AFP but also
especially post-transplant AFP may provide useful clin-
ical information concerning recurrence in HCC patients
who underwent liver transplantation.
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INITIAL LEARNING CURVE FOR
TOTALLY LAPAROSCOPIC
PANCREATICODUODENECTOMY
I. E. Khatkov1, V. V. Tsvirkun2, R. E. Izrailov2 and P.
S. Tyutyunnik1
1Chair of faculty surgery № 2, Moscow State Medical
Dentistry University, Moscow, Russia; 2FMBA №119
Clinical Hospital, Moscow, Russia
Background: Laparoscopic pancreaticoduodenectomy
(LPDE) has become increasingly popular in the world
and now is considered a technically feasible and safe pro-
cedure for patients with tumors of the head of the pan-
creas and the periampullare area. Presently, laparoscopic
pancreaticoduodenectomy is an alternative to traditional
surgery. At the same time according to the literature data
a lot of surgeons stop performing totally laparoscopic
pancreaticoduodenectomy (TLPDE) after 5–15 proce-
dures because of the difficulties of learning curve. Nowa-
days, there are only about 7 medical centers which have
the experience of performing more than 30 LPDE.
Aims: To evaluate the learning curve of totally laparo-
scopic pancreaticoduodenectomy.
Methods: The data of 43 patients who were planned
for LPDE during 5 year were analyzed. The same sur-
gical team performed all the procedures. 35 patients
were underwent Totally Laparoscopic Pancreaticoduo-
denectomy (TLPDE). For 8 patients procedure was
palliative or converted. Patients were divided in three
groups. Group A, B and C–12;12;11 patients respec-
tively. Operative time, intraoperative blood loss and the
level of postoperative morbidity were examined.
Results: Among the 43 patients, 35 patients underwent
TLPDE. The conversion rate was in the group A–33% (4
patients), group B–33% (4 patients) and group C–no con-
versions. Mean operative time of TLPDE for the group A
was–542 min; group B–542 min and group C less than
360 min, minimally–280). The median operating time in
early cases was longer than in the later cases and may rep-
resent the learning curve of TLPDE.Mean blood loss was
for group A–683 mL, group B–612 mL and group C
250 mL. Total level of postoperative morbidity was: Post-
operative complication rate was in group A–66, 5%,
group B–65, 5% and group C–66, 5%. Total postopera-
tive mortality was: group A–8, 3%(one of the patients
died from insufficiency of the pancreatojejenostomy,
another–because of acute heart failure without any surgi-
cal complications); group B–0% and group C–0%.
Conclusions: The results become significantly better
after 25 procedures. The most difficult and potentially
dangerous for intra and postoperative complications
were: dissection along superior mesenteric and portal
vein and suturing of pancreaticojejuno anastomosis.
Performing TLPDE by 1 team including nurses is the
very important factor quick learning curve and safe.
1043
TECHNIQUE OF LAPAROSCOPIC
PANCREATICOJEJUNAL
ANASTOMOSIS DURING TOTALLY
LAPAROSCOPIC
PANCREATICODUODENECTOMY FOR
PANCREATIC CANCER TO: INITIAL
LEARNING CURVE FOR TOTALLY
LAPAROSCOPIC
PANCREATICODUODENECTOMY FOR
PANCREATIC CANCER
I. E. Khatkov1, V. V. Tsvirkun2, R. E. Izrailov1 and P.
S. Tyutyunnik1
1Chair of faculty surgery № 2, Moscow State Medical
Dentistry University, Moscow, Russia; 2FMBA №119
Clinical Hospital, Moscow, Russia
Pancreaticojejunal anastomosis is the most difficult and
important stage during totally laparoscopic pancreati-
coduodenectomy (TLPDE). The question of the best
technique for pancreatic anastomosis after totally lapa-
roscopic pancreaticoduodenalectomy is still open. For
today technique of pancreaticojejunal anastomosis is
not standardized in different hospitals.
Objectives: To create the most effective technique for
pancreaticojejunal anastomosis during TLPDE for
patients with cancer of the head of the pancreas and
periampullary area.
Methods: From January 2007 to August 2012, 38 pan-
creaticoduodenectomy were performed by totally lapa-
roscopic approach. Pancreaticojejunostomy is done 3
different ways: A) A two layer end-to-side anastomosis
was done by using 2 semicircle running sutures (front
layer) and separate precise sutures to the main pancre-
atic duct (inner layer). B) A single layer end-to-end
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invagination anastomosis by using 2 semicircle running
sutures. C) A single layer end-to-side invagination
anastomosis with interrupted sutures. Usual pancreat-
icojejunostomy is performed by Vicryl 4.0. We did not
use any tubes when performing the pancreaticojejunos-
tomy.
Results: From January 2007 to August 2012, 38
patients undergone laparoscopic pancreaticoduodenec-
tomy at the single center by totally laparoscopic
approach. Insufficiency of duct-to-mucosa pancreat-
icojejunal anastomosis was observed in 10% of
patients. Insufficiency of invagination pancreaticojejun-
al anastomosis was observed in 5% of patients. The
mean time of performing of duct-to-mucosa pancreat-
icojejunal anastomosis was 55.8 min (34–75 min). The
mean time of performing of invagination pancreatojej-
unal anastomosis was 45.5 min (31–68 min).
Conclusions: TLPDE is a safe procedure. The invagina-
tion pancreaticojejunal anastomosis provides more
safety and less time for performing.
1060
COMPARISON OF SHORT TERM
OUTCOMES BETWEEN
LAPAROSCOPIC DISTAL
PANCREATECTOMY AND OPEN
DISTAL PANCREATECTOMY FOR
PANCREATIC CANCER
Jeong Su Nam, Song Cheol Kim, Ki Byung Song,
Kwang Min Park, Jae Hoon Lee, Ji Wong Hwang and
Jong Hee Yoon
Department of Hepatopancreatobiliary Surgery, Asan
Medical Center, Seoul, South Korea
Background and aims: Laparoscopic distal pancreatec-
tomy (LDP) has been replacing open surgery for
benign pancreatic disease. However, there has been
debates regarding to oncologic adequacy for pancreatic
cancer. The purpose of this study is to present short
term oncologic outcomes of patients who underwent
LDP for pancreatic cancer and compare with those
who received open distal pancreatectomy (ODP).
Methods: Between December 2006 and September
2012, 102 consecutive patients with Pancreatic body or
tail cancer underwent either open or laparoscopic distal
pancreatectomy at Asan Medical Center by a single
surgeon. Data was collected from retrospective data-
base and Survival analysis was calculated using the
Kaplan-Meier method.
Results: 46 Patients received ODP and 56 patients
underwent LDP. In ODP group, 25 patients had
RAMPS (Radical antegrade modular pancreatosplenec-
tomy) and the rest had conventional distal pancreatec-
tomy with splenectomy (DPS). In LDP group, 41
Patients had RAMPS. Median follow-up period was
13.8 month for ODP group and 12.2 month for LDP
group. There were no statistical significant differences
in the number of lymph node harvested (13.7; ODP
group vs. 13.8; LDP group, p = 0.97), tumor size
(3.99 cm; ODP group vs. 3.34 cm; LDP group,
p = 0.07), R0 resection rate (82.6%; ODP group vs.
75%; LDP group, p = 0.353) between ODP group and
LDP group. Either patients who were categorized as
AJCC Stage III or IV by pathologic data or patients
who received portal vein or hepatic artery resection
were excluded from survival analysis. There was no sta-
tistical difference in overall survival rate between ODP
group (1 year; 74.1%, 3 years; 37.2%) and LDP group
(1 year; 87.0%, 3 years; 57.2%) (p = 0.139). Also, open
RAMPS group did not show survival benefit over lapa-
roscopic RAMPS group. (1-year, and 2-year overall
survival rate was 81.9%, 68.3% in open RAMPS
group, 80.5%, 73.8% in laparoscopic RAMPS group,
respectively) (p = 0.735).
Conclusions: There seems to be increasing evidence that
LDP is equivalent to ODP for Pancreatic cancer in
terms of oncologic outcome. However, Long term on-
cologic result will be required and further randomized
prospective studies should be performed to support the
validity of LDP for Pancreatic cancer.
1080
BILIARY COMPLICATION IN ABO
BLOOD GROUP INCOMPATIBLE LDLT
Gi Won Song, Sung Gyu Lee, Young In Yoon, Bo
Hyun Jung, Sung-Ha Kang, Chun Soo Patk, Yo Han
Park, Hyung Woo Park and Gil Chun Park
Asan Medical Center College of Medicine, Seoul, South
Korea
Background: Despite of recent improved survival out-
come after ABO-incompatible (ABOi) adult living
donor liver transplantation (ALDLT), the concern
about high incidence of biliary stricture (BS) still exist.
However, the report of actual incidence of BS has been
scarce.
Methods: From November 2008 to August 2011, 77
cases of ABOi ALDLTs have been performed. We
compared patient and graft survival and biliary stric-
ture-free survival rates (BSFSR) between ABOi ALD-
LTs and 734 ABO-compatible (ABOc) ALDLTs which
have been performed during same period. And we ana-
lyzed characteristics of BS in ABOi ALDLT.
Results: There was 1 in-hospital mortality (1.3%)
among 77 cases of ABOi LDLT. Only 1 patient under-
went re-transplantation due to small-for-size graft syn-
drome. Overall 1, 2 and 3-year patient survival rate
was 94.8% which was comparable to that of ABOc
ALDLT (93.7%, 90.1%, 90.1%, p = 0.20). BS occurred
in 11 (13.8%) patients. There was no significant differ-
ence in 1, 2 and 3-year BSFSR between ABOi and
ABOc ALDLT patients (87.5 vs. 88.1% and 83.4 vs.
87.5%, 83.4 vs. 86.4%, p = 0.55). Among 10 patients
with BS, 4 patients showed diffuse multiple intrahepatic
strictures which were related to the death in 2 patients.
Conclusions: The survival outcome of ABOi ALDLT is
comparable to that of ABOc ALDLT. The incidence of
BS of ABOi ALDLT was not superior to that of ABOc
ALDLT. However, ABO incompatibility is related with
the development of diffuse multiple intrahepatic biliary
strictures which are rarely seen in ABOc ALDLT and
can be the cause of graft failure and patient death.
© 2013 The Authors
HPB © 2013 Americas Hepato-Pancreato-Biliary Association HPB 2013, 15 (Suppl. 2), 15–82
64 CONCURRENT SESSIONS ORALS
1123
THE OPTIMAL DIVISION POINT TO
OBTAIN ONE OPENING OF BILE DUCT
IN LEFT SIDE GRAFT IN LIVER
TRANSPLANTATION
Young Rok Choi, Kwang Woong Lee, Geun Hong,
Tae You, Sukwon Suh, Hyeyoung Kim, Minsu Park
and Hae Won
Seoul National University, College of Medicine, Seoul,
South Korea
Background and aims: To get one opening in the graft,
it is important to know left BD anatomy and select
adequate division point. In this study, we tried to sug-
gest optimal division point during left side donor hepa-
tectomy for liver transplantation by analyzing donor’s
BD anatomy.
Methods: 1) The multiple ductal openings according to
graft type and BD type and remnant segment 4.
Graft type and BD branching type were investigated
from 72 cases of LDLT with left side grafts from Jan.
2004 to Jan. 2011. Grafts were subdivided into left lat-
eral graft (LLG, n = 43) and left hemi-liver graft
(LHL, n = 29). And, left BD of the donors was classi-
fied into 3 types (Fig. 1). And we looked into the
change of the remnant segment 4 in after living donor
left lateral hepatectomy.
2) Considerations when deciding the division point.
To know the safe division point in the left BD, the
distance between right and left bifurcation point of
BD (A) and left BD branching point (B) was esti-
mated and between the right side of umbilical por-
tion of PV (P) and point B based on preoperative
donor MRI images in another 64 cases from January
2012 to July 2012.
Results: 1) The high risk factors for multiple openings
and the fate of the remnant segment 4.
LLG had a significant high incidence of multiple open-
ings than LHG in type I (p = 0.044). And remnant B4
was dilated in 39 cases (95%) and all most of segment
4 was atrophied on follow-up CT in living donor for
LLG regardless of the number of BD opening in the
graft.2) A relative position of B to A and P.
Table I showed that a point B was more closer to a
point A in type II and III than in type I (AB length).
And it was apart from a point P to the bifurcation side
about 5–7 mm (PB length)
Conclusions: Remnant segment 4 could not be saved
anatomically in most of cases in procurement of
LLG which have the high risk for multiple BD open-
ings on graft in type I. Therefore, when you decide
where is the optimal division point for obtaining one
BD opening for left sided liver graft, a left BD
branching point (B) relative to a point A and P
should be considered regardless of the B4 position
and graft resection plane.
1143
INFLUENCE OF RESECTION MARGIN
WIDTHS ON OUTCOMES OF HEPATIC
RESECTIONS FOR COLORECTAL
LIVER METASTASES
Chen Hui Lionel Raphael1, Teo Jin Yao2, Lee Ser Yee2
and Wong Jen San2
1Yong Loo Lin School of Medicine, National University
of Singapore, Singapore, Singapore; 2Department of
Surgery, Singapore General Hospital, Singapore,
Singapore
Purpose: Hepatic resection is the most effective therapy
for patients with colorectal liver metastases (CLM)
with 5 year survival of up to 58%. Traditionally, clear
margins of at least 1 cm were considered a prerequisite
for better survival. However, recent studies have ques-
tioned the prognostic importance of the ‘1-cm rule’.
This study’s aim is to evaluate the effect of the resec-
tion margin width on patients’ outcomes.
Methods: From 2001 to 2011, all patients who under-
went liver resection for CLM were selected from the
Singapore General Hospital. Patients with extrahepatic
metastases prior to resection of CLM were excluded.
Results: Overall median survival, recurrence free sur-
vival (i.e. intra and extrahepatic recurrence) and intra-
hepatic recurrence free survival were 25, 10 and
14 months respectively. 165 (85.1%) and 36 (17.9%)
underwent R0 and R1/2 resection respectively. Kaplan-
Meier (KM) univariate survival analysis suggests
patients with R0 resection had better survival as com-
pared to R1/2 resection (HR = 0.635, 95% CI = 0.39–
1.04, p = 0.067). Among the R0 resections, 48 (29.1%),
48 (29.1%) and 69 (41.8%) had margin width of  1, 1
to 5 and >5 mm respectively. On univariate analysis,
multiple liver metastases, bilobar distribution and  3
segments resected were associated with narrower mar-
gin width. Multivariate analysis showed  3 segments
resected was independently associated with  1 as com-
pared to >5 mm resection margin (OR = 2.85, 95%
CI = 1.26–6.43, p = 0.012). Wider margins of >5 as
compared to >1 mm were associated with better intra-
hepatic recurrence free survival (HR = 0.544, 95%
CI = 0.32–0.93, p = 0.027). However, margin width
effect on overall survival and recurrence free survival
was not statistically significant with p-values of 0.298
and 0.484 respectively.
Conclusions: Wider resection margins are associated
with lower intrahepatic recurrence. However, it has no
influence on overall survival and recurrence free sur-
vival. Achieving a 1.0 cm margin is not necessary when
resecting CLMs.
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EXTRAHEPATIC ADJACENT ORGAN
INVOLVEMENT IN GALLBLADDER
CANCER – AN AGGRESSIVE
APPROACH IMPROVES
RESECTABILITY AND OUTCOME
Anil K. Agarwal, R. Kalayarasan, Amit Javed, Nikhil
Gupta, Puja Sakhuja, H. H. Nag, Sunil Puri and A. S.
Puri
Department of GI Surgery, GB Pant Hospital & MAM
College, Delhi University, New Delhi, India
Background: Involvement of extrahepatic adjacent
organs in gall bladder cancer (GBC) is often considered
as locoregionally advanced disease. While some con-
sider it as a sign of inoperability, others perform an
extended radical surgery (adjacent viscera resection
including pancreatoduodenectomy) to achieve Ro resec-
tion.
Methods: The prospectively collected database of GBC
patients operated from May 2006 to September 2012 at
our Centre was retrospectively analyzed. Patients with
extrahepatic adjacent organ involvement requiring syn-
chronous resection of involved viscera were analyzed to
determine its impact on curative resection rate and
extent of surgery.
Results: Of the 569 patients taken up for surgery 327
underwent curative resection. One hundred and thirteen
patients required resection of one (n = 49) or more
(n = 64) adjacent organs. Patients with gastroduodenal
involvement without pancreatic involvement (n = 63)
underwent duodenal sleeve resection for small area of
contact (n = 27) or distal gastrectomy with proximal
duodenectomy for wide area of contact (n = 36).
Wedge resection of pancreas was performed in seven
patients with minimal pancreatic involvement and he-
patopancreatoduodenectomy in six patients for exten-
sive pancreatic involvement or large retropancreatic
nodes. CBD excision was performed in 75 patients for
associated jaundice/bile duct involvement (n = 54),
choledochal cyst (n = 12) or to facilitate lymph node
clearance (n = 9). Colonic involvement (n = 33)
required sleeve/segmental resection of colon in 25
patients and right hemicolectomy in 8 patients. Resec-
tion of single adjacent organ improved overall resect-
ability from 37.60% (214/569) to 46.22% (263/569) and
addition of more than one adjacent organ resection
improved it to 57.47% (327/569).
Conclusions: Aggressive approach aimed at resection of
involved adjacent viscera improves curative resection
rate in GBC and survival. An R0 resection could be
achieved with limited resection in most cases without a
need for pancreatoduodenectomy.
1149
SURGICAL MANAGEMENT OF BILE
DUCT INJURIES DURING
LAPAROSCOPIC CHOLECYSTECTOMY
Chi Young Jeong, Jin Kyu Cho, Young Tae Ju, Eun
Jung Jung, Young Joon Lee, Sang Kyung Choi, Woo
Song Ha, Soon Tae Park and Soon Cha
Department of Surgery, Gyeongsang National University
Hospital, Jinju, South Korea
Background and aims: Laparoscopic cholecystectomy
(LC) has become the gold standard of management of
gallstone disease. Biliary duct injuries (BDI) are more
likely to occur during difficult LC. The incidence of
injury when LC is performed for acute cholecystitis
was reported to be three times higher than that for
noninflammatory gallstone disease and twice as high as
that for open cholecystectomy for acute cholecystitis.
We reviewed our experiences with the management of
bile duct injury during laparoscopic cholecystectomy.
Methods: From May 2006 to August 2012, 21 patients
with bile duct injuries following LC were managed in
Gyeongsang National University Hospital. Patients’
charts were retrospectively reviewed to analyze periop-
erative management.
Results: Among the 21 patients, fourteen patients sus-
tained their bile duct injuries at our hospital. Seven
patients were referred to our hospital to manage their
bile duct injuries. All patients except one with bile duct
injuries in our hospital were identified intraoperatively.
According to the Strasberg classification, there are 9
cases of type A, 3 cases of type C, 3 case of type D
and 6 cases of type E injuries (E1: 2, E: 1, E3: 1, E4:
2). Four cases of type A bile duct injuries were treated
by direct duct ligation during LC. All cases of type A
and C bile duct injury were managed by non-surgical
treatment. All cases of type D and E bile duct injuries
were managed by Roux-en-Y hepaticojejunostomy.
Conclusions: Bile duct injuries are rare but serious com-
plications that occur during laparoscopic cholecystec-
tomy. Most minor bile duct injuries (type A to C) are
well treatable with non-surgical management, whereas
major bile duct injuries (type D and E) require surgical
management. The combination of non-surgical manage-
ment and surgical treatment results in successful out-
comes in bile duct injuries. Intraoperative recognition of
BDI was very important. Intraoperatively recognized
type A BDI was effectively repaired by direct clipping. In
cases where type D and E BDI was diagnosed intra- and
postoperatively, Roux-en-Y hepaticojejunostomy was
the procedure of choice for reconstruction.
1153
LAPAROSCOPIC RADICAL
CHOLECYSTECTOMY FOR
GALLBLADDER CANCER
Anil K. Agarwal, R. Kalayarasan, Amit Javed, Nikhil
Gupta and Puja Sakhuja
Department of GI Surgery, GB Pant Hospital & MAM
College, Delhi University, New Delhi, India
Background: Traditionally laparoscopic surgery has
been contraindicated in patients with suspected gall
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bladder cancer (GBC), however recently studies have
advocated the use of minimal invasive approach in
GBC. This study was undertaken to determine the
safety and feasibility of laparoscopic radical cholecys-
tectomy (LRC) for GBC.
Methods: Prospective study performed at our institute
between June 2011 and September 2012. Primary GBC
patients with minimal liver infiltration and incidental
GBC (IGBC) patients following laparoscopic cholecys-
tectomy were considered for LRC. Patients with exten-
sive liver infiltration, jaundice, extrahepatic adjacent
organ involvement and IGBC patients following open
cholecystectomy were excluded. The procedure was per-
formed using five ports with the patient in the supine
position with modified lithotomy position. Standard rad-
ical cholecystectomy (resection of segments IVB and V)
was performed with standard lymphadenectomy (clear-
ance of nodes from the hepatoduodenal ligament skele-
tonizing the vascular structures and the bile ducts with
clearance of nodes anterior and posterior to the head of
the pancreas and the hepatic artery till its origin from the
celiac axis). All port sites were excised in IGBC patients.
Results: Thirteen patients (10 primary GBC and 3
IGBC) underwent LRC during the study period. Med-
ian (range) operating time was 300 min (240–340 min).
Median (range) blood loss was 150 mL (100–300 mL).
Median post-operative hospital stay was 5 days (range
3–16 days). Pathological T stage in primary GBC
patients were T1b in one, T2 in two and T3 in seven.
Of the 3 IGBC patients 2 did not have any residual
tumor in GB fossa and one had residual tumor with
free resection margins. Port sites were free of tumor in
all 3 IGBC patients. Median (range) lymph node yield
was 8 (4–14). During a median (range) follow up of 6
(1–15) months all patients were alive without any evi-
dence of recurrence or metastasis.
Conclusions: Laparoscopic radical cholecystectomy is
safe and feasible in selected patients with primary and
incidental GBC.
1161
A CLINICAL COMPARISON OF
LAPAROSCOPIC DISTAL
PANCREATECTOMY TO OPEN DISTAL
PANCREATECTOMY
Yi-Ping Mou, Kun Xie, Jia-Fei Yan, Wei-Wei Jin,
Xiao-Wu Xu and Yu-Cheng Zhou
Department of General Surgery, Sir Run Run Shaw
Hospital, 3 East Qingchun Road, Hangzhou, China
Aims: To evaluate the advantages and disadvantages
of LDP comparing with ODP in postoperative pain,
postoperative recovery and postoperative morbidity.
Methods: From December 2003 to May 2011, patients
suffering distal pancreatic diseases were enrolled to
analyze the postoperative data. Additionally, all
patients were divided into Early Group (2003–2005),
Medium Group (2006–2008) and Late Group (2009–
present). Postoperative characteristics among the three
groups were compared respectively to access the impact
of the surgical experience on LDP.
Results: 170 patients were included with 69 in LDP
group and 91 in ODP group. The operation time was
similar between two groups, while LDP group was
associated with less blood loss (183.56  120.34 mL vs.
382.4  144.6 mL, p < 0.05). First flatus, first liquid
diet and postoperative hospital stay in LDP group were
significantly shorter than those in ODP group. More-
over as well as VAS scores (1.9  0.6 vs. 2.6  0.6,
p = 0.05) and analgesics (20.7  11.6 vs. 55.6  30.2,
p < 0.001). The postoperative morbidity of LDP were
significantly lower than the ODP group (17.4% vs.
31.8%, p < 0.05), while the incidence of pancreatic fis-
tula was no significant statistical difference (11.6% vs.
18.6%, p = 0.221). About the learning curve of LDP,
The operative time, blood loss and postoperative hospi-
tal stay of the Late group were significantly lower than
that in the Early group, while postoperative morbidity
were no significant difference among the three groups.
Conclusions: LDP is a procedure as safe and feasible as
ODP, and has the advantage of mini-invasive, such as
recovery more quickly, alleviating the postoperative
pain. The change point of learning curve for LDP was
40 cases.
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EFFECTS OF MESENCHYMAL
STROMAL CELL TRANSPLANTATION
ON ACUTE HEPATIC INJURY IN RATS
Hai-Tao Zhu1, Rui Zhou1, Shu Zhang1, Fan-Pu Ji3,
Kun-Lun Chen1, Zhen-Ni Zhang2, Jun Yang2, Chen
Huang2 and Zong-Fang Li2
1Department of General Surgery, the Second Affiliated
Hospital, Medical College, Xi’an Jiaotong University,
Xi’an, Shaanxi Province, China; 2Biotherapy &
Translational Medicine Engineering Research Center of
Shaanxi Province, Second Affiliated Hospital, Xi’an
Jiaotong University, P. R. China; 3Department of
Infectious Disease, the Second Affiliated Hospital,
Medical College, Xi’an Jiaotong University, Xi’an,
Shaanxi Province, China
Background/Aims: The role of mesenchymal stromal
cells (MSCs) in hepatic regenerative medicine is still in
dispute, with the help of novel tracking agent, quantum
dots (QDs). We investigated whether MSCs have the
potential of engraftment in the special “niche” as well
as the therapeutic feasibility to repair liver injury.
Methods: Rat bone marrow MSCs were labeled by
QDs and the characteristics of the MSCs after labeling
were investigated. The labeled MSCs were then injected
into normal rats via tail vein; followed acute liver
injury was induced with carbon tetrachloride (CCl4).
The migration and engraftment of MSCs were observed
using in vivo imaging system, the distribution of deliv-
ered MSCs was assessed by histological analysis, and
liver function parameters were also examined.
Results: Labeling of MSCs with QDs did not signifi-
cantly affect cell viability, proliferation, and differentia-
tion activity. In the normal recipient rats, the imaging
system showed the labeled MSCs mainly engrafted in
the bone marrow of limbs, little in the lung. After liver
injury was induced, the labeled MSCs could be found
in the peripheral blood immediately, which were mainly
observed in the liver parenchyma at last. Meanwhile,
Serum ALT and AST levels decreased significantly post
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labeled MSCs injection as compared with the control
groups (p < 0.05), consistent with the improvement of
hepatic histology.
Conclusions: The MSCs have the ability of homing and
migration to the injured liver, and contribute to hepatic
regeneration as a therapeutic potential.
Acknowledgements: The work was supported by the
National Natural Science Foundation of China
(81070354).
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PORTAL BILIOPATHY – ROLE OF
SHUNT SURGERY
Avinash Kumar, Rajneesh Kumar Singh, Rajan
Saxena, Anand Prakash, Anu Behari, Ashok Kumar
and Vinay Kumar Kapoor
Sanjay Gandhi Post Graduate Institute of Medical
Sciences, Lucknow, India
Background: Portal cavernoma due to extrahepatic
portal vein obstruction leads to several changes in the
extrahepatic bile ducts. Severe changes present with
strictures and/or stones in the bile ducts. The treatment
of such symptomatic portal biliopathy is complex due
to the risk to torrential hemorrhage during surgical or
nonsurgical intervention.
Aims: We analyzed our experience over the last
20 years with the surgical treatment of symptomatic
portal biliopathy by retrospective chart review.
Results: We treated 38 patients with symptomatic portal
biliopathy with surgery over the last 20 years. The
M : F ratio was 25 : 13 and the mean (SD) age was 29.8
(11.6) years. The clinical presentation was obstructive
jaundice in all, with cholangitis in 20 and upper gastro-
intestinal bleed in 25 patients. In all except 1 patient the
etiology of portal vein obstruction was idiopathic. One
patient had chronic pancreatitis with portal vein block.
The serum bilirubin mean (SD) was 9.3 (8.6) mg/dL. Six
patients had had prior attempted cholecystectomy in
other hospitals. Portal biliopathy could be classified as
(Group A) bile duct strictures (n = 17), (Group B) bile
duct stones (n = 7) and (Group C) both strictures and
stones (n = 14). Overall, staged surgery (decompressive-
porta-systemic shunt only at first surgery) was done in
31, simultaneous surgery (decompressive shunt and bili-
ary surgery) was done in 2 and only biliary surgery was
done in 5 patients. In those who underwent staged sur-
gery (n = 31), decompressive shunt surgery alone was
sufficient for treatment in 15 patients. The rest under-
went biliary surgery (n = 5), endoscopic stenting (n = 8),
neither (n = 2) and intraoperative mortality (n = 1).
Group A (n = 17) underwent staged surgery (n = 16)
and simultaneous shunt and biliary surgery (n = 1).
Group B (n = 7) underwent staged surgery (n = 5) and
only biliary surgery (n = 2). Group C (n = 14) under-
went staged surgery (n = 10), simultaneous shunt and
biliary surgery (n = 1) and only biliary surgery (n = 3).
The overall follow-up (mean) (SD) was 2.3 (2.2) years.
The morbidity included re-exploration (n = 6) and mas-
sive hemorrhage (n = 2). The overall postoperative mor-
tality was 2 patients. Overall, the treatment was
successfully completed in 21 patients. Some patients
(n = 15) are still under treatment with stent exchanges.
Conclusions: Symptomatic portal biliopathy is a com-
plex problem requiring a multidisciplinary approach.
Staged surgical procedure is desirable to avoid massive
hemorrhage during biliary surgery. Decompressivepor-
ta-systemic shunt alone is sufficient treatment in almost
half the patients.
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PROGNOSTIC SCORE OF OPERATIVE
MORTALITY IN
PANCREATEODUODENECTOMY
Adianto Nugroho and Toar Lalisang
Digestive Division, Cipto Mangunkusumo Hospital,
University of Indonesia, Jakarta, Indonesia
Background: Pancreaticoduodenectomy (PD) has long
been associated with high rates of morbidity and mor-
tality. The aim of this study was to identify preopera-
tive risk factors for morbidity and mortality after PD
and to construct a prediction tool to facilitate risk
stratification prior to surgery.
Materials and Methods: Patients who underwent elec-
tive PD from 1995 to 2012 were identified from the
Digestive surgery database. Multivariate logistic regres-
sion identified prediction of morbidity and mortality.
ROC curve estimation is use to determined the cut off
value of the prognostic score.
Results: Of 138 patients who underwent PD, 35
(25.4%) suffered a serious complication and 27 (19.6%)
died. The most frequent complications were sepsis and
bleeding. The mortality was reduced after 2005, but it
was statistically not significant. The predictor of mortal-
ity are age above 50 years old, male gender, elevated
total bilirubin, high creatinin, low hematocrit, high
ALP. A longer duration of surgery, amount of blood
loss and the need or reoperation are associated with
higher mortality, but it was not statistically significant.
A prognostic score was created with a cut off value of 6.
Conclusions: The prediction tool and a prognostic score
estimates the possibility of early morbidity and mortal-
ity for patients undergoing PD. The tool may be used
to provide information for patient counseling during
the informed consent process and to identify high-risk
patients for the purpose of tailoring perioperative care.
1181
LAPAROSCOPIC COMMON BILE DUCT
EXPLORATION COMBINED WITH
FIBROCHOLEDOCHOSCOPE FOR
CHOLEDOCHOLITHIASIS:EXPERIENCE
WITH 1230 CASES
Yue-Ming Sun and Chun-Hua Xi
Department of Minimally Invasive Surgery, the First
Affiliated Hospital of Nanjing Medical University,
Nanjing, China
Objective: To study the feasibility and clinical applica-
tion of laparoscopic surgery for choledocholithiasis.
Methods: A retrospective cohort study was conducted
to compare laparoscopic common bile duct exploration
(LCBDE) (n = 1230) with conventional common bile
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duct exploration (CCBDE) (n = 800) in the manage-
ment of choledocholithiasis. 1230 patients with chole-
docholithiasis were performed laparoscopic common
bile duct exploration. For those cases diagnosed preop-
eratively, we had incised common bile duct and taken
out the calculuses with fibrocholedochoscope. Some
patients had suffered from obstructive jaundice, pance-
atitis, bilirubinemia, alkaline phosphatase (AKP) raise,
c-glutamyltranspeptidase (c-GGT) raise and∕00) in the
management of choledocholithias cm, and intraopera-
tive cholangiography must be carried out. 915 cases
needed T-tube insertion. The common bile duct of 315
cases were sutured with no T tube.
Results: All cases were operated successfully. The span
of LCBDE operation time of T-tube group
(106  37 min) and I stage suture group (89  36 min)
were not significantly longer than the CCBDE group
(92  35 min), while the postoperative hospitalization
was shorter in the LCBDE (8  3 days) group than in
the CCBDE (14  4 days) group. No statistic differ-
ence between the two groups about bile leak, bleeding,
and retained stones as well. But the ratio of infection
of incisional wound was lower in the LCBDE group (6/
1230) than in the CCBDE group (26/800).
Conclusions: The laparoscopic surgery is a safe and
effective method for choledocholithiasis, it have advan-
tages of minimal injury and rapidly recovery and it can
shorten hospital stay, Especially in the I stage suture
group.
1249
TEAMWORK APPROACH TOWARDS
THE SUCCESS OF ROBOTIC-ASSISTED
LAPAROSCOPIC
PANCREATICODUODENECTOMY
Akaraviputh T., Trakarnsanga A.,
Chinswangwatanakul V. and Yeingprusawan A.
Minimal Invasive Surgery Unit, Division of General
Surgery, Department of Surgery, Faculty of Medicine
Siriraj Hospital, Mahidol University, Bangkok, Thailand
Background: Use of robotic surgery has gained increas-
ing acceptance over the last few years. For pancreatico-
duodenectomy, this complex procedure needs a long
operative time and delicate surgical skills causing the
stress and fatigue to a single surgeon. To overcome the
learning curve and shorten the operative time, we have
established a team approach. There are three surgeons
who have experiences in Robotic-assisted laparoscopic
procedure. The surgical operator would be switched
every 2 hours among these 3 surgeons. This study
showed an initial experience of robotic-assisted pan-
creaticoduodenectomy using a team approach in
patients with periampullary carcinoma.
Materials & Methods: A series of patients who under-
went robotic-assisted pancreaticoduodenectomy using a
team approach at the Minimally Invasive Surgery unit,
Division of General Surgery, Department of Surgery,
Faculty of Medicine Siriraj Hospital, Bangkok, Thai-
land was reviewed.
Results: From October 2007 to January 2009, 6
patients underwent robotic-assisted pylorus preserving
pancreaticoduodenectomy (PPPD) using a team
approach by the da Vinci S robotic system. Of all, 4
patients were female. The average age was 62.8 years
(range 52–80). Mean operative time was 609.5 min.
(range 540–732) which was decreased to 6 h. for the
most recent case. The mean estimated blood loss was
946.7 mL. For post-operative complications, there were
2 patients with delay gastric emptying and one with
superficial surgical site infection without any mortality.
The mean length of hospital stay was 20.5 days (range
14–30).
Conclusions: This is the first series of robotic-assisted
PPPD in Thailand. The results demonstrate that it is fea-
sible and safe. The learning curve of this complex proce-
dure can be shortened by using the team approach.
1260
THE EFFECT OF GASTRIN AND THE
GASTRIN RECEPTOR ANTAGONIST
PROGLUMIDE ON PROLIFERATION
OF HEPATOCELLAR CARCINOMA
CELL LINES
Chun-Ping Jiang and Yi-Tao Ding
Department of Hepatobiliary Surgery, the Affiliated
Drum Tower Hospital of Nanjing University Medical
College, Nanjing, China
Background/Aims: To investigate the effects of gastrin
and its receptor antagonist proglumide on the growth
of hepatocellular carcinoma (HCC) cell lines, and to
research the possibility of non-cytotoxic endocrinous
treatment for HCC.
Methodology: We observed the vitality and cycle distri-
bution of 4 HCC cell lines treated with gastrin and pro-
glumide by MTT colorimetric assay and flow
cytometric analysis.
Results: Gastrin can significantly stimulate the prolifer-
ation of QGY-7701 and Bel-7402 cell lines at concentra-
tions that approximate to physiological levels, and
shifted G0/G1 phase to S、G2/M phase of Bel-7402 cell
lines, which could be blocked by gastrin receptor antag-
onist proglumide, and the excess gastrin gave the inhibi-
tory effect in QGY-7701 cell lines. Gastrin had no effect
on HepG2 and SMMC-7721 cell lines. Proglumide at
high concentration seriously inhibited all cell lines.
Conclusions: Gastrin can promote proliferation of liver
cancer cells and DNA synthesis; Gastrin receptor
antagonist may become a non-cytotoxic endocrinous
treatment approach of some liver cancer.
1262
AN UNUSUAL PROBLEM OF CHRONIC
SURGICAL WOUND INFECTION
FOLLOWING BILIARY TRACT
SURGERY IN NORTH INDIA: AN
UPDATE
Vijaya Lakshmi Nag1, Nihar Ranjan Dash2, Anu
Behari1 and Rajneesh K. Singh1
1Sanjay Gandhi Post graduate Institute of Medical
Sciences, Lucknow, India; 2AIIMS, New Delhi, India
Background: Chronic wound infection following rou-
tine biliary surgery is difficult to manage. The problem
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is compounded when the infection is due to non-tuber-
culous mycobacteria (NTM).The management of such
cases is different from tuberculosis. We describe our
experience of managing such cases over the past
5 years.
Material and methods: 18 cases of post surgical wound
problem of recurrent discharging sinuses with or with-
out surface nodularity were referred to the mycobacte-
riology laboratory. Fourteen cases had biliary tract
surgery. The specimens (FNAC- 5; Discharges -18)
were smeared and stained with Z-N stain. All samples
were cultured in L-J media and then incubated at 37°C
for maximum up to 8 weeks. Each isolate underwent
biochemical and molecular characterization. The sam-
ples were also simultaneously processed for bacteria,
nocardia and fungi. Antibiotic susceptibility was
checked by disc diffusion method.
Results: 9 cases had laparoscopic cholecystectomy, 3
cases of biliary stricture had hepatico-jejunostomy, one
case had open cholecystectomy and CBD exploration
and one case had open cholecystectomy. Two patients
had associated drain site infections. In two cases no
organism could be isolated. Two cases showed pseudo-
monas as the only isolate. Rapidly growing mycobacte-
ria were detected in 10 cases, in more than two
occasions (2–6) in each case. M. fortuitum and M.
chelonae were the main organisms isolated .In one case
the species could not be identified. All the strains were
sensitive to Levofloxacin and Linezolid. All were resis-
tant to Ampicillin-sulbactum. The sensitivity to floxa-
cin, aminoglycosides, clindamycin, cyclines and
cefotaxime were varied on case per case basis. 9 cases
were treated with wide excision and combination of
Levofloxacin and Linezolid for 6 months. The wounds
were completely healed by 6 months in all cases. One
case had developed nodules underneath the healed
wound after one month of completion of therapy. The
FNAC did not show any isolate. One case of stricture
hepaticojejunostomy had recurrence of sinus after one
year which required wound exploration, debridement
and dressing. These two cases were also treated with
Ciprofloxacin.
Conclusions: Post surgical non healing wounds with
persistent serosanguinous discharge with or without
appearance of nodularity, should be subjected to myco-
bacteriological examination. Tuberculosis, NTM, no-
cardia and fungal infections constitute the spectrum of
suspicion. Examination of multiple samples at different
stages should be done to diagnose NTM. Wound
debridement and culture based anti-microbial therapy
constitutes the main stay of management. The strains
and the sensitivity pattern remains similar over the last
3 years.
1270
MODIFIED TECHNIQUE OF
PANCREATICOGASTROSTOMY FOR
SOFT PANCREAS WITH TWO
CONTINUOUS HEMSTITCH SUTURES:
A SINGLE CENTER PROSPECTIVE
STUDY
F. Zhu, M. Wang, X. Wang, R. Tian, C. Shi, M. Xu,
M. Shen, J. Han, N. Luo and R. Qin
Department of Pancreatic-Biliary Surgery, Affiliated
Tongji Hospital, Tongji Medical College, Huazhong
University of Science and Technology, Wuhan, Hubei,
China
Background: Postoperative pancreatic fistula (POPF)
remains a persistent problem after pancreaticoduoden-
ectomy (PD), especially in the presence of a soft, non-
fibrotic pancreas. To reduce the risk of POPF,
pancreaticogastrostomy has gained favor in recent
years. This study presents a new technique of pancreat-
icogastrostomy for a soft, nonfibrotic pancreas with
double binding continuous hemstick sutures and evalu-
ates its safety and reliability.
Methods: From January 2011 to June 2012, 92 cases of
patients with periampullary malignancy with a soft
pancreas underwent this technique. A modified tech-
nique of PG was performed with two continuous hem-
stitch sutures placed in the mucosal and seromuscular
layers of the posterior gastric wall, respectively. Than
the morbidity and mortality was calculated.
Results: This technique was applied in 92 patients after
PD all with soft pancreas. The median time for the
anastomosis was 12 min (range 8–24). Operative mor-
tality was zero, and morbidity was 16.3% (n = 15),
including hemorrhage (n = 2), biliary fistula (n = 2),
pulmonary infection (n = 1), delayed gastric emptying
(DGE) (n = 5, 5.4%), abdominal abscess (n = 3, 1
caused by PF), and POPF (n = 2, 2.2%). Two patients
developed a pancreatic fistula (1 type A, 1 type B) clas-
sified according to the International Study Group on
Pancreatic Fistula.
Conclusions: The described technique is a simple and
safe reconstruction procedure after PD, especially for
patients with a soft and fragile pancreas.
1271
A MODIFIED TECHNIQUE OF END-TO-
END PANCREATICOJEJUNOSTOMY
WITH TRANSPANCREATIC
INTERLOCKING MATTRESS SUTURES
Min Wang, Feng Zhu, Xin Wang, Rui Tian,
Cheng-Jian Shi, Ming Shen, Meng Xu, Juan Han,
Nian-Nian Luo and Ren-Yi Qin
Department of Biliary-Pancreatic Surgery, Affiliated
Tongji Hospital, Tongji Medical College, Huazhong
University of Science and Technology, Wuhan, Hubei,
China
Background: Postoperative pancreatic fistula (POPF)
represents the most important cause of morbidity after
pancreaticoduodenectomy and contributes to prolonged
hospitalization and increased mortality rates. This
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study presents a new technique, which involves end-to-
end pancreaticojejunostomy with transpancreatic inter-
locking mattress sutures, and evaluates its safety and
reliability.
Methods: From January 2011 to May 2012, 79 patients
with periampullary malignancies underwent pancreati-
coduodenectomy by using this modified technique, and
the morbidity and mortality rates were calculated.
Results: In this study, all cases recovered well from pan-
creaticoduodenectomy. Four transpancreatic interlock-
ing mattress sutures were performed in 79 patients. The
median duration of surgery was 3.9 h (range 3.1–6.8),
and the median time to perform pancreaticojejunostomy
was 15.3 min (range 9–24). Overall, morbidity occurred
in 8 patients (10.1%), and the causes included upper
gastrointestinal bleeding (n = 2), biliary fistula (n = 1),
pulmonary infection (n = 1), delayed gastric emptying
(n = 1), abdominal abscess (n = 1, caused by PF), and
POPF (n = 2, 2.53%). One patient had grade A POPF,
one had grade B POPF, and none of them had grade C
POPF. No deaths occurred during surgery.
Conclusions: The end-to-end pancreaticojejunostomy
with transpancreatic interlocking mattress sutures is a
simple procedure that could be performed safely and
rapidly, and it reduces the rates of leakage and delayed
massive hemorrhage that may occur after pancreatico-
duodenectomy.
1273
A SAFE SURGICAL TECHNIQUE FOR
UNCINATE PROCESS RESECTION
DURING
PANCREATICODUODENECTOMY
USING A SELECTIVE ARTERY OR VEIN
FIRST APPROACH AND COMBINED
BLOOD FLOW BLOCKAGE OF THE
MESOUNCINATE: A SINGLE-CENTER
STUDY
Ren-Yi Qin, Min Wang, Feng Zhu, Rui Tian, Xin
Wang, Cheng-Jian Shi, Meng Xu and Ming Shen
Department of Biliary-Pancreatic Surgery, Affiliated
Tongji Hospital, Tongji Medical College, Huazhong
University of Science and Technology, Wuhan, Hubei
China
Background: Integrated resection of the pancreatic
uncinate process is the most difficult step in radical
pancreaticoduodenectomy (RPD) to achieve curative
resection (R0). We have developed a surgical technique:
a selective artery or vein first approach with combined
blood flow blockage of the pancreatic mesouncinate,
which allows for successful and safe completion of inte-
grated radical resection of the uncinate process.
Methods: From March 2005 through May 2012, a total
of 582 patients underwent selective artery or vein first
RPD according to whether the portal vein (PV) and
superior mesenteric vein (SMV) were invaded by the
tumor. Surgical data, postoperative outcomes, and
pathological results of patients were reviewed.
Results: Among the 582 patients, 454 and 128 under-
went pancreaticoduodenectomy with the SMV first
approach and SMA first approach, respectively. The
median operative time was 4.2 h (range, 3.7–7 h).
The median intraoperative blood loss was 450 mL.
The complication rate was 15.7%, and the incidence
rates of postoperative bleeding, postoperative pancre-
atic fistula, biliary fistula, delayed gastric emptying,
and abdominal abscess were 2.2%, 6.1%, 2%, 3.3%,
and 1.6%, respectively. In the overall series, 102
(17.5%) cases were classified R1 resections and 480
(82.5%) as R0 resections. Seven (1.2%) patients died.
No patients had tumor recurrence around the pancre-
atic uncinate process at 3 months after pancreatico-
duodenectomy.
Conclusions: The selective artery or vein first approach
with combined blood flow blockage is a safe and useful
technique for integrated radical resection of the unci-
nate process for patients with periampullary malignant
tumors.
1279
TOWARDS R0 LIVER RESECTION FOR
COLORECTAL CANCER LIVER
METASTASES
Bulajic P., Basaric D., Galun D., Bogdanovic A.,
Bidzic N. and Milicevic M.
First Surgical Clinic, Clinical center of Serbia, Belgrade,
Serbia
[Correction added on 7 June 2013, after first online
publication: Bulajic P. was added in the author list in
abstract 1279.]
Background and aims: Recurrence following surgery
with curative intent for colorectal liver metastasis
remains a serious clinical challenge. First and the most
frequent recurrence site is intrahepatic. Surgical margin
recurrence rate after resection of colorectal liver metas-
tases is 1.2%–10.4%. Reduction of the overall recur-
rence rate could be done by minimizing the surgical
margine recurrence rate. We hypothecate that surgical
margine recurrence zero rate is possible when a transec-
tion plane is placed trough radiofrequency ablation
(RFA) area formed in the macroscopically healthy liver
tissue along metastases surface.
Methods: Between January 2002 to December 2011,
177 patients underwent 203 liver resection for colorec-
tal liver metastases (liver re-resection were performeed
in 23 patients). We used the surgical technique that
comprised transection trough RFA area formed of
multiple overlapping RFA zones. Each RFA zone was
positioned in the macroscopically healthy liver tissue
along metastases surface. Forming RFA area and tran-
section were performed in stepwise fashion as
described. RFA zone (nua cm wide and 1–3 cm long)
was created by applying maximal intensity of radiofre-
quency electric current from the start of ablation.
Immediate longitudinal transection trough whole
length, and half of the width of the RFA zone was per-
formed. Succeeding RFA zone is placed: so that it
overlaps not transected part of the previous RFA zone;
and in the direction that allows accomplishing the
planned resection plane. RFA and transections were
repeatedly performed until liver resection is completed.
Metastasis that infiltrates the liver bilio-vascular struc-
ture was en block resected with affected part of bilio-
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vascular structure. Devascularized part of the liver was
subsequently resected. When re-resection was per-
formed, sites of previous resections were examined, and
when needed, frozen section biopsy was performed.
Postoperative follow-up consisted of clinical examina-
tion, measurement of CEA, and abdominal imaging in
three months intervals for the first two years, then, twice
a year in the next two years, and once per year thereaf-
ter. All data were collected in a prospective manner.
Results: The median age of the patients was 66.3 years.
34.4% patients undervent resection  3 metastases.
Average diameter of the metastases was 35.5 mm
(range 8 to 200 mm). A total of 450 metastases was
resected. Follow-up was 29.8 months. There was no
surgical margin recurrence. Mortality was 1,9%. Mor-
bidity was 16,8%.
Conclusions: Surgical technique that comprised liver
transection trough area formed by radiofrequency abla-
tion which encapsulates colorectal liver metastasis
could be a useful tool for minimizing surgical margin
recurrence.
1289
AN EVOLVING APPROACH TO
RADICAL SURGERY FOR
COMPLICATED HYDATID CYSTS OF
THE LIVER
Xin-Yu Peng, Shi-Jie Zhang, Xiang-Wei Wu and
Hong-Qiang Yang
Department of Hepatobiliary Surgery, the First
Affiliated Hospital, School of Medicine, Shihezi
University, Shihezi/Xinjiang, China
Background and aims: In terms of surgical treatment of
liver hydatid cysts, complication and recurrence rates
seem to be higher with conservative surgical procedures
compared to more radical treatment, but indiscriminate
application of total pericystectomy or major liver resec-
tion may be followed by a higher incidence of major
postoperative complications and mortality. Therefore,
radical surgery is performed with exorbitantly strict
indications and contraindications, especially for some
complicated cases.
Methods: Here, we arbitrarily define complex hydatid
cysts of the liver as cysts with big size, multiple and
recurrent cysts, or cyst-associated complications (most
commonly, intrabiliary communication or rupture). We
revisited a series of patients who underwent an evolving
approach to radical surgery for complex hydatid cysts
over a period of 10 years at our single center to deter-
mine the evolution of the surgical treatment.
Results: The evolving approach to treatment of compli-
cated hydatid cysts is, at least in our center, the most
effective and reliable treatment procedure in the
selected cases.
Conclusions: Although the surgical approach to liver
hydatid cyst have been well developed, surgical tech-
niques still have a broad space for development and
evolution. In terms of radical treatment of complicated
hydatid cysts, our experience is summarized as follows:
① Preoperatively, contrast-enhanced CT is extremely
useful to evaluate the cyst status such as the viability of
the parasite, and the relationship between the cyst and
intrahepatic vessel. ② Pericyst wall should remove as
much as possible because it is the major incentives of
the recurrence. ③ It is indeed possible to separate the
pericyst from the liver without damaging the surround-
ing parenchyma along an interspace observed in our
practice. ④ The concept of “functional” vessel and
“non-functional” vessel has to be kept in mind during
the removal of pericyst, which guides the choice of liga-
tion or not. ⑤ Adscititious operation such as biliary-
digestive tract reconstruction for cyst with large biliocy-
stic fistula, probably increasing the difficulty and risk,
is worth considering because it benefits the decrease of
biliary complications.
1290
NATURAL HISTORY OF LIVER
HYDATID CYST: PRELIMINARY
CLINICAL OBSERVATION
Xin-Yu Peng, Shi-Jie Zhang, Xiang-Wei Wu,
Hong-Qiang Yang and Gui-Sheng Liu
Department of Hepatobiliary Surgery, the First
Affiliated Hospital, School of Medicine, Shihezi
University, Shihezi/Xinjiang, China
Background and aims: The hydatid cyst of the liver is
benign, usually uncomplicated disease, and there is,
therefore, controversy regarding the use of surgery to
deal with the benign disease. It is important to clarify
the natural history of the disease in human, which pro-
vides a key to the clinical decision-making. However,
the natural history is still not fully understood, and
ambiguity exists within this field. The aim of this study
was to gain a deeper insight into the natural history of
such lesion, and to draw up comprehensive guidelines
for treatment.
Methods: A series of patients with CE were studied
over a period of 10 years at our single center, and liver
hydatid cysts were analyzed by CT, Ultrasonography,
and clinical observation of specimens to determine the
cyst size, the features of cyst wall, the viability of cyst
content, and so on.
Results: In agreement with previous findings, our study
confirmed that the cyst growth was characterized by a
“small – large – small” process. The cystic lesion
expands slowly over years, and then gradually becomes
smaller and solidified. Finally, dead cysts are character-
ized by a thick calcified wall. But the growth did not
fully follow the traditional description that the evolution
of cyst change progressing from Type CL to Type CE5.
Conclusions: Despite lack of evidence-based studies,
our observation provides some new insight into the
natural history of liver hydatid cysts. Perhaps the
most important finding in this study is that, after
slowly expanding, the cyst gradually becomes smaller,
which might result from biliary-cystic communica-
tions. This hypothesis was supported by the phenom-
ena that the volume of cyst usually was much bigger
than that of residual cavity as long as biliary-cystic
communication exists, and that an observed “crater”-
like changes located the surface of the junction of
cyst and the surrounding liver tissue were also associ-
ated with high frequency incidence of biliary-cystic
communications.
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LIV-1 PROMOTES EPITHELIAL TO
MESENCHYMAL TRANSITION IN
HEPATOCELLULAR CARCINOMA
CELLS
Rong-Xi Shen
Eastern Hepatobiliary Surgery Hospital, Shanghai,
China
LIV-1, a zinc transporter, is a mediator downstream
from STAT3, both in zebrafish and mammalian cells,
and is involved in epithelial to mesenchymal transition
(EMT). Despite the implication of LIV-1 in cancer
growth and metastasis, little is known about the associ-
ation of LIV-1 with human liver cancer development.
Therefore, expression of LIV-1 mRNA was analyzed
by reverse transcriptase polymerase chain reaction (RT-
PCR) in 4 cultured cell lines (3 carcinoma and 1 nor-
mal liver cell lines), localization of LIV-1 protein was
investigated by immunohistochemistry. Expression of
LIV-1 protein was analyzed by Western blot both in 4
cultured cell lines and 120 liver tissues (100 carcinoma
and 20 histologically normal tissues),and the relation
between its expression and clinicopathological findings
was investigated in 100 hepatocellular carcinoma(HCC)
tissues. Then stable siRNA expressing Hep-G2 cells
were generated to assess the function of LIV-1 in liver
cancer cells. Higher expression of LIV-1 mRNA was
found in liver cancer cell lines compared to normal
liver cell line. Western blot showed LIV-1 expression in
61% of liver carcinoma tissues was higher than the
mean level of normal liver tissues. Down-regulated
LIV-1 cells showed significant inhibition of prolifera-
tion in vitro and reduction of tumor growth in vivo.
Furthermore, E-cadherin expression was increased in
LIV-1 siRNA expressing Hep-G2. These findings indi-
cate that LIV-1 may promote the induction of epithe-
lial to mesenchymal transition in HCC cells.
1297
ERCP WITH BILIARY DRAINAGE AND
SIMULTANEOUS STONE EXTRACTION
COMPARED WITH BILIARY DRAINAGE
ALONE IN CHOLANGITIS – A CASE
MATCH ANALYSIS
Derek T. L. Fung, Canon K. O. Chan and M. T.
Cheung
Queen Elizabeth Hospital, Kowloon, Hong Kong S.A.R.,
China
Background: Biliary drainage by Endoscopic Retro-
grade Cholangiopancreatography (ERCP) has been the
first line treatment in cholangitis secondary to choledo-
cholithiasis. However, the role of simultaneous stone
extraction together with biliary drainage has not been
elucidated in the literature.
Objective: This study is set out to investigate the out-
come of stone extraction together with biliary drainage
as compared to drainage alone by ERCP in cholangitis
due to choledocholithiasis.
Methods: A case-matched analysis involving all consecu-
tive patients undergoing emergency ERCP for choledo-
cholithiasis associated cholangitis over a 6-year period
were reviewed. ERCP with biliary stenting (BS) were
matched 2 : 1 to ERCP with simultaneous stone extrac-
tion and stenting (SEBS) by age, gender, pre-ERCP sys-
temic inflammatory response (SIRS) parameters, and
pre-ERCP biochemical parameters. Main outcome com-
parison was the rate of post-ERCP pancreatitis.
Results: Seventy SEBS cases satisfied the inclusion crite-
ria and were matched to 140 BS patients. SEBS and BS
patients were similar in age (67.8 vs. 65.2 p = 0.15), gen-
der (percentage female 35.7 vs. 49.3 p = 0.08), papilloto-
my rates (58.6% vs. 50.0% p = 0.31), as well as clinical
and biochemical sepsis parameters. The overall rate of
post-ERCP pancreatitis for the entire cohort was 8.6%.
SEBS patients had significantly lower rate of post-ERCP
pancreatitis (2.9% vs. 11.4% odds ratio 0.23 CI: 0.051–
1.021 p = 0.038), but similar hospital mortality rates
were observed (SEBS 1.4% vs. BS 4.3% p = 0.43). Rate
of normalization of the liver enzymes and bilirubin lev-
els post-ERCP between the two groups were similar.
Post-ERCP length of stay were 2 days shorter in SEBS
(SEBS 4.6 days vs. BS 6.7 days p = 0.006).
Conclusions: In patients with common ductal stones
causing cholangitis, emergency ERCP with stone
extraction and biliary stenting is associated with less
post-ERCP pancreatitis and a shorter hospital stay
when compared to ERCP stenting alone.
1305
HEPATIC ANGIOMYOLIPOMA:
CLINICAL, IMAGING AND
PATHOLOGICAL FEATURES IN 178
CASES
Xiao-Yu Yang, Ai-Jun Li and Meng-Chao Wu
Eastern Hepatobiliary Surgery Hospital, Shanghai, China
Aims: To review the main clinical, imaging and patho-
logical features of hepatic angiomyolipoma (HAML).
Methods: We retrospectively analyzed the imaging,
pathological and clinical features of 178 patients who
underwent surgical resection for HAML.
Results: Forty-three males and 135 females with a med-
ian age of 43.5 years (range: 17–76 years) were enrolled in
the study. Routine blood tests, including those for a-feto-
protein (AFP), carcinoembryonic antigen (CEA), and
carbohydrate antigen determinant (CA19-9), were nor-
mal. Liver function was classified as Child-Pugh A for all
patients. Twenty-one patients were positive for hepatitis
B surface antigen (HBsAg), while two had liver cirrhosis.
Seventy-five lesions were located in the right hepatic lobe,
42 in the left hepatic lobe, 12 in the hepatic caudal lobe
and 49 in both left and right lobe. All patients underwent
examination by ultrasound sonography (US), and addi-
tional examinations by computed tomography (CT) and
magnetic resonance (MR) were carried out for 115 and 81
patients, respectively. Various diseases including HAML,
liver cancer, liver hemangioma, hepatic lipoma, hepatic
hamartoma, focal nodular hyperplasia and liver ade-
noma, were diagnosed before operation. CT and MRI
show more conclusive than US (US vs. CT: v2 = 17.72,
p = 0.00; US vs. MRI: v2 = 12.14, p = 0.00), but for the
sensitivity of these three imaging modalities, MRI per-
form the best (US vs. MRI: v2 = 5.938, p = 0.015; CT vs.
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MRI: v2 = 2.544, p = 0.111). All the patients underwent
liver resection (96 right hepatic lobectomy, 41 left hepatic
lobectomy, and nine caudal lobe hepatic lobectomy). Sev-
eral sampled tissues were positive for HBsAg (21/168,
12.5%), b-catenin (4/41, 9.8%), CD-34 (119/165, 72.1%),
HMB-45 (162/169, 92.9%), SMA(145/158, 91.8%), and
vimentin (20/27, 74.1%).
Conclusions: The diagnosis of HAML remains difficult
and mainly relies on pathological findings. For the imag-
ing modalities, we recommend MRI examination because
of its better definition and sensitivity. Although HMB-45
is considered the main histopathological biomarker for
HAML, SMA may be also helpful in the diagnostic pro-
cess (HMB-45 vs. SMA: v2 = 2.37, p = 0.123). When the
diagnosis of HAML is suspicious or hypothesized, surgi-
cal resection remains the recommended strategy due to
the difficulty in diagnosis preoperatively and the poten-
tially invasive growth of the lesion.
1306
FAST-TRACK RECOVERY AFTER
PANCREATODUODENECTOMY: A
PROSPECTIVE RANDOMIZED
CONTROLLED STUDY
Gang Jin, Zhuo Shao, Hong-Yun Ma, Yang Ou, Bin
Song and Xian-Gui Hu
Changhai Hospital, Shanghai, China
Background and aims: To evaluate the impact of Fast
track surgery for pancreatoduodenectomy.
Methods: Between January 2011 and January 2012,
370 patients undergoing PD or PPPD in our depart-
ment of general surgery. These patients are divided into
FTS group and control group because the use of FTS
methods. The differences if the incidence of postopera-
tive complications, the serum albumin leval, the body
mass index (BMI), postoperative hospital stay and
expenses were compared between 2 groups.
Results: There were no significant difference in the inci-
dence of postoperative complications, the serum albu-
min leval and the body mass index (BMI). However,
the FTS group has less hospital stay and expenses com-
pared with the control group (p < 0.05).
Conclusion: The pancreatoduodenectomy can be fur-
ther optimized by the use of fast-track-surgery, which
can make patients recovered better and faster.
1316
RADIOFREQUENCY ASSISTED LIVER
RESECTION IN THE MANAGEMENT OF
GIANT HEMANGIOMAS
Bogdanovic A., Zuvela M., Bulajic P., Basaric D.,
Galun D., Bidzic N. and Milicevic M.
Clinical Center of Serbia-First Surgical Clinic, Belgrade,
Serbia
[Correction added on 7 June 2013, after first online
publication: Bogdanovic A. was added in the author
list in abstract 1316.]
Introduction: Liver hemangioma is the most common
benign tumor of the liver. Management outcome
depends on patient selection and surgical technique.
Methods: Between October 1st 2004 and October 31st
2011, 30 patients underwent surgical management of
liver hemangioma at the First Surgical Clinic-Clinical
Center of Serbia. The radiofrequency assisted (RF) se-
quentional “coagulat-cut liver resection technique” was
used for liver resection or enucleation of the hemangi-
oma. All operations were performed without any hepa-
tic vascular occlusion. Patient demographics, clinical
and pathological features, operative data, biochemical
parameters and outcome were analyzed.
Results: The median age of the patients was 52 years
(range, 35–63); 22 patients (73%) were female. Indica-
tions for surgery were abdominal pain (50.0%); rapid
increase size (26.7%); and uncertain diagnosis (23.3%).
The median tumor size was 9.3 cm (range, 1–40). Two
patients (6.7%) underwent RF enucleation, 11 (36.7%)
subsegmental resection, three (10.0%) segmentectomy, 9
(30.0%) bisegmentectomy and 5 (16.7%) patients hemi-
hepatectomy. The median specimen weight was 526.67 g
(range, 50–1500 g). Three (10%) patients required intra-
operative blood transfusion, and the postoperative trans-
fusion rate was 3.33%. Postoperative complications
included biliary fistula in two (6.66%) patients and spon-
taneous small bowel perforation in one (3.33%) patient.
There was no postoperative mortality.
Conclusions: RF assisted liver resection and enucleation
for giant liver hemangiomas is safe and has low mor-
bidity and mortality rate.
1324
LAPAROSCOPIC LATERAL
PANCREATICO JEJUNOSTOMY IN A
PATIENT WITH MULTIPLE
ABDOMINAL SCARS
Rao PP and Bhagwat S
Mamata Hospital, Dombivli East, India
Laparoscopic Pancreatico jejunostomy can be in itself a
challenging procedure but more so in a abdomen with
multiple scars. We present a case of a young patient
who presented with chronic pain in the abdomen
related to chronic pancreatitis and a dilated pancreatic
duct. The patient had undergone 4 prior laparotomies
for unrelated diseases. After some hesitation in offering
to do the procedure laparoscopically, we managed to
safely enter the abdomen and after extensively adhesiol-
ysis, we managed to achieve a successful laparosopic in-
tracorporeal lateral pancreatic jejunostomy with a good
end result. We submit that a previously scarred and
scary looking abdomen shouldn’t deter one from offer-
ing the benefit of minimal access surgery for major sur-
gery to a patient as this can be frequently achieved and
the benefit of minimal access of the present surgery
stands on its own merit despite the previous scars. The
video also depot the complications created and man-
aged in the course of this surgery.
© 2013 The Authors
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1330
QUALITY OF LIFE AFTER MAJOR
SURGERY FOR HEPATOBILIARY AND
PANCREATIC CANCER
Aditya Shriya, Mehmood Ahmed Wani, Bejoy
Abraham and H. Ramesh
Lakeshore Hospital & Research Center, Cochin, Kerala,
India
Introduction: The outlook in pancreatic and hepatobil-
iary (HBP) cancers continues to be grim. Recent
reports demonstrate improving outcomes in 5 year sur-
vival. Over the last 10 years the importance of Quality
of life (QOL) in cancer patients has been highlighted,
as overall survival does not necessarily translate to a
meaningful or beneficial outcome unless there is a good
QOL.
Aims: Since studies reporting QOL after major surgery
for HBP are scarce, the aim of this study is to examine
the QOL after major surgery for HPB cancers
Materials and Methods: 55 patients undergoing major
surgery for HPB cancers were enrolled for the study.
The European Organization for Research and Treat-
ment of Cancer (EORTC) modular questionnaires were
used after conversion to Malayalam (local language).
EORTC QLQ-C30 was used as a general cancer ques-
tionnaire and QLQ HCC18, QLQ PAN 26 and QLQ
BIL 21 were used as specific questionnaires for Hepato-
cellular, Pancreatic and Biliary cancers respectively. All
patients completed the questionnaires preoperatively
and then during follow up at 3, 6 12 and 18 months.
Collected data was then analyzed using SPSS version
20 (wilcoxon test or Mann Whitney test as appropriate)
Results: The mean age in the study was 56.7 (Range 31
–78). Three groups were studied separately: pancreatic,
hepatic and biliary. Overall 28 (51%) patients devel-
oped complications. During follow up a total 4 (7.2%)
patients died and recurrence was noted in 9(16.3%)
patients. In the pancreatic group significant QOL
improvement was noted in functional scales of global
health (p = 0.007), emotional (p = 0.004), physical
(p = 0.035) and cognitive functions (p = 0.017) and
symptom scales of pain (p = 0.001), fatigue (p = 0.009),
sleep (p = 0.007) and appetite (p = 0.008). Diarrhea
was noted to worsen significantly (p = 0.013). Intra-
operative blood transfusion, operative time, venous
resection, stage and pathology, complications did not
show significant influence on the postoperative QOL.
The hepatic and biliary groups showed improvement in
most scales as compared to preoperative values. How-
ever statistical significance was only noted in global
health (p = 0.04) and fatigue (p = 0.04) in the hepatic
group.
Conclusions: QOL improves after major resection for
HPB cancers. In pancreatic cancer, QOL scales are not
affected by duration of surgery, intra-operative blood
loss, venous resection, stage, pathology, complications
and adjuvant chemotherapy. Further studies with large
sample size and longer follow up are required.
1351
UNIQUE GENETIC ALTERATIONS AND
CLINICOPATHOLOGICAL
CHARACTERISTICS OF
HEPATOCELLULAR ADENOMAS IN
CHINA
HP Liu, HH Fu, GZ Jin, YW Qian, H Dong, YJ Gu
and WM Cong
Department of Pathology, Eastern Hepatobiliary
Surgery Hospital, Second Military Medical University,
Shanghai, China
Background and Aims: Hepatocellular adenomas
(HCAs) are common benign hepatocellular tumor
and are frequently associated with young women on
oral contraceptives (OCs) in European countries but
not in China. Recently, HCAs have been classified
into 4 subtypes based on genotype and phenotype
correlations by European experience. In order to dis-
cover authoritative genetic mutation types, related
gene microsatellite instability (MSI) and the corre-
sponding clinicopathological characteristics of HCAs
in China.
Methods: Among 189 HCAs of our single center, we
randomly selected 36 cases for sequencing HNF1A, b-
catenin and gp130, 60 cases for MSI detection. The
correlations between gene mutations, gene MSI and
clinicopathological features were analyzed.
Results: Compared with previous European studies,
male patients with HCAs displayed a dominant sex
ratio of 2.32 : 1, and only two females had taken
oral contraceptives in this study. All detected 36
HCAs had HNF1A mutations (including 78% mis-
sense mutation and 22% synonymous mutation), but
no mutations of b-catenin and gp130 were found.
Two new missense mutations hotspots of HNF1A
were identified at codons 1460G>A, S487N (n = 17,
47%) and 79A>C, I27L (n = 10, 27.8%), a common
SNP site (rs1169304) in the intron 9 of HNF1A was
found in 32 of 36 (88%) HCAs. Analysis of MSI of
34 overweight/obese patients suggested pathogenesis
of Chinese HCAs were associated with metabolic dis-
turbances of various relevant, including HNF-1a inac-
tivated pathway (D12S1398) and HIPPO pathway
(D6S1064).
Conclusions: Contrast to the European reports, the
current study suggested that Chinese HCAs were fre-
quent in males and overweight/obese patients, accom-
panying by related pathological molecular variation,
which were also quite different from European
reports.
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1383
HEPATITIS B VIRUS X PROTEIN
TRANSCRIPTIONALLY ACTIVATES
SMYD3 TO ENHANCE
HEPATOCARCINOGENESIS
Jun-Yao Xu1, Qing-Qi Hong2, Chuan-Chao He1,
Hua Ye1 and Jie Wang1
1Department of Hepatobiliary Surgery, Sun Yat-Sen
Memorial Hospital, Sun Yet-Sen University, 33
Yingfeng Road, Guangzhou, 510288 China; 2Department
of General Surgery, the First Affiliated Hospital of
Xiamen University, 55 Zhenhai Road, Xiamen, 361003
China
Background & Aims: Hepatitis B Virus-encoded X pro-
tein (HBx) is strongly related with HBV-associated
hepatocellular carcinogenesis and the oncogenic poten-
tial of HBx largely lies in its function of transcription
transactivation on targeted genes. SET and MYND
domain containing 3 (SMYD3) is a newly identified
histone methyltransferase (HMT) participating in epige-
netic modifications and highly expressed in HCC. The
present study is to identify SMYD3 as a target gene of
HBx and explore the role of SMYD3 in HBx-induced
hepatocarcinogenesis.
Methods: The expression of HBx and SMYD3 in
HBV-related HCC samples were detected by immuno-
histochemical staining and western blot. HBx gene
transfection, RNAi, and histone methyltransferase (H3-
K4) activity assay were performed to reveal the regula-
tory effect of HBx on the expression and activity of
SMYD3 in HCC cell lines. Chromatin immunoprecipi-
tation (ChIP), Co-immunoprecipitation (Co-IP), and
Dual-luciferase reporter assay were applied to investi-
gate the underlying mechanism. The biological function
of HBx-mediated SMYD3 upregulation was evaluated
by cell proliferation assays and tumorgenesis in nude
mice.
Results: The expression of SMYD3 was significantly
correlated with HBx expression in HCC samples
(p = 0.008). Ectopic over-expression of HBx upregulat-
ed SMYD3 expression and enhanced its HMT activity
in HepG2 cells, while knockdown of HBx reduced
SMYD3 expression and activity in HepG2.2.15 cells.
HBx transcriptionally upregulated SMYD3 gene
expression by interacting with transcription factor Neu-
rogenic differentiation factor 1 (NeuroD1) via a novel
HBx-responsive element. Moreover, decreasing the
expression of SMYD3 in HepG2-HBx cells inhibited
cell proliferation in vitro and reduced tumor formation
in vivo.
Conclusions: HBx transcriptionally upregulates
SMYD3 expression to enhance HBx-induced hepato-
carcinogenesis.
1384
TARGETING TUMOR HYPOXIA IN
PATIENT-DERIVED PANCREATIC
XENOGRAFT USING TH-302
Jun-Yao Xu1, Inus Lohse2, Pin-Jiang Cao2, David
Hedley2, Hua Ye1 and Jie Wang1
1Department of Hepatobiliary Surgery, Sun Yet-Sen
Memorial Hospital, Sun Yet-Sen University, 33
Yingfeng Road, Guangzhou, 510288 China; 2Department
of Medical Oncology, Princess Margaret Hospital,
Ontario Cancer Institute, 610 University Ave, Toronto,
M5G2M9
Background and aims: The hypoxia-activated cytotoxic
prodrug TH-302, specifically and selectively targets
extreme hypoxia found in solid tumors and is therefore
believed to not only increase the treatment response of
the primary tumor but also reduce tumor recurrence
and metastasis. We examined its effect in xenograft
models of human pancreatic carcinoma.
Methods: We used 7 patient-derived primary pancreatic
pancreatic xenograft models with varying levels of
hypoxia to examine the effect of TH-302 on tumor
growth, following treatment with TH-302 alone, or in
combination with ionizing radiation (IR). Mice received
a chronic treatment with TH-302 alone, IR alone or
the combination treatment; where TH-302 treated mice
received 3 doses of 50 mg/kg TH-302 and IR treated
mice received 2 Gy on 3 consecutive days.
Results: The findings presented here demonstrate that
TH-302 specifically targets the hypoxic zone in the
xenograft models inducing DNA damage as measured
by cH2AX staining in tumor tissue as well as in adja-
cent normoxic regions. TH-302 treatment efficiency in
primary patient-derived xenograft depends on tumor
hypoxia and growth rates. While showing high treat-
ment efficiency even as a single agent in fast-growing
hypoxic models, TH-302 treatment had no effect on
tumor growth in slow growing models independent of
the hypoxia level.
Conclusions: Our results demonstrate that TH-302 may
provide a promising therapeutic option for patients
with fast-growing hypoxic tumors. Consistent with our
findings, TH-302 has been reported to show antitumor
activity in Phase 1 clinical trials.
1393
SINGLE STEP MANAGEMENT USING
2 MM FORCEPS FOR INCIDENTALLY
DIAGNOSED COMMON BILE DUCT
STONES
Akiko Umezawa, Tomomi Watanabe, Yosuke Seki,
Hirofumi Imoto, Kazunori Kasama and Yoshimochi
Kurokawa
Yotsuya Medical Cube, 7-7 Nibancho Chiyoda-ku
Tokyo, 1020084 Japan
Objective: To determine the feasibility of needle for-
ceps usinglaparoscopic common bile duct exploration
(CBDE) for incidentally diagnosed common bile duct
stones (CBDs).
Materials and methods: Conventional LC is performed
with 2 puncture and 2 incisions. 2 punctures are
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applied through thin caliber trocar Mini-Port (Covedi-
en, USA) with needle forceps BJ needle (Niti On Com-
pany, Japan). BJ-needle is a thin caliber grasper with a
diameter of 2.1 mm. The puncture sites are below the
right costal margin on the mid-clavicular line (MC)
and on the anterior axillary line of the navel level
(AA). We performed intraoperative cholangiography
(IOC) routinely during LC. Once confirming the diag-
nosis of CBDs with IOC, laparoscopic CBDE was car-
ried out according to the number and size of stones.
The number less than four and the size under 8 mm
was the indication for trans-cystic duct exploration
(LTCE). Others were indicated for transcholedochal
exploration (LCHE).
Results: There was no complication caused by using
BJ-needle. IOC had been performed through Mini-
Port with catheter. Its success rate was 99%. Of 771
LC cases, there were 26 cases of CBDE. Incidentally
diagnosed CBDs were detected in 11 patients. Those
were 1.5% who received IOC. 9 out of 11 patients
were performed LTCE. There was one case switched
to LCHE from LTCE because of tears off the cystic
duct. During LCHE, BJ needle had sufficient ability
as suturing forceps which was comparable to 5 mm
forceps. The length of postoperative hospitalization
for LC was 2.0 days, LTCE was 2.3, and LCHE was
2.5.
Conclusions: BJ-needle was feasible for CBDE and
improved the cosmetic satisfaction. Especially, LTCE
shows uncomplicated post operative course which was
as same as LC alone. LTCE is feasible and should
be the first line of treatment for incidentally diag-
nosed CBDs and LCHE will be as redeeming
approach.
1394
LAPAROSCOPIC PANCREAS-SPARING
SUBTOTAL DUODENECTOMY IN
GASTROINTESTINAL STROMAL
TUMOR OF THE DUODENUM
Sung Hoon Choi, Chang Moo Kang, Ho Kyoung
Hwang and Woo Jung Lee
Department of Surgery, Yonsei University College of
Medicine, Pancreaticobiliary Cancer Clinic, Institute of
Gastroenterology, Yonsei University Health System,
Seoul, Korea
Background: Primary duodenal gastrointestinal submu-
cosal tumor (GIST) has a malignant potential. In well-
selected patients, however, minimally invasive resection
technique with gross negative margin is regarded to
have oncologic justification because status of the micro-
scopic margin of resection did not affect survival and
lymph node metastases are extremely rare. Although
organ-preserving operation for benign and borderline
duodenal tumors has been regarded as reasonable strat-
egy, laparoscopic pancreas-sparing subtotal duodenec-
tomy was rarely reported.
Methods: A 52-year-old female was admitted to our
institution because of general weakness, dizziness, and
poor oral intake. Her hemoglobin level was 5.5 g/dL.
Endoscopy and computed tomography revealed a
4.4 cm sized duodenal submucosal tumor at distal from
Ampulla of Vater (AOV). Laparoscopic pancreas-pre-
serving subtotal duodenectomy was scheduled.
Results: Endoscopic tattooing for localization of AOV
was performed preoperatively. A hard submucostal
duodenal tumor was identified and preservability of
AOV was determined at first measuring the distance
between the tumor and the tattooing site of AOV. Dis-
tal duodenum from AOV was meticulously dissected
from the pancreatic head to completely mobilize and
proximal duodenum was resected using endo-GIA at
distal from AOV. Duodenojejunostomy was anastomo-
sed by side-to-side pattern. Total working time was
about 5 hours, and blood loss was scanty. She returned
to an oral diet on postoperative day 3 and discharged
on postoperative day 7.
Conclusions: Laparoscopic pancreas-preserving subtotal
duodenectomy is feasible and attractive strategy in
well-selected benign or borderline duodenal tumors.
1396
MINIMALLY INVASIVE LIVER
RESECTION FOR HEPATOCELLULAR
CARCINOMA: FROM LAPAROSCOPIC
APPROACH TO ROBOTIC APPROACH
Dai Hoon Han, Gi Hong Choi, Eun Jung Park and Jin
Sub Choi
Department of Surgery, Yonsei University College of
Medicine, Seoul, South Korea
Background and aims: The robotic systems have been
recently introduced to improve a surgeon’s ability in
operative field. We investigated outcomes of minimally
invasive liver resection for HCC and attempted to
reveal the role of the robotic system for treatment of
HCC.
Methods: From March 2008 to September 2011, 151
consecutive patients underwent curative resection of
HCC. Case-matched analysis was performed and 31 of
35 patients with minimal invasive liver resection
(MILR) were matched to 48 patients with conventional
open liver resection (COLR).
Results: The tumors were more frequently located in
segments 2 to 6 in MILR group (74.2% vs. 39.6%,
p = 0.003). Although the extent and type of liver
resection was not different between the two groups,
the average operative time was significantly longer in
MILR group. The blood loss, transfusion rate and
postoperative complication rate were not significantly
different. Median length of stay in the hospital after
the operation was significantly shorter in MILR
group (8 vs. 12 days, p < 0.001). In MILR group,
major resection was only performed with robotic sys-
tem (n = 7). The 1-, 2-, 3-year disease-free survival
rate of MILR were 90.0%, 67.5%, and 60.0%
respectively, which were comparable to those of
COLR (p = 0.518).
Conclusions: Although operative time was longer in
MILR group, MILR showed similar postoperative
complication rate, significantly shorter hospital stay
and comparable oncologic results. According to the
complexity of procedures, the robotic surgery may
expand the indication of minimally invasive liver resec-
tion in patients with HCC.
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CASE REPORT: MASSIVE HEMOBILIA
SECONDARY TO ACUTE ARTERIO-
BILIARY FISTULA FOLLOWING ERCP
STENTING
Loh Wei Liang, Lee Chee Meng, June Lee, Andrew
Tan and Andrew Wong
Changi General Hospital, Simei Street, Singapore
529889, Singapore
Introduction: Hemobilia is a known complication of
endoscopic retrograde cholangio-pancreatography
(ERCP), and is usually due to bleeding at the sphinc-
terotomy site. Arterio-biliary fistula causing hemobilia
has been associated with neoplasms, biliary surgery,
percutaneous or angiographic hepatic instrumentation,
and inflammatory-infective causes. However, to our
knowledge, hemobilia secondary to an acute traumatic
arterio-biliary fistula following ERCP has not been
described before. This case report aims to highlight this
very rare complication to endoscopists who are faced
with hemobilia following ERCP.
Conclusions: Arterio-biliary fistula causing hemobilia
following ERCP stent placement is a rare but serious
complication. The presentation can still be delayed in
an acute traumatic arterio-biliary fistula, especially if a
biliary stent has been placed. Angiographic intervention
remains the best option for treatment.
1399
LOCAL DELIVERY OF VEGF BY
BIODEGRADABLE NANOFIBERS
IMPROVES PROLIFERATION OF
HEPATOCYTES FOLLOWING 70%
HEPATECTOMY IN RATS
Yuan-Quan Yu1, Xue-Song Jiang2,3, Rui Ma1, Song
Gao1, Yun Jin1, Xing Jin1, Shu-You Peng1, Hai-Quan
Mao2,3 and Jiang-Tao Li1
1Department of Surgery, Second Affiliated Hospital
Zhejiang University College of Medicine, 88 Jiefang Rd,
Hangzhou, China, 310009; 2Translational Tissue
Engineering Center, Johns Hopkins School of Medicine,
Baltimore, MD 21287, U.S.A.; 3Department of
Materials Science and Engineering, Whiting School of
Engineering, Johns Hopkins University, Baltimore, MD
21218, U.S.A.; 4Department of Clinical Laboratory,
Second Affiliated Hospital Zhejiang University College
of Medicine, 88 Jiefang Rd, Hangzhou, Zhejiang, China,
310009
Background and aims: Vascular endothelial growth fac-
tor (VEGF) serves as a crucial angiogenic factor in liver
regeneration. Rapid down-regulation of endogenous
VEGF of the remnant liver following 70% hepatectomy
may be a restrictive factor for liver regeneration. There
has been no effective method to locally deliver VEGF to
the liver immediately after hepatectomy. Here we report
a nanofiber-based VEGF delivery method and and eval-
uate its effect on improving liver regeneration by acceler-
ating proliveration of hepatocytes.
Methods: A total of 375 ng of exogenous VEGF164
was encapsulated in each biodegradable polycaprolac-
tone (PCL) nanofibers film using electrospinning
method. Rats were subjected to 70% hepatectomy.
Liver capsule of remnant lobes was torn in an area of
0.5 cm2 and covered with the film. Animals were
assigned into VEGF group or control group according
to whether the film was loaded with VEGF. After the
observation period, peripheral blood were collected for
liver function test. The remnant liver lobes were
removed. Liver body weight ratios (LBR) and regenera-
tive liver weight ratios (RLR) were calculated. Relevant
regenerative indexes were analyzed by H&E staining
and immunohistochemical staining with proliferating
cell nuclear antigen (PCNA) expression.
Results: The LBR and RLR was increased gradually
during 72 h postoperatively in both groups respec-
tively, but there were no statistical differences between
the two groups at 24 h, 48 h and 72 h. An obvious
increase of mitotic hepatocytes index and PCNA
labeling index was observed during the observation
period in both groups. The numbers of mitotic and
proliferous hepatocytes increased markedly in the
VEGF group. At 48 h and 72 h, the two indexes were
higher in the VEGF group than that in the control
group with statistic significances. Liver function tests
revealed no significal differences between the two
groups.
Conclusions: Biodegradable PCL nanofiber film served
an appropriate vehicle provides a convenient and effec-
tive method for local delivery of exogenous VEGF to
the remnant liver following hepatectomy, which could
accelerate proliferation of hepatocytes. This method
might be a valuable strategy for improving liver regen-
eration. Optimization of VEGF dose and release rate is
currently ongoing. Other novel administrative pathways
such as via the porral vein or the bile duct are antici-
pated.
1400
SUBJECT REVIEW OF DIAGNOSIS AND
TREATMENT FOR LIVER METASTASES
OF PANCREATIC ENDOCRINE
TUMORS IN CHINA: THE REPORT OF
133 CASES
Yun Jin, Yuan-Quan Yu, Xin Jin, Shu-You Peng and
Jiang-Tao Li
Department of Surgery, Second Affiliated Hospital
Zhejiang University College of Medicine, Hangzhou,
China, 310009
Background and aims: Pancreatic endocrine tumors
(PETs) are rare diseases, liver metastases of endocrine
tumors are more than 50%, only 10% to 20% of
patients with liver metastases are eligible for resection.
The aim of this report was to review the experiences
for liver metastases of pancreatic endocrine tumors in
China.
Methods: Three major Chinese full text databases were
retrieved, (1) Chinese Journal Full Text Database
(http://dlib.cnki.net/kns50/), (2) Wan Fang Data
Resource System (http://www.wanfangdata.com.cn/),
(3) Wei Pu Chinese Scientific Journal Database (http://
www.cqvip.com). The MESH search terms were pan-
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creatic endocrine tumor, hepatic/liver metastases, diag-
nosis, treatment.
Results: Total of 25 related papers were retrieved,
including 5 reviews and 20 original reports. From Janu-
ary 1968 to October 2011, 133 cases of PETs with liver
metastases were summarized. Pathology diagnosis were
achieved in 129 cases (Table 1). 79 cases were under-
went surgery (59.3%), hepatic arterial chemotherapy or
embolism was used in 42 (42/133, 31.58%), systemic
chemotherapy, radiotherapy, radiofrequency ablation
was used in 24 (24/133, 18.05%), respectively. In 79
patients who with surgery, 35 cases were underwent the
synchronous resection of primary lesion and hepatic
metastasis (35/79, 44.30%), 40 cases were treated by
primary lesion of resection (include primary lesion rem-
ovel and liver biopsy)(40/79, 50.63%), liver transplanta-
tion was underwent in 1 (1/79, 1.27%), hepatic
metastasectomy in 3 (3/79, 3.80%). 1 died of intra-
abdominal infection and multiple organ failure after
operation. For those patients with resection overall sur-
vival was 6 months to 4 years.
Conclusions: For resectable metastatic liver tumor, sur-
gical resection is still the optimum modality. While pri-
mary PETs are resectable with unresectable metastatic
liver tumor, curative resection may simply be a more
thorough cytoreductive operation for primary tumors.
For surgery is not feasible, radiofrequency ablation,
radiotherapy and systemic chemotherapy even liver
transplantation can be used for control of symptoms
and for cytoreduction in patients with liver dominant
metastases.
1402
LIVER RESECTION WITH VASCULAR
RECONSTRUCTION
Miyazaki Masaru, Shimizu Hiroaki, Ohtuka Masayuki,
Yoshidome Hiroyuki, Kimura Fumio, Kato Atsushi,
Hideyuki Yoshitomi and Katsunor
Department of General Surgery, Graduate School of
Medicine, Chiba University, Japan
The combined vascular resection for obtaining the
curative resection for hilar cholangiocarcinoma has
been usually required due to its anatomical specificity.
Portal vein, hepatic artery, hepatic vein, and IVC are
usually involved by various biliary tract cancer such as
hilar cholangiocarcinoma and intrahepatic cholangio-
carcinoma, and gallbladder cancer. For obtaining a
curative resection, combined resection of these vessels
should be required, and also should be safely done
without bringing about serious surgical complications.
However there have been reported to occur several
complications sometimes after combined vascular resec-
tion. In our series combined portal vein resection might
improve survival after resection in the patients with
hilar and intra-hepatic cholangiocarcinoma without
increasing surgical mortality. However, the hepatic
artery resection might not always bring about the bene-
ficial effect on the long-term prognosis in most patients.
Therefore combined vascular resection might be applied
to some patients with advanced biliary tract carcinoma
with strict patient selection to obtain its beneficial effect
on the prognosis of the patients. Herein, our surgical
technique of combined vascular resection of the portal
vein, hepatic artery, and inferior vena cava for the
patients with advanced biliary tract carcinoma would
be presented with the video.
1403
SURGERY FOR HILAR
CHOLNAGIOCARCINOMA
Masaru Miyazaki, Hiroaki Shimizu, Hiroyuki
Yoshidome, Masayuki Otuka, Atsushi Kato, Hideyuki
Yoshitomi and Katsunori Furkawa
Department of General Surgery, Chiba University
Graduate School of Medicine, Japan
There are several procedures of hepatectomy for the
surgical treatment of hilar cholangiocarcinoma. Right
sided hepatectomy, left sided hepatectomy, central hep-
atectomy such as parenchyma-preserving hepatectomy,
extended hilar bile duct resection using transhepatic
anterior approach. Portal vein, hepatic artery, hepatic
vein, and IVC are usually involved by advanced hilar
cholangiocarcinomas. Surgical margin-free, curative
resection has brought about 37% of 5-year survival.
On the contrary, non-curative resection has resulted in
5.6% of 5-year survival, which was significantly worse
than that of the curative resection group, but signifi-
cantly better than the survival of the irresectable
patients. In the curative resection, the non-vascular
resection group had significantly better survival than
the vascular resection group, 42% of 5-year survival
rate. The survival after resection was not significantly
different between two groups of right-sided and left-
sided hepatectomies. Left-sided hepatectomy is a safe
procedure and represents the only curative resectional
option for type IIIb hilar cholangiocarcinoma. How-
ever, there are many cases of initially unresectable or
boderline respectable locally advanced cholangiocarci-
noma. Recently, an improved efficacy has been
revealed in patients with initially unresectable locally
advanced cholangiocarcinoma to improve the progno-
sis by the advent of useful cancer chemotherapy. We
evaluated the effect of downsizing chemotherapy in
patients with initially unresectable locally advanced
cholangiocarcinoma. Chemotherapy with gemcitabine
and/or CDDP was given to 22 patients with initially
unresectable locally advanced BTC. Tumor was signifi-
cantly down-sizing in nine patients and surgical resec-
tion was performed in eight of 22 patients (36.4%).
Surgical resection resulted in R0 resection in four
patients and R1 resection in four patients. Patients
who underwent surgical resection had a significantly
longer survival compared with those unable to
undergo surgery. Preoperative chemotherapy enables
the down-sizing of initially unresectable locally
advanced cholangiocarcinoma, with radical resection
made possible in a certain proportion of patients.
Down-sizing chemotherapy should be proactively car-
ried out as a new multidisciplinary treatment strategy
for the patients with initially unresectable locally
advanced cholangiocarcinoma for the aim of expand-
ing the surgical indication.
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PELIOSIS HEPATIS: A RARE CAUSE OF
MULTIPLE SPACE OCCUPYING
LESIONS IN THE LIVER
Chinthakindi Madhusudhan, Komanduri Suneetha, D.
V. L. Narayan Rao and R. Pratap Reddy
Department of Surgical Gastroenterology, Osmania
General Hospital, Hyderabad, AP, India
Background: Peliosis Hepatis is a rare benign vascular
condition characterized by randomly distributed multi-
ple blood-filled cavities throughout the liver which can
be seen in a variety of settings. Image findings often
mimic true tumors and strongly enhance on arterial
phase on CT/MRI. Persistant contrast uptake within
the lesion is due to blood- pooled condition. We pres-
ent a case report on this condition.
Methods: A 60 years female presented with pain upper
abdomen of 2 days duration associated with vomitings.
Past history of similar attack was present 8 years back,
received symptomatic treatment in another hospital. On
examination she found to be well built and well nour-
ished. Abdominal examination revealed tenderness in
right hypochondrium and epigastric area. Hepatomeg-
aly was present. Blood investigations show leukocytosis
and elevated serum lipase levels. Blood and urine cul-
tures were negative. Viral screening was non reactive
for HIV, HCV and HBV.
Results: Ultra sound abdomen was showing multiple
well defined hypo echoic lesions in both lobes of
liver. Doppler was showing increased vascularity .CT
abdomen showing multiple well defined densely
enhancing lesions in both lobes of liver. These lesions
are isodense to liver on noncontrast CT and follow-
ing contrast administration there was a arterial
enhancement with no washout, the lesion remaining
slightly hyper-attenuating compared to surrounding
liver on portal venous phase. Magnetic resonance
image (MRI) Findings: These lesions are not well
visualized on MRI and are seen as faint hyper inten-
sities on T2WI. Contrast MRI was not performed.
Fine needle aspiration cytology from these lesions
revealed only blood elements.
Conclusions: It is usually asymptomatic found inciden-
tally on imaging or autopsy, but can present as hepato-
megaly, jaundice, liver failure, hemoperitoneum. It is
important to recognize the imaging characteristics of
peliosis hepatis because these lesions mimic several dif-
ferent types of focal hepatic lesions. Most commonly
identified in the liver the same process may also involve
kidney, spleen, lymph nodes, bone marrow and gut. It
is associated with many conditions and treatment
involves the underlying cause.
1408
ISOLATED CAUDATE LOBE
RESECTION (THE “ALTERNATING
LEFT-RIGHT-LEFT APPROACH”)
Chinthakindi Madhusudhan, D. V. L. Narayan Rao,
R. Pratap Reddy, Moksha Prasuna, T. Ravimohan and
J. Vinod Kumar
Department of Surgical Gastroenterology, Osmania
General Hospital, Hyderabad, AP, India
Background: The caudate lobe is an autonomous seg-
ment of the liver. Isolated caudate lobe resection is a
complex surgical procedure that requires technical
expertise and knowledge of the surgical anatomy. Cur-
rently, hepatic hemangioma is the most frequently diag-
nosed benign liver tumor and is the most frequently
resected non-malignant liver tumor. We present here a
case report on isolated caudate lobectomy for hae-
mangioma of liver.
Patient and Methods: A 45 year male presented with
pain upper abdomen of 2 months duration. Triphasic
CT abdomen revealed an 8 9 7 cm size haemangima
involving the caudate lobe. Blood investigations were
within normal limits. He underwent isolated caudate
lobe resection using the “alternating left-right-left
approach”.
Results: Operative time was 140 min; with blood loss
of around 750 mL. patient developed significant bleed-
ing 8 hours after surgery, which was managed with rel-
aparotomy and suture ligation of bleeding vessels.
Patient had minor bile leak managed conservatively.
Patient was discharged on the 14th postoperative day.
Conclusions: For large hemangioma of the caudate
lobe, surgery is only recommended for symptomatic
cases. Caudate lobectomy of hepatic hemangioma can
be performed safely, provided it is carried out with
optimized surgical judgment and detailed knowledge of
the caudate lobe anatomy. It is, however, associated
with increased perioperative risks.
1409
POST TRAUMATIC HEPATIC ARTERY
PSEUDO ANEURYSM: PERCUTANEOUS
EMBOLIZATION WITH GLUE
Chinthakindi Madhusudhan1, Vinod Jyothiprakasan2,
Kesava Rao R. C2, Shashidhar Kaza2, D. V. L.
Narayan Rao1 and R. Pratap Reddy1
1Department of Surgical Gastroenterology, Osmania
General Hospital, Hyderabad, AP, India; 2Department
of Radio Diagnosis, Mediciti Hospitals, Hyderabad, AP,
India
Background: Post traumatic hepatic artery pseudo
aneurysm is uncommon, appearing in approximately
1% of hepatic trauma cases. Currently the treatment of
choice is endovascular embolization with coils or cov-
ered vascular stents or open surgery. We describe the
case of a hemobilia following the rupture of post trau-
matic hepatic artery pseudo aneurysm. This was suc-
cessfully treated by percutaneous injection of
cyanoacrylate glue under sonographic guidance.
Patient and methods: We describe the case of a young
boy with blunt trauma abdomen having a large hepatic
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laceration associated with pseudo aneurysm of the right
hepatic artery .The latter was suspected on day 15, with
a triphasic CT abdomen and CT angiography. The
pseudo aneurysm was arising from a segmental branch
of the right hepatic artery, which was managed with
trans hepatic percutaneous embolization with cyanoac-
rylate glue under ultrasound guidance.
Results: Patient had mild pain abdomen after the pro-
cedure which was managed symptomatically. Post pro-
cedure CT angiography showed total obliteration of
pseudo aneurysm without compromising the blood flow
to the liver.GI bleeding was stopped and patient’s gen-
eral condition was improved after the procedure.
Conclusions: Hepatic artery pseudo aneurysm is a
potentially life threatening vascular disorder usually
treated with vascular embolization or vascular stenting.
However, ultrasound guided percuataneous glue/throm-
bin injection may be considered as an alternative to
embolization or surgical therapy for this condition.
When compared to angio embolization, this method is
simple, easily available and avoids hepatic infarction.
1410
SAFE HEPATIC RESECTIONS FOR
GIANT HAEMANGIOMAS OF LIVER
Chinthakindi Madhusudhan, D. V. L. Narayan Rao,
R. Pratap Reddy and J. Vinod Kumar
Department of Surgical Gastroenterology, Osmania
General Hospital, Hyderabad, AP, India
Background: Hepatic haemangiomas are the most com-
mon benign tumours of the liver. Surgical treatment
for symptomatic giant haemangioma can be difficult as
a result of the high risk of intraoperative haemorrhage.
However, such surgery is treating a benign condition,
so it is essential to minimize surgical morbidity and
mortality. Surgery can be Enuclation or Hepatic resec-
tions. Enucleation is dangerous when the lesion is large
occupying entire lobe or deep seated. The present study
highlights the need of safe hepatic resections for symp-
tomatic giant haemangiomas.
Methods: 12 patients with symptomatic giant hepatic
haemangioma (>5 cm) underwent hepatic resections at
the Osmania General Hospital, Hyderabad between
July 2007 and August 2011. Patient demographic, clini-
cal, and surgical characteristics and outcomes were
reviewed retrospectively. Inclusion criteria’s are symp-
tomatic haemangioma of >5 cm size, diagnostic uncer-
tainty or presence of complications. Exclusion criteria’s
are asymptomatic haemangioma of any size or symp-
tomatic haemangioma <5 cm.
Results: 10 females and 2 male patients underwent hep-
atectomies during the study period. The median age
was 30 years (range, 3 to 60 years). Indications for sur-
gical interventions were abdominal pain (66.6%), an
increasing abdominal mass (25%), and diagnostic
uncertainty (8.3%). The haemangioma were solitary in
83.3%, multiple (8.3%) and bilobar (8.3%) and had a
median size of 14.5 cm (range, 7 to 27 cm). 4 patients
underwent Right hepatectomy, 3 patients required left
hepatectomy, 1 needed Right extended hepatectomy, 1
left extended hepatectomy, 1 mono segmentectomy and
1 underwent caudate lobectomy. All patients underwent
anatomical hepatic resections with early selective extra
hepatic vascular control using the conventional hepatic
transection method. Parenchymal transaction done with
harmonic scalpel. There was no major morbidity or
mortality. The minor morbidity rate was 25% with
transfusion rate of 25%.
Conclusions: Enucleation is risky when the lesion is
very large involving entire lobe or when lesion is deeply
located in hepatic parenchyma. Resections were safe in
large lesions. Early selective extra hepatic vascular con-
trol is essential for safe resection of large hepatic hae-
mangioma.
1412
PORTAL BILIOPATHY – ROLE OF
SHUNT SURGERY
Avinash Kumar, Rajneesh Kumar Singh and Rajan
Saxena
Sanjay Gandhi Post Graduate Institute of Medical
Sciences, Raebarielly Road, Lucknow, India
Background: Portal cavernoma from extrahepatic por-
tal vein obstruction leads to several changes in extrahe-
patic bile ducts like strictures and/ or stones in the bile
ducts. The treatment of such symptomatic portal bili-
opathy is complex due to the risk to torrential hemor-
rhage during surgical or nonsurgical intervention.
Aim: We analyzed our experience over the last 20 years
with the surgical treatment of symptomatic portal bili-
opathy by retrospective chart review.
Results: We treated 38 patients with symptomatic por-
tal biliopathy with surgery over the last 20 years. The
M : F ratio was 25 : 13 and the mean (SD) age was
29.8(11.6) years. The clinical presentation was
obstructive jaundice in all, with cholangitis in 20 and
upper gastro-intestinal bleed in 25 patients. In all
except 1 patient the etiology of portal vein obstruction
was idiopathic. One patient had chronic pancreatitis
with portal vein block. The serum bilirubin was mean
(SD) = 9.31(8.6) mg/dL. Six patients had had prior
attempted cholecystectomy in other hospitals. Portal
biliopathy could be classified as (Group A) bile duct
strictures (n = 17), (Group B) bile duct stones (n = 7)
and (Group C) both strictures and stones (n = 14).
Overall, staged surgery (decompressive shunt only at
first surgery) was done in 31, simultaneous surgery (de-
compressive shunt and biliary surgery) was done in 2
and only biliary surgery was done in 5 patients. In
those who underwent staged surgery, decompressive
shunt surgery alone was sufficient for treatment in 15
patients. The rest underwent biliary surgery (n = 5),
endoscopic stenting (n = 8), neither (n = 2) and intra-
operative mortality (n = 1). Group A (n = 17) under-
went staged surgery (n = 16) and simultaneous surgery
(n = 1). Group B (n = 7) underwent staged surgery
(n = 5) and biliary surgery (n = 2). Group C (n = 14)
underwent staged surgery (n = 10), simultaneous shunt
and biliary surgery (n = 1) and only biliary surgery
(n = 3). The overall followup was (mean) (SD) 2.33
(2.23 years). The morbidity included re-exploration
(n = 6) and massive hemorrhage (n = 2). The overall
postoperative mortality was 1(+1 LAMA) patients.
Overall, the treatment was successfully completed in 21
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patients. A few patients (n = 13) are still under treat-
ment with stent exchanges.
Conclusions: Symptomatic portal biliopathy is a com-
plex problem requiring a multidisciplinary approach.
Staged surgical procedure is desirable to avoid massive
hemorrhage during biliary surgery. Decompressive
shunt alone is sufficient treatment in almost half the
patients.
1430
MIR-101 INHIBITS AUTOPHAGY AND
ENHANCES CISPLATIN-INDUCED
APOPTOSIS IN HEPATOCELLULAR
CARCINOMA CELLS
Yong-Hua Xu, Yun Wang, Chang-He Zhang, Hai
Zhang, Chang-Jun Huang, Hao Jiang, Xue-Hao Wang
and Xiang-Cheng Li
Liver Transplantation Center, First Affiliated Hospital of
Nanjing Medical University, Key Laboratory of Living
Donor Liver Transplantation, Ministry of Public Health,
Guanzhou Road 300, Nanjing 210029, P.R. China
Hepatocellular carcinoma (HCC) ranks third in cancer
deaths because of late diagnosis and poor treatment
option. Autophagy is a lysosome mediated protein and
organelle degradation process which is characterized by
the formation of double-membrane vesicles, named as
autophagosomes. Recently, more and more evidences
showed that autophagy functions as a survival mecha-
nism in liver cancer cells against drug-induced apopto-
sis. In this study, we found that autophagy was
suppressed by miR-101 in HCC cell line Hep G2. miR-
101 inhibited autophagy via targets including RAB5A,
STMN1 and ATG4D. Moreover, miR-101 enhanced
apoptosis induced by cisplatin in cell line Hep G2. The
possible mechanism of this effect may be through inhi-
bition of autophagy. Our results indicate a novel and
important role for miR-101 and autophagy in chemore-
sistance of cisplatin in HCC. We propose that gene
therapy targeting miR-101/autophagy should be investi-
gated further as a potential alternative therapeutic
strategy for HCC.
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